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Abstract 
‘Axial spondyloarthritis’ (axSpA) is a term describing a group of immune-mediated 
rheumatologic diseases - the archetypical condition being ankylosing spondylitis (AS). The 
diseases predominately cause pain and stiffness of the spine, and can lead to spinal fusion. 
Although they can now be well managed, they are not curable - and since the usual age of 
onset is early adulthood, can be associated with a high burden of disease. Exercise has long 
been considered an essential ‘cornerstone’ of management, with general recommendations 
about regular exercise included in all recognised management guidelines. However, 
significant questions remain regarding specific exercise type, dosage and safety, and how 
exercise prescription should be tailored to the individual for optimal effect.  
The first part of this thesis seeks to assess the current literature for exercise interventions in 
AS and provide guidance to health professionals, by the development of an evidence-based 
consensus statement. The process included systematic reviews, with meta-analysis where 
sufficient evidence was available, for the topics of: assessment; monitoring; safety; 
exercise type; physical activity; concurrent medications; setting and adherence. Specific 
recommendations were generated by an expert panel for each topic, and are presented as a 
framework which facilitates adjustment according to assessment findings, that is, an 
individually tailored approach. 
A further knowledge gap is around the role of exercise designed to improve muscle fitness, 
that is, strength, power, endurance or motor control in axSpA.   Early findings suggest 
there are pathophysiological changes in muscles with axSpA and the lumbar paraspinal 
muscles are almost always symptomatic. Therefore, more information about morphology 
and pathophysiological changes (such as inter-muscular adipose tissue (IMAT)) of these 
muscles could inform future exercise trial design. The second part of this thesis presents an 
exploratory pilot study investigating the size, symmetry and quality of the paraspinal 
muscles in a cross-sectional sample of people with axSpA. The most important finding 
from the magnetic resonance imaging (MRI) measures, was that there was significant fatty 
infiltration in both multifidus and erector spinae muscles, with a distribution that was 
largely symmetrical and most prominent at the lower lumbar levels. These findings support 
the need to investigate interventions targeting paraspinal muscle fitness. 
In summary, the first set of evidence-based recommendations to guide exercise advice in 
AS, including important considerations such as safety, were developed. They are designed 
to be clinically useful, by incorporating a framework which can be adapted according to 
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individual needs. Information on morphometric muscle changes, and associated 
strengthening (resistance) exercise trials, are an identified knowledge gap. The pilot study 
findings of increased IMAT in a symmetrical distribution in the lower lumbar paraspinal 
muscles, may contribute to improved understanding of disease, and support the concept of 
evaluating an exercise program designed to improve paraspinal muscle fitness in axSpA. 
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Chapter 1: Introduction 
‘Axial spondyloarthritis’ (AxSpA) is a chronic, incurable, painful and physically disabling 
condition that affects several million people worldwide. Since onset is typically in early 
adulthood, the personal lifetime burden of disease can be high. Traditional best practice 
management has included a combination of anti-inflammatory medication and exercise – both 
to be taken daily, for life. Recent advances in pharmacological management have improved 
outcomes for some people with axSpA; however, exercise is still considered a ‘first line’ 
management. Despite consistent recommendations for lifelong exercise, there are knowledge 
gaps regarding the best exercise choices to achieve the best outcomes. This project aims to 
consolidate the evidence, and thus optimise exercise advice, for people with axSpA. 
1.1 What is axial spondyloarthritis? 
Spondyloarthritis nomenclature 
A group of immune-mediated arthritic diseases with a varied clinical phenotype are classified 
under the overarching term – ‘spondyloarthritis’ (SpA) – which is sub-divided into conditions 
affecting predominantly the peripheral (appendicular) and vertebral (axial) musculo-skeletal 
systems. These conditions are known as peripheral SpA (pSpA) and axial SpA (axSpA) 
respectively [1]. They share genetic and pathologic features, can be overlapping, and include 
psoriatic spondyloarthritis (PsSpA) and arthritis associated with inflammatory bowel disease, 
including Crohn’s disease [2].  
Ankylosing spondylitis (AS) is considered the archetypical axSpA condition [3]. The name is 
derived from the Greek words ‘angkylos’ meaning bent and ‘spondylos’ meaning spinal 
vertebrae [4], referring to the end point of untreated disease, that is, a spine that is fused in a 
position of kyphotic (flexed forward) deformity. By definition (see Figure 1.1), a diagnosis of 
AS must include at least mild-moderate structural damage to the sacro-iliac joints – sufficient 
to be seen radiographically on X-ray.  
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Figure 1.1 Assessment of SpondyloArthritis International Society (ASAS) criteria for 
Ankylosing Spondylitis.  
 
ASAS slides downloaded from website (https://www.asas-group.org/) 01/09/2018: slides may 
be used freely therefore specific permission not required. 
 
Increased knowledge over the last two decades led to the recognition of similar disease 
processes that are earlier or have less structural damage – hence the publication in 2009 of a 
new nomenclature and classification for the AS related conditions, as shown in figure 1.2 [5]. 
Within this classification, AS is considered a subset of the broader term ‘axSpA’, and can also 
be termed ‘radiographic axSpA’ – however, the AS ‘label’ remains in common use. Those 
who have similar clinical findings, but without at least moderate x-ray changes, are classified 
as having ‘non radiographic-axSpA’ (nr-axSpA). .  
In this thesis, ‘AS’ is used in Chapter 3, since at the time of the literature search there were no 
published exercise studies using the ‘new’ nomenclature. However, the more modern term of 
‘axSpA’ is predominantly used elsewhere 
 
Modified New York Criteria for 
Ankylosing Spondylitis (1984) 
1. Clinical criteria: 
a.Low back pain and stiffness for more than 3 months which 
improves with exercise, but is not relieved by rest. 
b.Limitation of motion of the lumbar spine in both the sagittal and 
frontal planes. 
c.Limitation of chest expansion relative to normal values correlated 
for age and sex. 
2. Radiological criterion: 
Sacroiliitis grade ~ 2 bilaterally or grade 3-4 unilaterally 
Definite ankylosing spondylitis if the radiological 
criterion is associated with at least 1 clinical criterion. 
van der Li nden Set al. Arth ritis Rheum 1984;27:361 
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Figure 1.2 Assessment of SpondyloArthritis International Society (ASAS) criteria for 
axial spondyloarthritis. Source: ASAS educational slide 
 
Epidemiology of axSpA 
Due to its heritable preponderance (further described below), the prevalence of axSpA varies 
across racial groups from 0.5 to 1% for AS and up to 1.4% for axSpA [6-8]. Since Tasmania’s 
population is largely of European origin [9], the population incidence is likely to be similar to 
that of Europe, that is, 0.54% – hence over 500 Tasmanians are likely to be affected by the 
condition. The incidence of axSpA in males and females is approximately equal, whilst more 
men than women are diagnosed with AS (that is, meet the radiographic criteria), in a ratio of 
3.1:2 [10]. The usual age of onset is during early adulthood, usually in the third decade of life, 
although up to 20% may experience their first symptoms before the age of 20 [11]. Written 
descriptions of skeletons with ankylosed spines appeared from the 16th century onwards [12], 
however, ancient skeletons with fused spines, belonging to Egyptian pharaohs and medieval 
Anglo-Saxons [12], provide evidence that AS has been affecting humans for considerably 
longer. 
AxSpA symptoms and signs 
The cardinal symptoms of axSpA are spinal stiffness and inflammatory back pain, which is 
ASAS Classification Criteria for 
Axial Spondyloarthritis (SpA) 
In patients with ~3 months back pain and age at onset <45 years 
Sacroiliitis on imaging* 
plus 
~1 SpA feature 
• sac roiliitis on imaging 
active (acute) inflammation on 
MRI highly suggestive of 
sacroiliitis associated with 
SpA 
definite radiographic 
sacroiliitis according to the 
modified New York criteria 
OR 
SpA features: 
inflammatory back pain 
arthritis 
enthesitis (heel) 
uveitis 
dactylitis 
psoriasis 
Crohn's/colitis 
good response to NSAIDs 
family history for SpA 
• HLA-B27 
elevated CRP 
Rudwale it M et a l. Ann Rheum Dis 2009;68:777-783 (with perm ission ) 
HLA-B27 
plus 
~2 other SpA features 
n=649 patients w ith back pain: 
Overall 
Sensi tivity : 82_9%. Specificity: 84 -4% 
!..!!lli9l.!]_ga_rm alone 
S ensitivity : 66.2%. Speci fi city: 97 .3% 
C l inical arm alone 
Sensitivity : 56.6%. Specificity: 83 .3% 
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further defined by the following criteria: spinal morning stiffness lasting more than 30 
minutes; nocturnal pain, especially during the second half of the night; improvement with 
exercise and not rest, and chronic back pain (present for more than three months) with onset 
before the age of 45 years [13]. Other common manifestations are enthesitis, which presents 
as tenderness and inflammation at ligament or tendon insertions (such as the Achilles tendon), 
joint effusions producing swelling (usually lower limb, for example the hip or knee) and 
fatigue. Extra-articular manifestations of the condition can include uveitis, inflammatory 
bowel disease (including Crohn’s) and psoriasis [7].  
Aetiology and pathophysiology 
The primary pathological change is enthesitis, that is, an inflammation at the anatomical 
region where ligaments, tendons or joint capsules attach to bone [3]. The enthesitis occurs at 
multiple sites and may be followed by osteitis, fatty degeneration of the adjacent bone 
marrow and secondary synovitis (Figure 1.3a,b) 
Figure 1.3 Magnetic resonance imaging and X-ray of the lumbar spine showing structural 
(bony) progression in axSpA.  
 
(a) osteitis, that is, active inflammation in the vertebral bodies; (b) fatty degeneration of  the 
bone marrow (dotted arrows), that is, part of the repair process that leads to syndesmophyte 
formation, and (c) syndesmophytes, that is, osteoproliferative repair.  
Adapted from Poddubnyy (2017) [14]. Permission granted by Springer Nature. 01/10/18; 
License Number 4440060734507 
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Disease localisation appears to be related to sites of higher biomechanical stress [6] – this 
includes the sacro-iliac joints in over 95% of cases. The subsequent healing process is thought 
to lead to exaggerated bone repair, resulting in the typical syndesmophyte formation, which 
can form a permanent ‘bridge’ over the joint space between one vertebra and another, as 
illustrated in figure 1.3c [14].  
Without treatment, progressive disease will result in a gradual reduction in spinal mobility, 
frequently with an increasingly kyphosed (flexed forwards) posture, as shown in figure 1.4. If 
spinal ankylosis occurs, the affected joints of the spine will become permanently fused by 
bony bridging, and when the entire spine is affected, this results in ‘total spinal ankylosis’ 
(TSA): the spine effectively becomes one ‘long bone’.  
This is the spinal ankylosis typical of AS, and these bony/ structural changes can mark the 
evolution of the disease process from nr-axSpA into AS.  
 
In addition to significantly restricting mobility, people who have advanced axSpA are 
predisposed to a number of disease consequences, resulting in a significantly raised all-cause 
mortality rate, with a hazard ratio of 1.6 compared to the general population [15]. Increased 
cardio-vascular disease is thought to be the leading cause of death [16], however, osteoporosis 
Figure 1.4 Person with advanced AS with 
total spinal ankylosis and severe thoracic 
kyphosis 
Source: ASAS Educational Slide  
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is the most common co-morbidity, it can occur within 10 years of symptom onset [17], and 
has a prevalence of over 50% [18, 19]. Due to the combination of osteoporosis and an 
ankylosed spine, there is an increased risk of both spinal fracture and associated spinal cord 
injury [20, 21].  Prevention of such disease sequelae by early diagnosis and optimal 
management is therefore paramount. However, as diagnosis is made by identification of a 
pattern of symptoms and signs, rather than one distinct or highly specific test, diagnostic 
delays remain common, and in Australia delays were found to be eight years on average [22].  
Causes of axSpA 
A number of predisposing associations with axSpA have been demonstrated, although their 
interactions and an exact pathophysiological sequence are not yet fully understood. Early 
descriptions recognised a familial component, and in 1973 an association with the human 
leucocyte antigen B27 (HLA-B27) was discovered [23]. The presence of HLA-B27 is thought 
to give an odds ratio for developing the disease of approximately 90, compared with those 
who are HLA-B27 negative [24]. However, since only about 5% of people with HLA-B27 
develop axSpA, it is accepted that the disease results from one or more gene-environment 
interactions [25]. One environmental contributing factor is considered to be the microbiome, 
with an association between structural axSpA imaging findings, abnormal mucosal 
permeability and subclinical gastro-intestinal histopathology [26, 27]. Moreover, a recent 
theory proposes another possible environmental contribution, in the form of biomechanical 
stress – such as micro-trauma to the sacro-iliac joints [28-30].  Section 1.6 further describes 
the latter concept, which contributes to the rationale for the second phase of this thesis. 
Diagnosis and assessment of axSpA 
In clinical practice, diagnosis takes into account many facets of a patient’s clinical findings, 
and the classification criteria may be interpreted more broadly for diagnostic purposes. For 
example,  expert clinical reasoning would also include consideration of absent findings and 
other (perhaps more subtle) clinical signs [2]. Although radiographic sacroiliitis is a 
requirement for AS diagnosis, modern imaging assessment for axSpA diagnostic and 
monitoring purposes is usually by magnetic resonance imaging (MRI) [31]. Additional 
disease monitoring tools are inflammatory blood markers (C-reactive protein (CRP) and 
erythrocyte sedimentation rate (ESR)), and a number of patient-reported outcome measures 
(PROMS) including the Bath AS Disease Activity Index (BASDAI) [32]. The most 
commonly used instrument for measuring axial mobility is the Bath AS Metrology Index 
(BASMI), which is a five-item index of spinal posture, lumbar spine flexion and lateral 
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flexion, cervical spine rotation and hip abduction [33].  
1.2  Management of axSpA 
Optimal axSpA management has long been established as comprising a combination of 
medical and non-medical management – the latter including education, exercise and other 
forms of physical therapy, rehabilitation and patient support groups , as illustrated in Figure 
1.5. 
Figure 1.5 Schematic diagram of the 2006 ASAS/ European League Against Rheumatism 
(EULAR) Guidelines for the Management of AS, indicating the long-established, relatively 
large contribution of exercise to AS management at all stages. 
Source: ASAS educational slide 
 
 
History of exercise and AS 
Although there was some early recognition that exercise could be helpful [35, 36], during the 
second world war there was an imperative to enable young men in the British armed forces, 
who developed AS, to continue active service. More vigorous attempts at therapeutic 
exercise, that is, Army ‘boot camp’ style training, were found to be surprisingly effective 
[37]. These observations were later supported by case series studies of patients admitted to the 
Royal National Hospital for Rheumatic Diseases in Bath, England, and exercise was 
ASAS/EULAR Recommendations for the 
Management of Ankylosing Spondylitis 
Education, 
exercise, 
physical 
therapy, 
NSAIDs 
I Sulfasalazine 
rehabilitation, 
patient 
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established as an integral part of AS treatment. To this day, it is recommended as a first line 
management [38, 39], and throughout the disease course, as shown in Figure 1.5. Currently, 
there are over twenty randomised controlled trials (RCTs), and subsequent systematic reviews 
with meta-analysis [40, 41], which consistently demonstrate benefits for exercise programs 
across a range of parameters, as described in Chapter 3.  
Note on terminology: 
‘Exercise’ is defined as “the prescription of a physical activity program that involves the 
client undertaking voluntary muscle contraction and/or body movement with the aim of 
relieving symptoms or improving function, or improving, retaining or slowing deterioration of 
health” [42] and physical activity as “any bodily movement produced by skeletal muscles that 
expends energy” [43]. Since these terms are defined by context, rather than the physiological 
effect produced, they are used interchangeably throughout this thesis. 
1.3 Why is optimal axSpA management (including exercise advice) 
important? 
Despite all the treatment advances, the personal and socioeconomic burden of axSpA remains 
high, and exercise remains integral to optimal disease management. Additionally, there is now 
a compelling body of evidence that regular physical activity is essential for health, quality of 
life and longevity, yet people with autoimmune rheumatic conditions such as axSpA face 
additional challenges in achieving recommended exercise levels. These factors are explored 
further in the following section. 
Medical management  
During the 20th century, various pharmacological treatments (such as Phenylbutazone and 
steroid preparations) and non-pharmacological therapies (such as radiotherapy and plaster 
jacket immobilisation) were trialed, and largely discontinued due to significant adverse 
effects. A group of medications known as ‘non-steroidal anti-inflammatory drugs’ (NSAIDs) 
became available from the 1960s: these were better tolerated and moderately effective for 
most [7].  
By the 1990s, more was known about the molecular and cellular pathology of axSpA and 
other types of inflammatory arthritis, allowing the development of a class of pharmacological 
treatments known as ‘biologic disease modifying anti-rheumatic drugs’ (bDMARDs), due to 
their capacity to down regulate specific antibodies and cells involved in autoimmune 
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inflammation [34]. The initial medications targeted tumour necrosis factor alpha (TNFα), a 
pro-inflammatory cytokine (cell signaling protein): and more recently other cytokines, such as 
Interleukin 17, have been targeted [2]. Taken together, the biologic medications have been a 
‘game changer’, with most people experiencing a large and rapid reduction in symptoms and 
(most likely) prevention of progression of the disease [6]. 
Biological DMARDs have allowed rheumatologists to aim for low disease activity or 
remission of axSpA – such that some patients may experience few symptoms and have 
normal physical function. However, this is most readily achieved if treatment is commenced 
during early disease (the so called ‘window of opportunity’), as if structural damage has 
already taken place, it cannot be reversed. Since the medications are expensive, people with 
axSpA have to meet specific criteria to receive subsidised medication, and the expected 
improvements are not universal. Therefore, the management of axSpA remains challenging, 
even with more effective medications. 
Personal impact of axSpA 
Due to the broad spectrum of disease severity, the personal impact of axSpA may vary from 
‘minimal’ to ‘devastating’ [44]. Since the usual life stage of onset is early adulthood, the 
cumulative burden of symptoms (including pain, fatigue, stiffness and sleep disturbance) and 
signs (such as loss of joint range /mobility and spinal deformity) can be large, significantly 
impacting on life choices including occupation, leisure activities and personal relationships 
[45]. A reduction in quality of life (QoL) and physical function can precipitate psychological 
distress, which may be exacerbated by a delay in diagnosis [46]. 
A further source of psychological distress is progression to spinal ankylosis with a postural 
deformity, which can be associated with anxiety and depression [47].  Comorbidities are also 
more prevalent in advanced disease, and in a review of over 3000 people with SpA, 51% 
reported at least one comorbidity, and these were associated with poorer QoL, physical 
function and decreased employment [48]. Overall, around one third of people with axSpA 
cease work due to their condition, and 15% reduce or modify their employment: the personal 
financial cost, therefore, may also be high [45].  
Lastly, translation of exercise recommendations into everyday life represents a time (and 
possibly financial) investment on the part of the individual concerned. A number of surveys 
have found variable adherence that appears likely to be similar to that of physical activity 
guidelines for the general population (Table 5, chapter 3) – in other words, at least one third 
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have very low levels of physical activity. A survey of 61 people with AS using the Exercise 
Benefits and Barriers scale [49] reported high scores for perceived barriers despite 
simultaneous high perceived benefits [50]. Thus, although many people with arthritis view 
exercise recommendations positively, for others the negative connotations of lifelong exercise 
represent an additional personal disease burden [51]. It therefore seems reasonable to ensure 
that only the most effective exercises are prescribed. 
Socioeconomic costs 
The direct healthcare costs associated with axSpA vary across countries, but have been shown 
to be ‘high’ [24], and, although annual costs are lower than for rheumatoid arthritis, the total 
cost is likely to be higher due to the lower mean age of onset [52]. In Australia, prescription 
of bDMARDs can only be made by a rheumatologist, and subsidy by the Pharmaceutical 
Benefits Scheme (PBS) under the National Health Act 1953 is restricted to adults with AS. It 
is likely that half to two-thirds of people with AS in Australia are managed long-term with 
bDMARDs [53], and the direct annual bDMARD costs range from $9516 to $14414 per 
person [54]. There are additional costs due to the PBS requirement of regular (six-monthly) 
rheumatologist monitoring for effectiveness. However, since in other countries, direct medical 
costs are estimated to represent only 23 to 50% of total annual costs for AS (due to loss of 
work productivity) [24], the total per person cost to Australian society is likely to be several 
tens of thousands of dollars each year. 
Is exercise still important with biologic treatment? 
With modern bDMARD management, there is an expectation that remission of the disease 
and maintenance of full axial mobility is achievable for some. Better symptom management 
may remove a ‘prompt’ for exercise therapy, and could call into question the need for exercise 
to remain as a first line management [55]. However, despite the goal of low disease activity or 
remission with these medications, axSpA is not yet curable. There is evidence that for some 
people, exercise levels may decline [56], and adipose tissue mass increase [57], following the 
onset of bDMARDs. Perhaps related to these findings, a number of studies (including high 
quality RCTs and a systematic review), have shown that exercise and bDMARDs are 
synergistic in their effect - that is, exercise adds significantly to a range of benefits (improved 
pain, mobility and disease activity) when people are already taking a bDMARD [58, 59]. 
Since costs for exercise interventions are perhaps one to five per cent of those for bDMARDs, 
cost effectiveness considerations alone support the ongoing inclusion of exercise as a primary 
management strategy.   
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‘Non-biologic’ disease management  
People who have (structurally) milder disease may be well managed with exercise and 
NSAIDs, and never need bDMARDs – and/ or may not meet the criteria for their prescription.  
This applies to up to 40% of people with axSpA [60] – some of whom may simply not choose 
this treatment pathway due to safety concerns. Although bDMARDs have a good safety 
profile, they do result in immune system mediation (suppression) and are relatively 
contraindicated for people with a prior history of malignancy, demyelinating disease or 
tuberculosis [61]. Thus, there is always likely to be a group of people who remain more 
reliant on exercise for disease management, especially for control of pain and stiffness. 
Although the evidence has limitations, the effect sizes (ES) for exercise across a range of 
parameters can approach those seen for NSAIDs alone, and are discussed in detail in Chapter 
3.  
Symptom management 
Significant proportions of people with axSpA experience ongoing symptoms, with mean pain 
ratings of 37/100 mm and 33/100 mm for spinal and spinal pain at night respectively, in a 
survey 333 people with axSpA: these scores were higher than for a comparison group with 
rheumatoid arthritis [62]. In addition, approximately two thirds of people with AS experience 
fatigue [47] and in a systematic review of 16 studies, reported depression ranging from 11 to 
64%, with a pooled prevalence of 15% for at least moderate depression [63].  Associated 
sleep disturbance is also common, with a range of 35-90% reported in fifteen studies in one 
systematic review [64]. 
For some people, these symptoms remain, even when disease activity is considered to be at a 
low level, and/ or well controlled with a bDMARD. For example, fibromyalgia, defined as the 
clinical expression of central sensitisation, or ‘up regulation’ of pain, is common in 
concurrence with axSpA, with a prevalence of up to 25% [65]. Exercise is considered to play 
an important role in managing these symptoms in the general population [66, 67], and there 
are RCTs demonstrating improvement in related outcome measures in axSpA [68-70]. 
However, symptoms such as pain and fatigue can also be seen as a barrier to exercise in 
axSpA [71, 72], and there is evidence that exercise interventions with an inappropriate dosage 
may aggravate pain syndromes such as fibromyalgia [73]. Therefore, symptom management 
remains a key reason why exercise advice is important in axSpA – and particularly for those 
with persistent pain, fatigue, depression and/ or sleep disturbance, the right advice is likely to 
be a requisite for a successful outcome. 
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Disease modification and prevention of co-morbidities 
There are at least three postulated pathways in which exercise may modulate disease 
progression, and positively influence lifetime health: 
Firstly, in clinical practice, people with axSpA can make at least short-term gains in mobility 
[74-77]. However, it is not known whether regularly repeated mobility exercises can prevent 
syndesmophyte formation, that is, the bony bridging of the vertebra, which can result in spinal 
fusion, by physically moving joints through their available range. Only three published RCTs 
have included long-term follow-up, with one suggesting some long-term (12 months) benefit 
for mobility [78], and two reports suggesting that gains in axial mobility can be maintained 
with sustained, long-term exercise practice [79, 80]. 
Secondly, bone density loss is a known consequence of axSpA [81, 82], and muscle strength/ 
mass have been shown to decline in some studies, as discussed in Chapter 4. It is not known 
whether strengthening exercises could prevent these changes. However, in other populations, 
specific exercise has been shown to significantly improve bone density [83] and can be 
targeted to preferentially strengthen sites vulnerable to fracture [84]. Since bDMARDs have 
not yet been shown to prevent osteoporosis in axSpA [85], exercise has a potentially useful 
role in maintaining bone health. 
Lastly, there is now consistent evidence that exercise (in the right amount) can produce a net 
anti-inflammatory effect. In general populations, it has been recognised since the 1950s that, 
most people in industrialised countries need to deliberately exercise to be healthy [86]. Since 
then, there has been a large and compelling body of research to support this concept. Exercise 
acts by challenging homeostasis in all organ systems, activating acute & long-term adaptive 
mechanisms to preserve or re-establish homeostasis [87, 88]. At cellular level, this occurs via 
a complex combination of systems activation and crosstalk (Figure 1.6). Two main pathways 
are established: firstly, a reduction in visceral fat results in lower levels of circulating 
adipokines [89], that is, the pro-inflammatory cytokines released by adipose tissue, such as 
leptin and TNFα. Secondly, cytokines such as interleukin 6 (IL-6) are released by muscles on 
contraction [90]. It is hypothesised that IL-6 acts in a hormone-like manner to produce anti-
inflammatory effects, such as increasing IL-10, whilst decreasing TNFα [91a]. It should be 
noted that, although IL-6 is generally classified as a pro-inflammatory cytokine, when 
muscle-derived it is involved in the anti-inflammatory effect of exercise [91b, 91c]. These 
findings have led Pedersen et al to propose that muscles are in fact endocrine organs, and that 
the cytokines released on muscle contraction should be known as ‘myokines.’ [92]. 
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Figure 1.6 Anti-inflammatory effects (molecular response) of contracting skeletal muscle  
 
The anti-inflammatory cytokine IL-6 is produced by skeletal muscle fibres and released on 
contraction. This induces metabolic effects such as lipolysis and fat oxidation, and has a role 
in glucose homeostasis during exercise. IL-6 has significant anti-inflammatory effects and 
may inhibit TNF-induced insulin resistance. Other net anti-inflammatory effects are produced 
by the down-regulation of TNF, and up-regulation of IL-6RNA, sTNF-R, IL-10 and IL-
1ra.IL-6 = interleukin 6; TNF = tumour necrosis factor; IL-6mRNA = IL-6 messenger 
ribonucleic acid; sTNF-R = soluble TNF receptor; IL-10 = interleukin 10, IL-1ra = 
interleukin 1 receptor agonist.[88]. 
From Petersen et al (2005) The anti-inflammatory effect of exercise. Used with permission 
(granted 10/10/18) from the American Physiological Society. 
 
Knowledge about the application of these effects in autoimmune rheumatic diseases remains 
patchy [93-95]. One recent example is the use of high intensity exercise for myositis: results 
from Swedish studies indicating that the effect was not only anti-inflammatory, but may also 
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modify genetic expression and therefore mediate disease progression [96]. A recent 
exploratory study investigating the effects of higher intensity exercise in axSpA also pointed 
to anti-inflammatory effects – including a reduction in BASDAI by an effect size of 1.4, 
which is greater than that for other AS exercise studies and within the range reported for 
bDMARDs [97]. Risk factors for cardiorespiratory conditions, such as arterial stiffness, also 
significantly improved and inflammatory markers remained stable, with a trend towards a 
decrease in IL-17 and IL-23. 
Since inflammation is considered to be the unifying factor in many of the symptoms, 
consequences and comorbidities associated with axSpA, a reduction in lifetime inflammation 
may prove to be the most important reason of all to exercise regularly. 
1.4 Limitations of the evidence regarding exercise and axSpA 
Although clinical trials of exercise interventions for axSpA are now more numerous, 
significant knowledge gaps have been acknowledged in the literature [30, 55, 68], and remain 
problematic for both health professionals (HPs) involved in exercise prescription, and people 
who have axSpA. Due to the nature of the intervention, it is clearly difficult to avoid bias in 
exercise trials – for example, blinding of participants to the type of exercise in which they 
actively participate may not be possible. However, the level of evidence has improved from 
early non-controlled or blinded case series [98-100]: there is now an accumulation of over 
twenty RCTs: eighteen of which score six points or more on the Physiotherapy Evidence 
Database (PEDro) scale [101], indicating high internal trial validity.  
Despite this trend towards better methodological validity, the following problems and 
knowledge gaps concerning therapeutic validity remain: 
i. Size of RCTs. Table 1.1 presents the RCTs meeting the selection criteria for the study 
described in Chapter 3, with the addition of the RCTs that have been published since 
then – that is, all eligible exercise RCTs prior to 1st August 2018. Most exercise trials 
have small sample sizes: only 6 (30%) enrolled more than 25 participants in each 
group. This means that groups are usually not stratified – for example, by testing the 
effect of an intervention in early versus late stages of the condition, or active versus 
inactive, disease. This is important, since optimal exercise choices may be different 
for these groups, and hence the applicability of the intervention to clinical practice 
may be less clear. 
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ii. Length of trial. A lack of longer term studies investigating the effect of exercise (and 
evaluating the outcome if an exercise program is ceased) has also been recognised in 
the literature [102]. Most groups are followed for 12 weeks or less (15 or 75% of trials 
in Table 1.1). The short duration may mean that it is physiologically difficult for 
participants to attain optimal exercise benefits, particularly if they have commenced 
the intervention with a low level of baseline physical fitness, and the absence of good 
quality longitudinal studies means that it is not possible to evaluate the effects on 
disease progression.  
iii. Quality of exercise program design. Problems with the design of exercise programs 
in trials led Hoogeboom et al to develop a measure for therapeutic validity: the 
Consensus on Therapeutic Exercise Training (CONTENT) scale [120]. This nine-
point scale addresses aspects of exercise intervention such as participant selection; 
therapist competence; rationale for exercise content and dosage; intensity of 
intervention; appropriate monitoring, individual adjustment and adherence. Only nine 
studies (45%) assessed met the recommended cut-off score of six or more for 
therapeutic validity (Table 1.1). Furthermore, assessment of exercise associated 
physiological change (such as mobility, strength or cardiorespiratory function), was 
largely restricted to mobility (16, 80% of studies). Cardiorespiratory outcomes were 
measured in only 8 (40%) of trials, and none were identified that reported strength 
outcomes, despite evidence for reduced in strength in axSpA [121-124a].  
iv. Lack of basic science to inform exercise program design - such as information about 
muscle pathophysiology in SpA. Historically, much more attention has been paid to 
SpA bony and entheseal changes than to the muscles themselves - despite long-held 
clinical beliefs about the effectiveness of exercise therapy. Physiotherapists and others 
have therefore empirically evolved and utilised muscle techniques, such as the 
principles of stretching (or lengthening) muscles that appear shortened, and re-
training/ strengthening lengthened ones [74-78, 98]. These techniques could 
potentially be optimised for greater effect, if more was known about any underlying 
muscle pathophysiology. It also seems plausible that muscle changes may be more 
modifiable (with exercise) than bony changes. Lastly, identification of any loss of 
muscle mass or quality in middle age may allow targeted exercise interventions aimed 
at improving mobility in older age, with resultant positive effects on quality of life and 
mortality [124b]. 
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In summary, although there have been improvements in the volume and methodological 
quality of exercise trials in axSpA, there appear to have been few attempts to trial novel 
exercise regimes which carefully consider exercise design and alignment with axSpA 
pathophysiology.  
Chapter 1: Introduction 
 
17 
 
Table 1.1 
Exercise for AxSpA: Randomised Controlled Trial Content, Quality and Therapeutic Validity 
Study Exercise Description No in 
group 
Duration 
(weeks) 
Exercise type PEDro 
Score 
/10 
CONTENT  
score/9 
Measure of 
relevant 
physiological 
change? Mobility Strength Cardio. Unspec. 
Altan (2012) 
[103] 
I: Pilates  
C: CE 
30 
25 
12 X X    8 4 Mobility only 
Analay (2003) 
[104] 
I: Supervised 
C: HEP 
23 
22 
6 X X X  7 4 Mobility, 
cardio-resp  
Cagliyan (2007) 
[105] 
I: Supervised 
C: HEP 
23 
23 
13 
26 
X X   4 3 Mobility only 
Demontis (2016) 
[106] 
I: Multi-modal group exs & 
education 
C: Education only 
20 
22 
8 
8 
√  X  6 6 Mobility only 
Dragoi (2015) 
[107] 
I: CE + respiratory muscle 
strengthening 
C: CE only 
23 
24 
8 X √*   7 7 Respiratory 
muscle 
function only 
Dundar (2014) 
[108] 
I: Aquatic exercise 
C: HEP 
35 
34 
4 X X X  7 4 Mobility only 
Fernandez-de-las-
Penas (2005) [74] 
I: Supervised GPR 
C: Supervised CE 
20 
20 
6 √ X   6 7 Mobility only 
Hidding (1993) 
[109] 
I: Multi-modal group exs 
C: HEP 
67 
68 
36 X X X  7 5 Mobility, 
cardio-resp 
Hsieh (2014) 
[110] 
I: Multi-modal HEP 
C: Mobility only HEP 
9 
10 
12 √ √ √  7 6 Mobility, 
cardio-resp  
~ - ~ 
I 
~ 7 
- -
-
-- -
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Ince (2006)  
[75] 
I:Multi-modal group exs 
C: Education only 
15 
15 
12 √  √  7 5 Mobility, 
cardio-resp 
Jennings (2015) 
[111] 
I: Cardio + mobility 
C: Mobility only 
35 
35 
12 √  X  8 6 Mobility, 
cardio-resp 
Karahan (2016) 
[112] 
I: Exergames 
C: No exercise 
30 
30 
12    X 6 3 N 
Kraag (1990)  
[76] 
I: Home PT  
C: No exercise 
22 
26 
16 √ X X  8 5 Mobility only 
Lee (2008)  
[113] 
I: Supervised tai chi 
C: Tai chi HEP-video 
13 
17 
8 X    6 3 N 
Lim (2005) 
[114] 
I: HEP  
C:No exercise 
25 
25 
8 X    6 2 Mobility only 
Maseiro (2011) 
[77] 
I: Multi-modal group exs & 
education 
I: Education only 
C: No intervention 
20 
 
20 
22 
6 √  X  7 7 Mobility only 
Neidermann 
(2013) [115] 
I: Cardio + mobility exs 
C: Mobility exs only 
53 
53 
12 √  √  8 8 Mobility, 
cardio-resp 
Rosu (2014) 
[116] 
I: McKenzie exs 
C: CE 
24 
24 
24 √    5 4 Mobility, 
cardio-resp 
So (2012) 
[117] 
I: IS breathing exs + HEP 
C: HEP 
23 
23 
16 X    6 6 Pulmonary 
function only 
Sveaas (2014) 
[118] 
I: Cardio + strength exs 
C: No intervention 
10 
14 
12  √ √  7 9 Mobility, 
cardio-resp 
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√ = exercise program assessed as meeting American College of Sports Medicine (ACSM) guidelines for physiological effectiveness [119]; X  = 
no evidence that exercise program met ASCM guidelines for physiological effectiveness; √* = inspiratory muscle strength training only; Home 
PT* Physiotherapy/ exercise delivered in participants’ home, and customised to individual problem list; I intervention group; C control group; 
CE conventional exercises; HEP home exercise program; ‘multi-modal’ = components of three or more exercise types, that is, mobility, strength, 
cardio-pulmonary; GPR global postural re-education exercises; IS incentive spirometer; Mobility = mobility exercise (includes stretching); 
Strength = strengthening (resistance) exercise; Cardio. = cardio-pulmonary (aerobic) exercise; Unspec. = exercise type not specified; PEDro 
score = Physiotherapy Evidence Database scale for internal validity; CONTENT = Consensus on Therapeutic Exercise Training scale for 
therapeutic validity of exercise programs. 
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 Issues for patients and HPs 
In practical terms, the evidence gaps described make the interpretation and translation of 
the available evidence problematic – for both people with axSpA and HPs with the role of 
providing exercise guidance. Typical pragmatic questions from the latter group were 
collated in the initial stages of the Consensus Statement (CS) project (chapter 3), and are 
listed in as supplementary appendix B. Given that these questions were generated by a 
group of physiotherapists experienced in providing advice to people with axSpA, it can be 
seen that ‘real-life’ implementation of exercise advice can be problematic – and 
presumably is more so for those HPs with less knowledge or experience. 
For people with the condition, there are now excellent resources that include detailed 
instruction on a wide variety of exercises, such as the United Kingdom’s National 
Ankylosing Spondylitis Society’s web-based videos and mobile device ‘apps’ [125]. 
However, it is difficult for such resources to address issues around actual exercise choice 
for optimum effect, due to the wide spectrum of axSpA expression and severity, and the 
countless possible variations in exercise indications and performance. For those people 
with an ankylosed spine, the increased risk of falls [126-128] and subsequent spinal 
fracture/ spinal cord injury [20, 129, 130] are significant safety issues that clearly require 
consideration.  
The identified evidence gaps around exercise dosage can also impact on both short-term 
implementation of regular exercise programs (“where to begin”) and sustainability. One of 
the most significant barriers may be fear of causing a flare-up – either of pain, or of 
inflammation/ the disease itself , with a cross-sectional study concluding that a large 
proportion (78%) of 148 people with AS experienced barriers to physical exercise, and 
these were mostly disease related – for example, pain, stiffness, fatigue and disability [72].  
Lastly, the introduction of bDMARD medication has led some to question the necessity of 
exercise in the management of axSpA [55, 131, 132]. The objectives of the project 
described in Chapter 3: ‘Exercise for ankylosing spondylitis: an evidence based consensus 
statement’ were therefore to analyse the existing evidence, apply an expert consensus 
process to interpretation of the evidence, and develop more specific recommendations to 
guide sustainable exercise advice.         
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1.5 Strength and stability in axSpA 
Exercises that aim to enhance aspects of muscle fitness, that is, strength, endurance, motor 
control and power, broadly fit under the umbrella term of ‘strength’ or ‘resistance’ 
training, and are recommended by the ACSM and in national physical activity guidelines 
for adults of all ages [43, 119]. Muscle size and quality, measured by imaging, 
histopathological examination and body composition measures, are accepted surrogate 
markers for muscle function [133-135]. Although there are some conflicting findings, 
which are discussed in Chapter 5, it is recognised that there can be  pathophysiological 
changes in the muscles of people with axSpA [136-138] – resulting in loss of both axial 
and appendicular strength. There is little information to indicate whether such changes are 
primary, that is, as a result of inflammatory intra-muscle processes, or secondary - that is, 
consequential to disease signs or symptoms. 
Given these findings, there is a surprising paucity of evidence to investigate the effect of 
resistance exercise aimed at improving muscle fitness in people who have axSpA. 
Although a number of exercise trials stated that they included performance of strength 
exercise, only six could be identified that met the ACSM criteria for physiological 
effectiveness - that is at least 8–12 repetitions of each exercise, with resistance such that 
fatigue is reached, performed two-three times per week. In these studies, exercises were 
described that were adequate for producing a change in strength, but the effects of the 
exercise programs adopted on either axial or appendicular strength were not reported 
(Table 1.1). No axSpA studies were identified that aimed to assess or improve other 
aspects of muscle function, such as motor control, endurance or power, or that specifically 
targeted improvement in paraspinal muscle function.  
1.6 Rationale for investigating the paraspinal muscles  
Given that the cardinal symptom in axSpA is painful low back stiffness, commonly 
described as lumbar region ‘muscle soreness’, the paraspinal muscles would appear to be 
an obvious target for further investigation. The relevant functional anatomy and how it 
may relate to the disease is further discussed in the following section. 
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Lumbar paraspinal muscles 
The term ‘paraspinal muscles’ encompasses the complex group of strap-like muscles 
which lie adjacent (lateral) to the posterior mid-line formed by the spinous processes, and 
posterior to the plane of the transverse processes of the vertebral bodies (Figure 1.7) [139].  
The muscles thus lie in a largely vertical plane from pelvis to skull. The lumbar paraspinal 
muscles are defined as those that exert action on the lumbar spine [140], and can be 
considered as two main groups: 
o The lumbar multifidus (LM) is the most medial muscle (figure 1.7) and comprises a 
series of overlapping fascicles – the deepest (intersegmental) fascicles spanning 
between two vertebrae only, and the more superficial fascicles spanning two or 
more joints. The whole forms a fan shape over the lumbo-pelvic region, arranged 
so that the posterior aspect of each lumbar vertebra has muscle fascicles radiating 
to each vertebra below it, and to the sacrum and iliac crest [140]. This structure 
thus reflects the key function of LM as a dynamic spinal stabiliser, providing 
continuous small adjustments to counteract the forces of gravity, movement and 
loading, and thus maintain vertebral alignment and stability [139, 140]. 
Anatomically the most stable position for the lumbar spine is the lordotic curve 
[141]: each fascicle of LM is therefore considered to control the lumbar lordosis at 
its particular spinal segmental level. 
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Figure 1.7 Cross section of body musculature and fascia through L3 showing intrinsic 
spinal musculature. 
 
 
Used with permission from Musculoskeletal Key, granted 10/10/2018. 
https://musculoskeletalkey.com/lumbar-musculature-anatomy-and-function/ 
 
o The lumbar erector spinae (LES) comprises of the lumbar sections of the 
longissimus and iliocostalis muscles. The lumbar longissimus lies lateral to the LM 
muscle and is made up of five fascicles: each one originates from the transverse 
process of a lumbar vertebra and inserts caudally into the erector spinae 
aponeurosis [142]. The latter is a sheet of tendinous fibres that attach onto the 
sacrum and ilium, to form a common attachment for the LES muscles. The 
iliocostalis is a more superficial muscle: its fascicles originate from the lower 
posterior rib cage, and attach to the ilium via the LES aponeurosis, with no direct 
attachment to the lumbar spine [139]. Both LES muscles control forward lumbar 
flexion by eccentrically controlling the rotation (in conjunction with the MF 
muscle) and anterior translation of one vertebra upon another, and are highly active 
during spinal extension from a flexed position [140]. 
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Why investigate the lumbar paraspinal muscles in axSpA? 
As discussed in section 6 of this chapter, there are important evidence gaps regarding 
exercise that targets muscle fitness parameters in axSpA – and in addition, there is a 
limited amount of information regarding paraspinal muscles in the condition. A previous 
MRI study provided absolute values for individual muscle total cross-sectional area (CSA) 
and grading of muscle quality (fat infiltration) using a three-point scale, at the  L2 to L5 
vertebral levels. Comparison (without further analysis) was made between a group of 22 
participants with radiographic axSpA (AS) with 14 participants with non-radiographic 
axSpA (nr-axSpA) and it was concluded that the AS participants had higher levels of inter-
muscular adipose tissue (IMAT) than those with nr-SpA [136]. Bok et al measured total 
paraspinal muscle CSA on MRI at the L4/5 vertebral level only, comparing 31 males with 
AS with 31 control participants with LBP, matched for age and spinopelvic alignment, and 
a further group of 20 males with AS and spinal deformity (for whom matched controls 
could not be found). This measure of a paraspinal muscles at a single vertebral level was 
significantly smaller in the AS group with spinal deformity, compared with the AS group – 
and the latter was significantly smaller than controls [137]. Lastly, a recent MRI study 
assessed the total CSA and graded fatty infiltration of the combined paraspinal muscles 
from L1/2 to L4/5 vertebral levels for 51 participants with AS and 51 control participants 
matched for age and sex. Comparison between the two groups revealed smaller total CSAs 
in the AS group at each level [138]. No studies were found that examined the L5/S1 
vertebral level, despite its close proximity to the SI joints and important biomechanical 
role. 
Therefore, further investigation, including separate measures for each of the paraspinal 
muscles, at multiple spinal levels (including L5/S1), and analysis of symmetry and muscle 
quality, with adjustment for the known confounders of age and sex, appears warranted.  
The following rationales are also submitted in support of further study: 
i. Disease understanding. As previously discussed, the most common region for 
inflammatory change in axSpA is the lumbo-pelvic region – that is, the sacro-iliac 
joints and lumbar spine, and the primary tissue target is the enthesis. However, it is 
not known whether the local inflammatory environment produces either primary or 
secondary change within the anatomically adjacent muscles. Should a 
pathophysiological change be identified, it may explain why axSpA symptoms 
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typically ease with exercise and become worse with rest or static postures – the latter 
commonly described as ‘muscle stiffness’ [143]. 
ii. Better exercise advice. Identified changes in the size, symmetry or quality of the 
paraspinal muscles may indicate a target for trials of novel exercise programs, such as 
those that aim to re-educate motor control of these particular muscles, functional 
stability, strength and endurance. Such programs have been demonstrated to be 
effective in appropriately selected groups with ‘non-inflammatory’ low back pain 
(LBP) [144]. 
iii. Improved function. The lumbar paraspinal muscles have separate but overlapping and 
coordinated roles in maintaining the lumbar lordosis, that is, the neutral and 
anatomically stable postural curve of the lumbar spine that is integral to normal spinal 
function [145, 146]. Since loss of the lumbar lordosis (flattening of the lumbar spine) 
is a typical consequence of axSpA progression, it seems plausible that specific 
exercise programs aiming to maintain the lordosis could be beneficial. An additional 
reason to examine the concept of paraspinal muscle involvement in axSpA is the role 
played by the LM muscle in spinal proprioception and balance [147-149]: again 
balance is known to be decreased [127, 150, 151] and there is an increased risk of 
falls [129, 130, 152] in some people with axSpA. 
iv. Relationships with general health. There has been a growing increase in recognition 
of the role of muscles in maintaining general health, due to their role in managing 
metabolic inflammation, as discussed in section 1.3. Diminished muscle quality, as 
determined by the presence of ectopic adipose tissue (inter-muscular adipose tissue 
(IMAT)) is also known to be positively associated with insulin resistance, 
hypercholesterolaemia and strength and mobility impairment [153].  
v. Causative factors. Biomechanical strain is postulated to be a causative factor for 
axSpA: increased tone in the paraspinal muscles has been hypothesised to increase 
lumbo-pelvic compressive forces [143, 154], with such strain producing microtrauma 
which triggers or maintains local enthesitis [30, 155, 156]. An alternative cause of 
biomechanical strain could be muscle asymmetry – which has been shown to be 
associated with LBP [157, 158]. The biomechanical hypothesis in axSpA is based 
upon the results of a transgenic mouse model study, where spinal traction (decreased 
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force across the spinal joints) was found to prevent joint ankylosis, and weight 
bearing (increased force) to be associated with ankylosis [29, 159]. The finding has 
resulted in questions in the literature arising with respect to the potential for exercise 
to add to disease progression [30, 155, 156, 160]. However, given that:  
(a) the lumbar paraspinal muscles play an essential role in the performance of upright 
(anti-gravity) physical activity and maintenance of optimal spinal posture, inter-
segmental stability and balance [140, 161, 162]; 
(b) LM and LES have different primary functions (as described above), and,  
(c)  there are a multitude of compelling reasons in favour of exercise targeting general 
muscle fitness [153, 163], further information on axSpA muscle changes and 
complementary exercises would seem imperative.  
vi. Lastly, evidence of axSpA conditions was historically based on x-ray (and thus bony) 
changes and that emphasis continues to this day. Any identified between group 
differences (AS/axSpA and healthy controls) in imaged appearance of the paraspinal 
muscles may make a useful contribution to diagnosis and therapeutic monitoring and 
evaluation.  
Chapter 5 describes a pilot study to examine the size, symmetry and quality of the LM and 
LES muscles seperately at multiple lumbar vertebral levels, in order to inform future 
research directions including exercise prescription aimed at targeting specific aspects of 
muscle fitness in axSpA. 
1.7 Summary 
Axial spondyloarthritis is an auto-immune rheumatic disease that predominantly affects the 
spine, but is associated with a high incidence of systemic co-morbidities. The disease ‘end 
point’ is total fusion of the spine, and this circumstance is associated with significantly 
increased morbidity and mortality. Contemporary management aims to prevent such 
structural progression - however, the effective disease modifying medications are costly 
and their subsidised use is restricted to those people demonstrating specific criteria for 
disease activity and structural progression. Exercise is a long established, integral 
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component of management, and regular exercise - for life - is recommended in all axial 
spondyloarthritis guidelines. Despite this, and the extensive amount of evidence for the 
necessity of exercise to maintain health in the general population, substantial knowledge 
gaps remain. There is a lack of detail about how exercise may interact with the 
pathophysiology of axial spondyloarthritis [160], and consequently, exercise advice lacks 
essential components such as the optimal type, dosage and frequency of exercise, and how 
it may be adapted to accommodate different disease stages and presentations. And, despite 
early evidence of decreased muscle strength and pathophysiological changes, there is 
negligible information to inform exercise that targets muscle fitness in axSpA. 
1.8 Structure of this thesis 
Chapter 2: Research Aims. This chapter briefly describes the aims of two studies: 
‘Exercise for ankylosing spondylitis: an evidence-based consensus statement’, and ‘Size, 
quality and symmetry of the lumbar paraspinal muscles in axial spondyloarthritis’.   
Chapter 3: Exercise for ankylosing spondylitis: an evidence-based consensus statement. 
This chapter presents the results of a systematic review with meta-analysis. It identifies 
key evidence gaps and develops an exercise framework and evidence-based 
recommendations, targeting health professionals who work with people who have 
ankylosing spondylitis. The text of this chapter has been published [69]. 
Chapter 4: Research Methods. This chapter describes the axSpA assessment measures 
utilised for the study presented in the following chapter. 
Chapter 5: Size, symmetry and quality of lumbar paraspinal muscles in axial 
spondyloarthritis.  This chapter reports morphometric measures of the lumbar paraspinal 
muscles, and their association with sex, age and body mass index, at multiple lumbar levels 
in a cross-sectional sample of people with axSpA.  
Chapter 6:  Summary.  This chapter summarises the findings and conclusions of the thesis. 
Chapter 7: Future directions. This chapter suggests directions for future research. 
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Chapter 2: Research Aims 
The aim of this thesis is to consolidate the evidence for advice provided to people with 
axSpA: firstly, by improving the specificity of exercise recommendations, and secondly by 
describing the lumbar paraspinal muscles, in order to inform future directions for research 
into developing optimal axSpA exercise programs. 
2.1 Exercise for ankylosing spondylitis – an evidence-based 
consensus statement 
The primary aim of this study was to develop specific recommendations, based on the best 
available level of evidence and expert consensus opinion, by addressing the following 
questions in adults with AS: 
o Which measures are beneficial for baseline mobility assessment, in order to inform 
exercise prescription?  
o What are the minimum requirements for monitoring these measures? 
o What safety aspects should be considered in relation to exercise prescription? 
o Is exercise effective for disease modification, compared with no exercise? 
o Are exercises in combination with a biologic medication more beneficial, for pain, 
function, disease activity and mobility, than medication alone? 
o Is therapeutic (specifically prescribed) exercise aimed at: (a) improving mobility and 
posture; (b) increasing strength; (c) improving cardiorespiratory fitness, and (d) 
improving function (balance, co-ordination, gait, agility and proprioception) more 
beneficial for pain, mobility, disease activity and physical function than no exercise or 
general physical activity advice only?  
o What types of physical activity are beneficial for pain, mobility, disease activity and 
function, compared with no physical activity? 
o What volume of exercise is best for pain, mobility, disease activity and function? 
o Which factors are beneficial for supporting adherence to an exercise plan? 
o Which exercise setting is most beneficial for pain, function, disease activity and 
mobility? 
The secondary aim of the study was to identify the evidence gaps in exercise for AS, in order 
to provide indicators for future research pathways. 
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2.2 Size, symmetry and quality of the lumbar paraspinal muscles in 
people with axial spondyloarthritis 
This exploratory pilot study aimed to describe the size, symmetry and quality of the lumbar 
paraspinal muscles (multifidus and the lumbar erector spinae group) in a sample of people 
with axSpA, and examine associations of muscle measures with age, sex and body mass 
index. 
 
 
Chapter 3: Exercise for ankylosing spondylitis: an evidence-based consensus statement 
 
44 
 
 
Chapter 3: Exercise for ankylosing spondylitis: an 
evidence-based consensus statement 
Preface 
This chapter describes the work of a national expert panel, comprising a rheumatologist 
and ten physiotherapists with experience in the treatment of AS, who represented all 
Australian states and the territories (except the Australian Capital Territory). The 
physiotherapists were members of a special interest group of the Australian Rheumatology 
Health Professionals Association. The submitter of this thesis was the lead author for the 
paper and supplementary appendices, and also: led the planning of the project; coordinated 
and collated the independently-generated clinical questions; performed the systematic 
reviews; developed the literature review tools; distributed papers for review by team 
members and collated the results; developed the exercise framework and generated and 
implemented surveys of HPs and people with axSpA to test the importance of the 
recommendations. Dr Zochling chaired and coordinated the two day face to face meeting 
of the panel members, which resulted in the exercise recommendations.  
This text of this chapter has been published [1].   
The paper has now been cited in almost 40 other publications, the most important of these 
being: 
i. Therapeutic guidelines: Rheumatology Version 3 2017 Rheumatology Expert 
Group. 
ISBN 978-0-9804764-8-4. Melbourne, Therapeutic Guidelines Limited  
The recommendations presented in this chapter are cited as the guide for further 
information about exercise in axSpA in the latest edition of this well regarded guideline, 
which is also available as an electronic version. 
ii. Hinze AM, Louie GH. Osteoporosis Management in Ankylosing Spondylitis. 
Current treatment options in rheumatology. 2016 Dec 1;2(4):271-82. 
This guideline for osteoporosis management in AS cites the information found on exercise 
safety in this chapter. 
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iii. Debusschere K, Cambré I, Gracey E, Elewaut D. Born to run: The paradox of 
biomechanical force in spondyloarthritis from an evolutionary perspective. Best 
Practice & Research Clinical Rheumatology. 2018 Sep 1. 
This recent review discusses the evidence for a biomechanical component to axSpA 
pathogenesis, citing the paper presented in this chapter as evidence in support of exercise. 
iv. Robinson Y, Olerud C, Willander J. Do biological disease-modifying antirheumatic 
drugs reduce the spinal fracture risk related to ankylosing spondylitis? A 
longitudinal multiregistry matched cohort study. BMJ open. 2017 Dec 1;7(12) 
A conclusion of this investigation cited the paper in this chapter as follows: “therefore, 
recommendations for physiotherapeutic guidance for spinal injury prevention are valid 
even for patients receiving bDMARD”. 
The exercise framework presented at Figure 1 has been recommended to members of the 
Spondylitis Society of America, and the plain language version of the recommendations 
translated into German by a patient support group. Material from the paper also formed the 
basis for the following presentations at national conferences: 
o ‘Exercise for ankylosing spondylitis’ - oral presentation selected following abstract 
submission to the Australian Rheumatology Association Annual Scientific 
Meeting, Perth, Australia May 2013 
o ‘An Australian Consensus Statement: exercise for ankylosing spondylitis’ – oral 
presentation selected following abstract submission to the Australian Physiotherapy 
Association national conference, October 2013 (presentation made by Errol Lim) 
o ‘Exercise for ankylosing spondylitis: it’s still important’ – poster selected for 
presentation following abstract submission to the American College of 
Rheumatology Annual Scientific Meeting, San Diego, October 2014 
o ‘Inflammatory Arthritis, Pain and Exercise: Where to begin?’ oral presentation 
(invited speaker) at the Australian Pain Society Annual Scientific Meeting, Hobart, 
April 2014 
o ‘Sounds like a plan: exercise preparation for arthritis and pain’ oral presentation 
(invited speaker) at the Australian Rheumatology Association Annual Scientific 
Meeting, Darwin, Australia May 2016  
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3.1 Abstract 
Objective 
Despite Level 1b evidence and international consensus that exercise is beneficial 
in ankylosing spondylitis (AS), there is a paucity of detailed information to guide exercise 
prescription, including the type and dosage of exercise required for the most benefit. This 
collaborative project, combining evidence with clinical expertise, was established to 
develop practical recommendations to guide sustainable exercise prescription for 
individuals with AS. 
Methods 
Using a modified Delphi technique, 10 clinical questions were generated and a systematic 
literature review was conducted for each. Draft recommendations were developed at a 2-
day meeting, based on the integration of evidence summaries and expert opinion. Feedback 
was obtained from patient and health professional groups prior to finalisation. 
Results 
Recommendations and practice points were developed for the following areas: assessment; 
monitoring; safety; disease management; AS-specific exercise; physical activity; dosage, 
adherence and setting. A framework was developed that could also be adapted for exercise 
in other chronic musculoskeletal conditions. Feedback suggests that the final consensus 
statement provides useful information for those seeking to provide best practice exercise 
prescription for people with AS. 
Conclusion 
The recommendations provide an up-to-date, evidence-based approach to the full range of 
issues related to the use of exercise in AS, as well as identifying evidence gaps for further 
research. Most importantly, this includes investigation of aspects of exercise programme 
design required to produce the largest effect, long-term adherence with exercise programs 
and the specific exercise requirements of sub-groups of people with AS. Widespread 
dissemination and implementation of the guidelines will be required to optimise exercise 
outcomes. 
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3.2   Introduction 
Individuals with ankylosing spondylitis (AS) experience pain and stiffness, which mainly 
affects the axial skeleton (spine, hips and shoulders). Since the condition is an 
inflammatory arthritis, fatigue can also be a prominent symptom [1]. The primary 
pathology includes enthesitis, or inflammation of the anatomical region of the bony 
attachment of tendons, ligaments or joint capsules [2]. Typically this occurs in the spine; if 
unchecked, new bone formation may result in ankylosis, or spinal fusion. The most 
common age of onset is in early adulthood, therefore the lifetime individual impact of AS 
can be high [3]. Traditionally, the condition has been managed with a combination of anti-
inflammatory medication and exercise, with the latter appearing anecdotally to be more 
effective than for other types of arthritis. 
Although exercise recommendations feature prominently in relevant clinical guidelines for 
the management of ankylosing spondylitis [4, 5, 6, 7], and are supported by a body of 
mixed-quality evidence [8], in clinical practice there is a lack of specific information to 
guide exercise planning [9, 10].  The majority of published evidence focuses on mobility 
exercise [9], and relatively little attention has been given to other aspects of exercise 
program design such as strengthening, balance or cardiovascular exercise, despite 
recognition that AS can affect muscle strength [11], balance [12] and cardiopulmonary 
function [13]. Similarly, there is little information about dosage (frequency, intensity and 
duration) or adherence to recommended programs [9]. Several trials are based on intensive, 
time-limited (often residential) exercise modalities which are not readily available in many 
regions - such as in-patient rehabilitation or spa therapy/ exercise combinations [14].  
Lastly, recent rapid advances in medical management, such as tighter control of disease 
activity by the use of anti-tumour necrosis alpha (anti-TNFα) factor agents, have raised 
questions about the ongoing relevance of exercise in the management of AS [15]. 
The task of developing an optimally effective, evidence based and sustainable exercise 
program for a person or a group with AS therefore remains challenging. The overall 
objective of this project was to develop more specific recommendations covering a range 
of topics which need to be considered for exercise prescription - primarily for use by health 
professionals, but also for people with AS who may wish to acquire more detailed 
information about the use of exercise as a self-management strategy. 
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3.3  Methods 
Systematic review  
The Writing Group (WG) comprised eleven physiotherapist members of an ankylosing 
spondylitis special interest group in Australia, and a rheumatologist (JZ) with experience in 
Delphi methodology and guideline development. WG members independently submitted 
up to ten questions of clinical importance to their practice, which were grouped into nine 
topics by the project coordinators (JM and JZ). These were: Assessment, Monitoring, 
Safety, Disease Management, AS-Specific Exercise, Physical Activity, Dosage, Adherence 
and Setting. A systematic review was carried out for each topic: details of the methods are 
shown in Appendix A (section A1). All WG members then participated in the assessment 
of included studies, using a pro forma ‘article summary’ tool to record quality, relevance to 
a non-residential setting and reproducibility of the exercises in a ‘real-life’ context.  Meta-
analysis was performed using random effects models where data was available to allow 
pooling – that is, for pain, disease activity, spinal mobility measures (cervical mobility, 
fingertip to floor distance, chest expansion and lumbar flexion) and physical function. An 
‘evidence matrix’ was compiled by the coordinators to show:  the number, type and quality 
of studies; overall level of evidence; consistency of results, and, (where applicable) effect 
sizes.   Any discrepancies were resolved by discussion. Details of the flow of studies are 
shown in Figure A1, included and excluded full text papers (with reasons for exclusion) at 
A2 and A3 and evidence for the recommendations at Appendix B.  
Consensus Meeting  
A two day face-to face meeting was held to review the evidence and develop 
recommendations, during which WG members presented topic summaries, as described 
above. These findings were discussed in the context of the collective clinical experience of 
the group, before recommendations were derived for each topic. After gaining appropriate 
ethics approval, consumer and health professional feedback on the draft recommendations 
was obtained by anonymously surveying people with AS (via patient support groups) and 
health professionals (via professional organisations). Further information regarding the 
surveys is provided in Appendix C, section 1 (C1). The consensus statement wording was 
adjusted and further independent voting by the WG was used to finalise each 
recommendation.  
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Grade of Recommendations  
The Australian National Health and Medical Research Council (NHMRC) hierarchy [16] 
was used to grade the recommendations as follows: Evidence Based Recommendation 
(EBR) Based on a body of evidence, graded A-D depending on types of studies and 
consistency of results; Consensus Based Recommendation (CBR) developed by the WG 
in the absence of direct evidence, or poor quality evidence, to answer the question, and 
Practice Points (PP) developed by the WG where there was a need to provide practical 
guidance to support the implementation of EBRs and CBRs. The derivation of PPs is 
shown in Appendix C, section 2 (C2). 
3.4   Results  
The final ten recommendations with practice points are listed at Box 1. The process of 
developing the recommendations highlighted the complexities of therapeutic exercise 
prescription and the potential for multiple interactions between the different topics 
examined. Figure 1 summarises the recommendations and relationships of these factors, 
and may be useful in informing joint (patient and health professional) decision making 
regarding exercise choice. A plain language summary of the recommendations and 
framework is also provided in Appendix C, section 3 (C3). Survey results (Table C1) 
demonstrated a high level of patient importance (mean for all recommendations 8.46/10; 
range 8.0 to 8.9) and health professional (HP) support (mean 8.66 and range 7.3 to 9.58). 
The mean proportion of HPs who stated that the recommendation was already their 
practice was 60.2%, whilst 21% stated that the recommendation would modify their 
practice. 0.8% of HPs reported that they did not wish to change their practice, and the 
remainder (17.8%) stated that the recommendation did not apply to their practice. The 
background, clinical question(s), results and rationale for each recommendation are 
outlined as follows: 
Assessment and Monitoring 
Background  
Pre-exercise objective physical measures are an established component of individual 
exercise prescription, serving to inform: individual training goals; appropriate exercise 
type(s); starting dose precautions (which may indicate exercise modification), and personal 
information regarding the need for specific exercise [17]. The clinical questions were: In 
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adults with ankylosing spondylitis, which measures are beneficial for baseline mobility 
assessment in order to inform exercise prescription? What are the minimum requirements 
for monitoring these measures? 
Results 
No evidence was found comparing the effectiveness of an exercise program informed by 
individual assessment, to a standardised program - hence the rating of this recommendation 
as clinically based. However, a number of (largely non-controlled) cross-sectional studies 
found relationships between axial mobility (anthropometric) measures and self-reported 
domains such as physical function, disability and quality of life [18-21], Van Weely [22] 
found that self-reported function was typically reported as being more impaired than 
objectively measured function. Self-reported scores therefore do not substitute for 
objective measures, and hence the rationale for an accurate assessment that includes both 
subjective and objective components. The choice of AS-specific tools is further discussed 
at B1.1 and C2.1, but as a minimum, validated axial mobility measures and chest 
expansion should be completed. As reflected in the statement below, a combination of self-
reported and objective information usefully informs exercise prescription and identifies 
where more detailed assessment may be indicated. Analysis of such tests is beyond the 
scope of this review, but many are simple and quick to perform in the clinical setting, and 
may be required to assess the consequences of more advanced AS on strength, balance or 
cardio-pulmonary function.  
Recommendation 1: Assessment 
Individual exercise prescription should be informed by a thorough and reproducible 
assessment which includes musculoskeletal and psychosocial factors, and AS-specific 
measures - including objective axial mobility and chest expansion. (CBR)  
No direct evidence was found to answer the question regarding monitoring. However, in 
the experience of the WG, there is also rationale for longitudinal monitoring of AS 
anthropomorphical measures, in order to evaluate exercise effectiveness, assess change in 
mobility and provide personal feedback, which may be motivational.  In clinical practice, 
patients appear to value the objective information provided by assessment and it appears to 
have a positive effect on exercise behaviour [23], hence the following recommendation. 
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Recommendation 2: Monitoring 
Sufficient monitoring and feedback should be provided on an individual basis, to achieve 
confidence and competence with exercise, and to inform changing needs for exercise 
prescription. This is recommended at least annually, and more often as symptoms, function 
and mobility indicate. (CBR) 
Safety 
Background 
The WG was anecdotally aware of single case adverse events associated with exercise, 
including spinal fracture/ cord injury, hip arthroplasty dislocation and spinal 
pseudarthrosis/ discitis. The clinical question was: In adults with AS, what safety aspects 
should be considered in relation to exercise prescription? 
Results  
Direct evidence for exercise safety issues (including adverse events) relating to AS was not 
found, therefore indirect evidence of secondary disease consequences was reviewed. The 
AS population includes people for whom the risks of exercise are higher than a non-AS 
population, secondary to:  
(a) Small increases in cardio-vascular risk factors and ischaemic heart disease; [24]. 
(b) Decreased pulmonary function (in association with decreased axial mobility); [13, 
25]  
(c) Spinal osteoporosis, which appears related to disease activity and duration, and has 
an incidence of 18-67%; [26] 
(d) Spinal fracture risk in established AS of between 14 and 19% [27], which (due to 
the biomechanics of an ankylosed spine) is more likely to result in spinal cord 
injury (SCI) than in a non-ankylosed spine [28], and, 
(e) Impaired balance and righting reactions, again in association with spinal ankylosis 
[12] 
Other less frequent but recognised complications of AS that may be impacted by 
inappropriate exercise include: discitis/ pseudarthrosis (most prevalent at T11/12 level) 
[29]; anterior total hip arthroplasty dislocation [30] and atlanto-axial subluxation [31].  
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Co-morbidity prevalence was consistently shown to be related to disease severity and/ or 
duration, so it should be emphasised that the additional risks described are largely 
restricted to those with more advanced disease. However, the potential consequence for an 
individual of an adverse event is high, and little attention has been paid to this aspect of 
exercise prescription to date. It seems likely that the benefits of exercise still outweigh the 
risks for almost all individuals, however, appropriate exercise prescription is paramount 
for those with more severe disease.  
Recommendation 3: Safety 
Throughout all aspects of exercise prescription, especially for those with more severe or 
advanced disease, the pathological changes of AS must be considered. These include the 
amount of bony change/ ankylosis, balance and mobility changes, osteoporosis, and 
cardiorespiratory consequences of the disease. (CBR) 
Disease Management   
Background 
It is not known whether the beneficial effects of exercise in AS occur at a systemic (e.g. 
anti-inflammatory) or local (e.g. enthesis) level.  In healthy adults, and those with a 
number of chronic diseases, exercise can produce systemic anti-inflammatory effects, [32-
35], but interactions between exercise and pathology are complex. It may be that exercise 
can have either pro or anti-inflammatory consequences for individuals with inflammatory 
arthritis, depending on the type of exercise and the condition concerned [36]. Two clinical 
questions were generated by the WG on this topic: (1) Is exercise effective in disease 
modification (reduction in progression), compared with no exercise? and, (2) are exercises 
in combination with an anti-TNFα medication more beneficial than medication alone? 
[15]. 
Results 
Insufficient evidence was found to determine whether exercise produces local and/ or 
systemic effects in AS, and so a recommendation regarding disease modification was not 
made. However, two RCTs [37, 38], two non-randomised experimental trials [39, 40] and 
one interrupted time series without controls [41] were identified in patients on anti-TNFα 
therapy. The trials consistently demonstrated the beneficial effect of a combination of anti-
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TNFα therapy and an AS-specific exercise program, compared with either anti-TNFα 
treatment or exercise alone, for both self-reported measures (such as function and disease 
activity) and objective measures, such as the Bath Ankylosing Spondylitis Metrology 
Index (BASMI) [42]. Further detail is shown in Appendix B, section 3. 
Recommendation 4: Disease Management 
Individuals receiving anti-TNFα therapy should continue with regular exercise 
prescription as it confers an additional benefit to anti-TNFα therapy alone. (EBR, grade 
B) 
AS-Specific Exercise   
Background 
Traditional goals of exercise in AS have focused on improving and/or maintaining physical 
function and posture by: mobility exercises for axial and peripheral joints; muscle 
strengthening (especially ‘antigravity’ muscles); stretching of specific muscle groups; and 
cardio-respiratory fitness [43]. The combination of soft tissue stretch and dynamic joint 
mobility exercises for ‘tight’ or shortened soft tissues/ restricted joints, and improved 
recruitment and strengthening of ‘lengthened’ muscles is thought to target the 
biomechanical, mobility and postural changes of AS. The clinical question was: In adults 
with AS, is therapeutic (specifically prescribed) exercise aimed at:  
(a) improving mobility/ posture; 
(b) increasing strength; 
(c) improving cardiorespiratory fitness, and, 
(d) improving function (balance, co-ordination, gait, agility and proprioception),  
 more beneficial for pain, mobility, disease activity and physical function than no exercise/ 
general advice only?  
Results 
There were eight systematic reviews (SRs) concerning exercise interventions that were 
widely available or could be reproduced in a non-residential setting. Three [6, 8, 9] 
included meta-analysis of outcome measures, with a consistent trend for small to medium 
effects (including pain, physical function, axial mobility, and other self-reported outcome 
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measures), in favour of various exercise interventions.  
Eleven individual RCTs met our criteria, and most (nine out of eleven) met the commonly 
used benchmark for a ‘good quality’ study, with a score of six or more on the 
Physiotherapy Evidence Database (PEDro scale) [44]. The results are summarised in 
Tables 1 and 2, and in more detail in Appendix B (section B1.4 and table B1), and again 
show a high level of consistency for small to moderate benefits for pain, disease activity, 
axial mobility and function. This was confirmed by our meta-analyses of these studies, 
displayed as Forest plots at figure 2. Statistical heterogeneity was low for most outcomes 
(cervical mobility, finger to floor distance, chest expansion, pain and disease activity) but 
was moderate for lumbar flexion and substantial for physical function.  Potential sources of 
heterogeneity in exercise trials include: the trial participants (in this case, disease severity 
is particularly relevant); exercise dosage (including variation in trial duration and exercise 
frequency, intensity and time); program design (for example, type of exercises, their 
delivery method and setting) and trial methodology and quality [45].  
While these effects are small to modest, recent academic discussion has also highlighted 
the issue of therapeutic validity of trials [46], that is, whether the exercises described meet 
guidelines for dosages known to produce physiological improvements. In general, there 
was poor reporting of exercise goals, program design, outcome measures and adherence, 
and the links between these components were not specified. Dosage (particularly intensity) 
appeared to be insufficient in most trials [9].These factors may account for the trial effect 
sizes being somewhat smaller than those reported anecdotally by patients and clinicians. 
Overall, the WG found that the consistent evidence of benefits for exercise in AS was 
sufficient to form recommendations focusing on axial mobility exercises plus stretch, 
strength, cardiopulmonary and functional fitness. Evidence for further specificity was not 
available, and the WG’s clinical question regarding the best exercise program could not be 
fully answered, although benefits for specific types of exercise could also not be excluded. 
Given the large spectrum of disease activity, severity and variation in presentation of 
mobility impairment in AS, it seems likely that ‘best practice’ will continue to be an 
individualized program where exercises are selected to target an improvement (or 
prevention of deterioration) of identified postural, biomechanical and functional changes. 
Clearly there is overlap and interaction between the different exercise categories, but in a 
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balanced program each aspect should facilitate performance of the other, as shown visually 
in Figure 1. 
Recommendation 5: AS-specific Exercise (Mobility) 
Individual exercise prescription with an emphasis on spinal mobility is paramount for best 
management of AS. Maintaining mobility of peripheral joints is also essential. This can be 
achieved through a number of approaches. At this time we are unable to recommend one 
approach over another, therefore individual goals should be informed by assessment 
findings. (EBR grade A) 
Recommendation 6: AS-specific Exercise (Other) 
Stretching, strengthening, cardiorespiratory and functional fitness are important 
components to include in a balanced exercise program. (EBR grade B) 
Physical Activity  
Background 
There is a large and compelling body of population-based evidence regarding the 
importance of physical activity (PA) for health, [47] resulting in national PA guidelines for 
‘healthy adults’ in most countries. Most current guidelines are based on 150-300 minutes 
of moderate intensity, or 75-150 minutes of vigorous intensity PA per week, plus muscle 
strengthening at least twice per week [48, 49]. The WG was interested in the interpretation 
of such guidelines for people who have AS, the clinical question being: which types of 
physical activity are beneficial for pain, mobility, disease activity and function? 
Results 
There is long-standing consensus that sports/ activities involving high impact, such as 
some football codes, martial arts or distance road running should be avoided in AS due to 
the risk of symptom exacerbation or structural damage to an inflamed or ankylosed spine 
[43, 50]. Similarly, activities which excessively challenge balance may increase falls risk 
and should therefore be avoided. A recent hypothesis [51] suggests that mechanical stress 
may have a role in the disease pathology, and if proven this could further influence activity 
choices. For now, the pragmatic advice remains to avoid high impact activities, particularly 
in disease that is more active, severe or long-standing.  
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Regarding types of widely available leisure activities, three small RCTs investigated the 
effects of tai chi [52], swimming [53] and Pilates [54]. These activities combine aspects of 
mobility, strength and functional (neuromotor) training, suggesting that they could be 
beneficial in AS, and the trials demonstrated small to moderate improvements for self-
reported and performance based measures. A larger survey of 1538 people with AS found 
an association with physical activity levels (PALs) and mobility, but evidence was not 
found for the superiority of one activity over another [55].  
In summary, there was insufficient evidence to show that one type of activity is more 
beneficial – but there is no reason to suggest that people with AS would not benefit from 
maintaining PALs as per the general population. It seems likely that individuals with early 
AS would benefit from a different set (and greater range) of activities than those with later/ 
more advanced disease. In the latter case, safety factors are paramount and physical 
activity guidelines for an older population (such as the National Physical Activity 
Recommendations for Older Australians) [56] may be appropriate.  
Recommendation 7: Physical Activity  
Regular physical activity should be encouraged to promote general health, well-being and 
functional outcomes. (EBR, grade B)  
Dosage  
Background 
 FITT-VP [17] is a widely used framework for exercise dosage and comprises six 
components: Frequency (how often); Intensity (how hard); Time (duration) and Type, 
resulting in a total exercise Volume with the last component being ‘Progression’. Exercise 
dosage should be considered for these parameters in all three of the exercise components 
shown in Figure 1, however, the many variables contributing to an individual’s dose 
response (including genetics, pathology, physiology, psychosocial factors and settings/ 
environments [57]), mean that personalised adaptation of any recommendations is 
desirable. A further consideration is the concept of intensive (larger volume) exercise 
doses that may be indicated in the short-term for a specific purpose, as opposed to 
sustainable (less intensive, smaller volume) doses for the long-term. For mobility, posture 
and stretch exercise, there is obviously an optimal level that can be achieved: once this is 
attained and is stable, a ‘maintenance’ dose (rather than progression) is appropriate. The 
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clinical question was: In adults with AS, what dosage of exercise is beneficial for pain, 
mobility, disease activity and function? 
Results 
The most extensively analysed exercise dosage is that for PALs in healthy adults, as per 
national physical activity guidelines [48, 49]. These are aimed at chronic disease 
prevention, and the evidence for long-term therapeutic exercise is less clear.  
As can be seen from Table 3, there were limitations to the reported dosage information in 
included RCTs. In general, information on exercise frequency was available, with ‘daily’ 
frequency reported in five out of 11 studies [52, 54, 58-60], but with a range down to once 
per week in one study [61]. Other components of exercise volume were often not reported, 
including exercise progression.  
The association between volume of habitual exercise in individuals with AS, and measures 
of pain, disease activity, mobility and function were examined in 13 cross-sectional 
studies, and these are presented in table 4. Again, it was difficult to differentiate between 
exercise types and reported dosage parameters, and all relied on self-reported measures 
except Arends [62] who measured PALs with an accelerometer. Following a survey of 
4282 people, Santos [63] suggested that exercise consistency is the most important factor. 
This term was not specified but appeared to relate to 2 to 4 hours of exercise per week on a 
sustained basis. This was supported by Ward [64] in the USA, who found that back 
exercises on more than five days per week, and recreational exercises for more than 200 
minutes per week, were associated with a decrease in pain and stiffness and improvement 
in function. The higher frequency of back exercises was also associated with slower 
progress of functional disability over five years. There was no direct evidence to suggest a 
minimally effective stretch time.  
Exercise dosage to address the strength, cardiorespiratory and functional (balance/ motor 
skills) consequences of AS received little attention in the literature. Dagfinrud’s [9] study 
found no trials that met ACSM criteria for physiological effectiveness for strengthening 
exercises, and only one trial (out of 12) met the criteria for cardio-respiratory exercise.  
However, it should also be noted that there is a curvilinear dose-response relationship with 
a steep initial slope [65] and most benefit is therefore to be gained by individuals moving 
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from a sedentary lifestyle to performing some regular exercise, in other words, ‘some 
regular exercise is better than none’. This may be pertinent to the significant proportion of 
people with AS who experience persistent pain and/ or fatigue [66], particularly when 
considering a commencement exercise dosage. 
In summary, the relative influence of many variables is unique for each person, so a 
precise ‘one size fits all’ dosage is not possible, and this is reflected in the 
recommendation. Care should be taken to balance an individual’s exercise capacity with 
attaining an adequate dose for effectiveness. Short-term, more intensive exercise dosage 
may be indicated to achieve a specific goal. However, long-term ‘maintenance’ AS-
specific dosages should be realistic and aim for high frequency (five or more days per 
week) and sustainability. This may require compromise from the ‘ideal’ but the dose-
response curve suggests that this may be a better outcome than short-lived attempts at 
unsustainable doses. 
Recommendation 8: Dosage 
Exercise frequency, intensity, duration and type must be tailored to the person’s 
assessment findings, goals and lifestyle.  
(a) For mobility, stretch and postural exercise, consistency is the most important factor  
(b) For other exercise types, national physical activity guidelines may require 
modification. Consideration should be given to disease stage, activity and progression, 
whilst aiming for optimal effectiveness.  (EBR, grade C)  
Adherence 
Background 
The World Health Organisation in its 2003 report ‘Adherence to long-term therapies: 
evidence for action’ defined adherence as ‘the extent to which a person’s 
behaviour….corresponds with agreed recommendations from a health care provider’, and 
further pointed out that an increase in adherence may be much more effective than a 
specific improvement in treatment for a population [67]. For people with AS, the data 
available (table 4) suggests that this is applicable. Predictors for low levels of exercise in 
cross-sectional studies appear inconsistent, as they include: less disability [19]; increased 
pain [68, 69], increased body mass index (BMI) [70] and lower spinal mobility [62]. The 
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relevant clinical question was therefore: which interventions are beneficial for supporting 
adherence to an exercise plan?  
Results 
Adherence was investigated by Barlow [71] in the 1990’s, who noted positive short-term 
effects on adherence with self-help groups and education, but long-term effects were not 
found. Only one lower quality RCT of participants with AS was found for which exercise 
adherence was a primary aim [72], and long-term information was not provided.  
Due to the paucity of research specific to AS, systematic reviews investigating strategies to 
increase adherence to exercise for chronic musculoskeletal conditions were also 
considered. A Cochrane review [73] looking at musculoskeletal pain in adults found 
moderate evidence that exercise adherence can be enhanced, but identified an urgent need 
for good quality research into long-term adherence to exercise interventions. Until that 
time, the authors recommended that patient preference should direct exercise type and 
setting: however, it should be noted that AS was a specific exclusion from this review. 
Conn in 2008 investigated physical activity interventions in adults with arthritis [74], and 
also the effects of education to increase PALs in adults with chronic illness [75]. Again, 
there was evidence that PALs can be positively influenced by interventions, with an effect 
size for educational strategies of 0.45, equivalent to 48 minutes of physical activity per 
week. The former study was a large evidence synthesis (22,257 subjects with chronic 
conditions) and suggested the largest educational effects were those targeting physical 
activity behaviour, reinforced by some sort of PAL monitoring. The latter study found a 
number of strategies that promote PALs: these are summarised in table 5 and reflected in 
the adherence recommendation.  
Recommendation 9: Adherence 
 It is important to assess adherence with regular exercise, encourage motivation and 
promote ongoing self-management (EBR, grade B) 
Exercise Setting 
Background 
A number of settings for exercise in AS have been studied, including: home; clinic/ out-
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patient; gymnasium, out-patient hydrotherapy pool; other leisure activity/ sporting 
environments, spa resort/ balneotherapy centres (often residential); and in-patient hospital 
settings. Balneotherapy refers to baths of warm, mineralised water, usually in combination 
with both active exercises and more passive treatments such as massage or mud packs [76]. 
Many countries lack access to  traditional spa/ balneotherapy centres and so this is not a 
widely available exercise option, however, ‘aquatic physiotherapy’ and ‘warm water 
exercise’ are moderately available. Residential or hospital in-patient treatment is much less 
widely available than in the past. Also relevant here is the mode of delivery, that is, 
whether the exercise was performed as part of a group and with or without health 
professional ‘supervision’. The clinical question was therefore: in adults with AS, which 
widely available exercise settings and modes of delivery are beneficial for pain, disease 
activity, mobility and function? 
Results 
The Cochrane review of physiotherapy (exercise based) interventions for ankylosing 
spondylitis included 11 trials, with a total of 763 participants, published prior to January 
2007 [8]. The outcomes analysed were: pain, stiffness, spinal mobility, physical function 
and patient global assessment, and all interventions were more beneficial than no 
intervention or ‘usual care’. In-patient spa exercise therapy (an exclusion from our study) 
plus group therapy was found to be more effective than group therapy alone; individual 
home-based or supervised exercise programs were better than no intervention, but 
supervised group physiotherapy was better than home exercises. 
Four further RCTs have been published (Appendix B, section 1.8) but these collectively 
demonstrate the difficulties in determining the effects of exercise type versus setting versus 
mode of delivery [37, 53, 54, 77]. Although different exercise settings appear to play a role 
in overall outcome, it is not possible to quantify whether benefits are due to the change in 
setting or environment, or the consequential support for motivation, adherence and higher 
exercise dosage that may arise from supervision and/ or a group mode of delivery. Clinical 
experience suggests that warm water exercise may be particularly beneficial for more long-
standing or severe disease. Unfortunately, since it is not possible to separate the effects of 
exercise in warm water from other passive components of spa therapy, there is currently 
insufficient evidence to support this clinical impression. Hence, the WG consensus was 
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that personal preference, local availability and dosage are more important aspects than 
setting. However, if available, group and / or warm water exercise are likely to provide 
additional benefit.  
Recommendation 10: Settings 
Priority should be given to patient preference in exercise choice to enhance adherence and 
optimise positive outcomes (CBR) 
3.5  Discussion 
This consensus statement provides the first set of comprehensive exercise 
recommendations to guide practitioners’ exercise prescription in AS with practical 
information. As a result of the consensus process, we developed a framework (Figure1) for 
considering all clinically relevant aspects of exercise prescription for people with AS, 
which has the potential to be adapted to other chronic musculoskeletal conditions, such as 
osteoporosis or osteoarthritis.     
The process we followed had a number of strengths and limitations. The WG brought 
considerable experience and expertise in the clinical application of exercise in AS, and the 
development of key topic areas facilitated the investigation of all the important facets of 
exercise prescription in a way that has not been previously attempted. However, there were 
also some limitations to the study. For pragmatic reasons only English language papers 
were considered, and papers were initially selected by one author only: however, included 
papers were subsequently independently reviewed by a second author for suitability. 
Studies of those with axial spondyloarthritis were not included, and more focus on this 
group may be desirable in future. Although one member of the WG has AS, and additional 
patient input was obtained once the draft recommendations were developed, this process 
could have been strengthened by inclusion of people with AS earlier in the process. 
Professions other than physiotherapy are also involved in exercise prescription, and 
broadening of the representation on the WG could be considered in future reviews. 
Although the HP survey results were comparable to external validity testing for other 
rheumatology recommendations [78], a broader range of participants may have 
strengthened the feedback process. Lastly, in clinical practice, exercise may be combined 
with other non-pharmacological modalities, such as joint mobilisation [79], and 
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investigation of such treatment combinations was beyond the scope of this review.   
Combining systematic reviews with consensus recommendations is a lengthy process. In 
order to address the time lag between the initial searches and publication, the review for 
AS-specific exercise was repeated for publications until 1st July 2015. A total of five SRs 
(two with meta-analysis) and seven RCTs met the inclusion criteria. The SRs added weight 
to the recommendations in terms of support for exercise for improved outcomes [80-84].  
More specifically, there was support for: ‘multi-modal’ programs (the main exercise types 
as shown in Figure 1) [80, 85-87]; cardio-vascular training (as per recommendation 6) [88] 
and the synergistic effect of exercise and anti-TNFα medication (recommendation 4) [80, 
82]. There was preliminary evidence for: ‘McKenzie’ (a protocol of repeated spinal 
mobility exercises) in early AS [89]; inspiratory muscle training [90, 91], and aquatic 
exercise [92] in cohorts with more established disease. However, there was agreement that 
‘the most effective exercise protocol remains unclear [86]. We believe that additional 
studies targeting sub-groups such as early or later AS (and the spondyloarthropathies) 
would enable greater specificity regarding exercise recommendations in the future, 
however, the basic framework (Figure 1) will apply to all. With regard to exercise settings 
and supervision, a SR of home-based exercise found small to moderate benefits for pain, 
function, disease activity and depression [81]. However, reviews by Gianotti and O’Dwyer 
[80, 84] and a 12-month follow-up to an RCT [93] support supervision and group 
components, and a large multi-centre trial in Portugal found only small measureable gains 
for a program with minimal supervised exercise practice [94]. These findings have been 
reflected as an additional PP (recommendation 10). 
As previous authors have noted [9], major concerns regarding trial quality and clinical 
relevance remain. In general, future trials should better describe the exercise interventions 
and dosage, and use validated objective measures, such as the BASMI 10 point scale [95]. 
Despite consistent findings that exercise is effective in AS, the potential interactions 
between the physiological effects of exercise and the pathological processes have yet to be 
clarified. More knowledge about this could facilitate precise targeting of exercise effects 
by more informed program design. Investigation of different patient groups (such as those 
with early, well-controlled AS versus long-standing, advanced disease) could determine if 
stratification of patient groups would increase effectiveness – it seems unlikely that ‘one 
size’ will ever ‘fit all’. Further evaluation of the effect of specific programs to address 
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strength, cardiorespiratory and functional factors (such as balance), is also warranted. 
Exercise program design should also be clearly linked to treatment aims and address 
physiological effectiveness, including progression: given that some subjects may start from 
a relatively low baseline, longer studies are therefore required. Such programs would allow 
better titration of dosage and thus may reflect the larger effect sizes that people with AS 
and clinicians often report. Accurate physical activity trackers should in future provide 
better objective data on exercise dosage, and studies that consider long-term outcomes and 
self-management strategies would be more relevant to the reality of limited availability of 
resources. Lastly, this would better inform the most urgently needed area of research, 
which is identified in this review as long-term adherence to exercise strategies.  
3.6  Conclusion 
The evidence found was of mixed quality, but consistently supported the beneficial effects 
of exercise in AS. However, lower quality research in some areas means that the current 
approach remains personalised and targeted to individual therapeutic goals. The ten 
recommendations are specific enough to be clinically useful, but flexible for adaptation to 
the needs of all individuals. This new framework is summarised in figure 1, and has the 
potential to be adapted for other chronic musculoskeletal conditions. Although developed 
for the Australian context, the recommendations would also apply to other regions, 
particularly where spa or residential centres are not routinely available, or to anyone 
seeking information on long-term exercise strategies. Widespread dissemination and 
implementation of the guidelines will be important to ensure a more consistent approach to 
AS exercise management, and optimise outcomes for people with this condition.  
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3.9 Figures and Tables 
Figure 3.1 Framework for Exercise and Ankylosing Spondylitis 
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Aims: 
1. Address primary (musculo-skeletal) consequences of AS 
2. Address secondary consequences of AS (cardio-resp, balance, osteoporosis) 
3. Facilitate physical activity according to national guidelines, with modification for 
AS symptoms, severity, activity & duration as required 
 
The three main types of exercise for a balanced program are shown in the circle, numbered 
for the sequence in which they would usually be addressed. The upper segments of the 
circle indicate exercise types that are therapeutic, that is, address specific aspects of AS 
management. The lower segment addresses exercise for maintenance of health, similar to 
the general population. The arrows indicate that there is interaction between the exercise 
types. The surrounding bars show key aspects of exercise prescription for consideration 
throughout the process, from initial assessment to ongoing practice. Finally, the 
recommendations are broadly applicable and continue to be relevant, even after 
commencement of anti-TNFα therapy. 
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Figure 3.2 Forest plots of meta-analyses 
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(A) Pain; (B) disease activity (BASDAI); (C) cervical mobility; (D) finger to floor distance 
(cm); (E) chest expansion; SD = standard deviation; CI = confidence interval. 
 
Meta-analyses of exercise trials for outcome measures of pain, disease activity, mobility 
(cervical mobility, finger to floor distance, chest expansion and lumbar flexion) and physical 
function, summarised as Forest plots for included studies. A random effects model was used 
due to the heterogeneity of the interventions. The boxes represent point estimates for each 
study, their size being proportional to the size of study. The horizontal bars represent 95% 
confidence intervals and the diamond the pooled effect size. Mean differences were calculated 
where the same scale was used for all studies, and standardised mean differences (SMD) 
calculated where different scales were reported. 
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Box 3.1 Recommendations and Practice Points 
Recommendation 1: Assessment 
• Individual exercise prescription should be informed by a thorough and 
reproducible assessment which includes musculoskeletal and psychosocial 
factors, and AS-specific measures - including objective axial mobility and chest 
expansion. (CBR)  
• The Bath Ankylosing Spondylitis 
Metrology Index (BASMI) [1] is the 
most widely reported, validated 
objective axial mobility measure 
• BASMI is associated with quality of 
life, physical function and 
psychological status 
• The BASMI 10-point scoring scale is 
recommended over the 3-point scale 
• Imaging review/ discussion with 
medical team may be indicated for 
more advanced disease 
• Tape-based hip internal rotation is a 
responsive measure for hip 
involvement 
• Strength, balance or 
cardiorespiratory function should 
be assessed as required 
Recommendation 2: Monitoring 
Sufficient monitoring and feedback should be provided on an individual basis, to achieve 
confidence and competence with exercise, and to inform changing needs for exercise 
prescription. This is recommended at least annually, and more often as symptoms, 
function and mobility indicate (CBR) 
• Feedback, particularly mobility 
measures, can be important for 
exercise adherence. 
• BASMI raw scores are more sensitive 
to change than index scores 
• In BASMI, lumbar side flexion is the 
most sensitive to change 
• The Edmonton AS Metrology Index 
(EDASMI) [2] may be useful for 
patient self-monitoring 
Recommendation 3 : Safety 
Throughout all aspects of exercise prescription, especially for those with more severe or 
advanced disease, the pathological changes of AS must be considered. These include the 
amount of bony change/ankylosis, balance and mobility changes, osteoporosis, and 
cardiorespiratory consequences of the disease (CBR) 
Most types of exercise are safe for the 
majority of patients. However, the following 
require assessment on a case by case basis, 
and may be contra-indicated in more 
advanced AS: 
• High impact exercise/ physical 
activity (e.g. contact sports, martial 
arts, four wheel driving, boating in 
rough seas, fairground rides) 
balance, postural stability or 
cardiorespiratory function (in a 
non-controlled environment) 
• High velocity or strongly resisted 
exercise, especially trunk flexion/ 
rotation 
• Excessive spinal or peripheral joint 
mobility gain where there is 
adjacent ankylosis 
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• Exercise which excessively challenges  • Excessive end range mobility gain 
following total hip replacement 
Recommendation 4: Disease Management 
Individuals receiving anti-TNFα therapy should continue with regular exercise 
prescription as it confers an additional benefit to anti-TNFα therapy alone (EBR, grade B) 
• Exercise could theoretically be a 
mediator of inflammation in AS, but 
trial results have been conflicting 
• Stabilisation with anti-TNFα therapy 
can be a ‘window of opportunity’ to 
optimise mobility and physical 
fitness 
 
Recommendation 5: AS-Specific Exercise – Mobility  
Individual exercise prescription with an emphasis on spinal mobility is paramount for 
best management of AS. Maintaining mobility of peripheral joints is also essential. This 
can be achieved through a number of approaches. At this time we are unable to 
recommend one approach over another, therefore individual goals should be informed 
by assessment findings. (EBR grade A) 
• Mobility goals may vary from 
restoration of full spinal range and 
normal posture [early, well 
controlled disease], to maintenance 
of existing range [later disease]. 
• Exercise choice (e.g. specific 
proprioceptive neuromuscular 
facilitation techniques) can be 
tailored to target movement or 
functional deficits 
Recommendation 6: AS-Specific Exercise -Other 
Stretching, strengthening, cardiopulmonary and functional fitness are important 
components to include in a balanced exercise program (EBR grade A) 
• There is preliminary evidence for 
(modified) Pilates and tai chi, 
incentive  
spirometry and global postural re-
education as effective modalities 
Recommendation 7: Physical Activity  
Regular physical activity should be encouraged to promote general health, well-being 
and functional outcomes (EBR, grade B)  
• No one activity has been found to be 
superior  
• Regular interruption of sedentary 
activities should also be encouraged 
• Occupational, transport and leisure 
activities contribute to total 
physical activity levels 
Recommendation 8: Dosage 
Exercise frequency, intensity, duration and type must be tailored to the person’s 
assessment findings, goals and lifestyle.  
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(a) For mobility, stretch and postural exercise, consistency is the most important  factor  
(b)   For other exercise types, national physical activity guidelines may require 
modification. Consideration should be given to disease stage, activity and 
progression, whilst aiming for optimal effectiveness  (EBR, grade C) 
• Factors which may indicate 
modification of baseline exercise 
dose include: pain/ fatigue; disease 
activity and any secondary AS 
consequences (cardio-respiratory, 
ankylosis, osteoporosis, balance 
impairment) 
• Dosage progression (titration) 
should balance individual exercise 
response with training for 
physiological change  
• Mobility exercise can be 
incorporated in regular breaks from 
sitting  
• Short-term more intensive doses 
may be appropriate for specific 
purposes. 
Recommendation 9: Adherence 
It is important to assess adherence with regular exercise, encourage motivation and 
promote ongoing self-management (EBR, grade B) 
• Group settings and monitoring have 
been shown to support adherence in 
AS  
 
Recommendation 10: Exercise Setting 
Priority should be given to patient preference in exercise choice, to enhance adherence 
and optimise positive outcomes (CBR) 
• AS-specific group therapy and warm 
water exercise may be beneficial 
adjuncts  
to an individual’s regular home 
exercise program. 
 
Recommendations are shown in bold type, with supporting practice points where there was a 
need to provide practical guidance to support the recommendation.  Development details, 
definitions and evidence are shown in Appendix B (recommendations) and Appendix C 
(practice points). 
EBR Evidence Based Recommendation, based on body of evidence[3]: 
grade A - Body of evidence can be trusted to guide clinical practice 
grade B - Body of evidence can be trusted to guide clinical practice in most situations 
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grade C – Body of evidence provides some support for recommendation, but care 
should be taken in its application 
grade D – Body of evidence is weak and recommendation should be applied with 
caution 
CBR Consensus Based Recommendation, developed by the WG where there was 
insufficient direct (or poor quality) evidence to answer the clinical question 
 
1. Jenkinson T, Mallorie P, Whitelock H, Kennedy G, Garret S, Calin A: Defining 
Spinal Mobility in Ankylosing Spondylitis (AS). the Bath Metrology Index. The 
Journal of Rheumatology 1994, 21(9):1694-1698. 
2. Maksymowych WP, Mallon C, Richardson R, Conner-Spady B, Jauregui E, Chung C, 
Zappala L, Pile K, Russell AS: Development and validation of the Edmonton 
Ankylosing Spondylitis Metrology Index. Arthritis Rheum 2006, 55(4):575-582. 
3. Australian Government National Health and Medical Research Council (NHMRC): 
additional levels of evidence and grades for recommendations for developers of 
guidelines. In., vol. 2009: NHMRC; 2009. 
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Table 3.1: AS-Specific Exercise: Interventions and outcomes (pain, disease activity and physical function)  
 
Study Treatment Groups PEDro 
Score 
/10 
No. in  
group 
Duration Assess. 
point(s) 
Outcome   
SMD (95%CI) 
Pain  Disease 
activity  
Physical 
function  
Altan 2012 I: Pilates with trainer, x3/week  
C: standard treatment program 
 
8 30 
25 
12 weeks Week 12 
Week 24 
 -1.00   
(-2.00, -
0.00) 
-0.36 
(-.90,0.19) 
Analay 2003 I: AS education session; supervised exercise programme, x3/week 
C: AS education session; instruction to perform the same exercises at 
home x3/week; weekly progress phone call 
7 23 
 
22 
6 weeks Week 6 
Week 12 
0.02  
(-.57,0.60) 
 -0.39 
(-.98,0.21) 
Cagliyan 
2007 
I: AS education session; supervised exercise program x2/ week 
C: AS education session; instruction to perform exercises at home; 
telephone follow-up 
4 23 
 
23 
12 weeks Week 12 
Week 24 
 -1.00 
(-1.84,  
-0.16) 
-0.62  
(-1.21, 
-0.03) 
Fernandez-
de-las-Penas 
2005 
I: Weekly supervised exercise session,  Global Postural Re-education 
method 
C: Weekly supervised exercise, using conventional exercises 
6 20 
 
20 
16 weeks Week 16  -0.02  
(-0.64, 
0.60) 
-0.04 
(-.66.0.58) 
Hidding 
1995 
I: Weekly group physiotherapy: mobility/ strengthening exercises, 
sports & hydrotherapy, plus daily individual home exercise program  
C: Daily individual exercise program  
7 67 
 
 
68 
36 weeks Week 36 not 
estimable 
 -0.12 
(-0.46, 
0.21) 
Ince 2006 I: Supervised multimodal exercise program (warm-up, aerobic step, 
stretching & pulmonary exercises) plus information on exercise 
benefits 
C: Information on exercise benefits only 
7 15 
 
 
15 
12 weeks Week 12    
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Kraag 1990 I: Home physiotherapy: combination of education, passive techniques 
plus therapeutic exercise according to individual problem list 
C: No treatment 
8 22 
 
26 
16 weeks Week 16 -0.73  
(-1.31, -
0.14) 
 -1.78  
(-2.47,-
1.10) 
Lee 2007 I: Tai chi for RA program; plus home practice; tai chi video; 
telephoned by researchers x2/week 
C: no structured exercise program; telephoned by researchers x2/ 
week 
6 13 
17 
8 weeks Week 8  -0.03 
(-1.19, 
1.12) 
 
Lim 2005 I: Home exercise program (for muscle relaxation, flexibility, strength, 
breathing and posture) taught individually; requested practise was 
daily x 30 minutes  
C: no intervention 
6 25 
 
25 
8 weeks Week 8 -0.34 [-
0.90, 0.21] 
Not 
estimable 
-0.67  
(-1.24, -
0.10) 
Maseiro 
2011 
I- A: Educational/ behavioural meetings x 2, then exercise training x 
2/ week: flexibility, stretches, proprioceptive, breathing & endurance. 
Home practice x3-4 / week requested; exercise DVD and monthly 
phone calls. 
I- B: Educational / behavioural meetings only 
C: No intervention 
7 20 
 
 
 
20 
22 
6 weeks Week 8 
Week 24 
-0.63 
(-1.25, 
 -0.01) 
-0.38 
(-1.72, 
0.96) 
-0.56 
(-1.18, 
0.06) 
So 2012 I: Incentive spirometer exercise program daily, plus education/ 
conventional home exercise program (spinal flexibility, stretches and 
breathing exercises) 
C: Education and individual counselling plus instruction in a 
conventional home exercise program 
6 23 
 
23 
16 weeks Week 16  -0.61 
(-1.53,  
0.31) 
-0.36 
(-0.95, 
0.22) 
Overall  
Effect 
 
NB. All in favour of intervention groups 
    -0.42  
(-0.74, -
0.09) 
-0.47 
(-0.84,  
-0.09) 
-0.51 
(-0.81, -
0.21) 
 
I Intervention group; C Contol group; MD Mean Difference; SMD Standardised Mean Difference; PEDro Physiotherapy Evidence Database; VAS 
Visual Analogue Scale; BASDAI Bath Ankylosing Spondylitis Disease Activity Scale; BASFI Bath Ankylosing Spondylitis Functional Index 
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Table 3.2 AS Specific Exercise: Axial mobility interventions and outcomes  
Study Exercise Type Mobility/ stretch exercise type 
 
Mobility outcomes 
DF AcS BS PS PNF U Lumbar flexion  
SMD [95%CI] 
Cervical mobility 
SMD [95%CI] 
Chest expansion 
MD cm [95%CI] 
Fingertip to floor 
distance MD cm 
[95%CI] 
Altan 2012 Pilates  X     X   0.50 
[-0.37, 1.37] 
 
Analay 2003 Multi-modal      X 0.40  
[-0.19, 1.00] 
 0.51 
[-0.68, 1.70] 
-2.63 
[-12.06, 6.80] 
Cagliyan 2007 Multi-modal      X  -0.09 
[-0.67, 0.48] 
  
Fernandez-de-las-
Penas 2005 
Global Postural 
Re-education  
X   X X  -0.24 
[-0.87, 0.38] 
0.00 
[-0.62, 0.62] 
  
Hidding 1995 Mobility 
 
     X Not estimable Not estimable Not estimable  
Ince 2006 Multi-modal  X  X   0.77 
[0.03, 1.52] 
 1.46 
[0.29, 2.63] 
-3.40 
[-14.62, 7.82] 
Kraag 1990 Mobility     X  0.57 
[0.01, 1.13] 
  -8.50 
[-16.06, -0.94] 
Lee 2007 Tai chi       X    0.50 
[-9.38, 10.38] 
Lim 2005 * Not specified      X  0.41 
[-0.11, 0.93] 
 -7.20 
[-16.71, 2.31] 
Maseiro 2011 Multi-modal X   X X  0.29 [-0.32, 0.90] 0.43 
[-0.18, 1.05] 
0.95 
[-0.10, 2.00] 
 
So 2012 Inventive 
spirometer  
     X   0.84 
[-0.16, 1.84] 
-5.00 
[-11.55, 1.55] 
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Overall Effect 
NB. All in 
favour of 
intervention 
groups 
       
0.35 [0.02, 0.67] 
 
0.20 [-0.09, 0.49] 
 
0.81 [0.35, 1.28] 
 
-4.87 [-8.38, -1.37] 
 
 
DF Dynamic Flexibility; PNF Proprioceptive Neuromuscular Facilitation; BS Ballistic Stretch; U Unspecified ; PS Passive Static Stretch 
* Data estimated from graphical presentation ; AcS Active Stretch; SMD  Standardised Mean Difference; MD Mean Difference  
 
NB. All effects in favour of intervention group  
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Table 3.3 RCT exercise volume in individuals with AS, compared with pain, disease activity, mobility or function 
Author Country Frequency 
(intervention group) 
Intensity Time in minutes/ 
week (session length 
if reported) 
Type Statistically significant 
beneficial associations with 
pain, disease activity, mobility 
or function 
Altan 2012 Turkey Daily  n/a 210 balneotherapy; 
210 HEP (30 min 
sessions) 
HEP + balneotherapy vs HEP 
only 
Pain, BASDAI, range of 
mobility measures, BASFI – for 
both groups 
Analay 2003 Turkey X3/week ‘to individual tolerance’ 150 (50 min sessions) Stretch, mobility, strength, 
aerobic 
Pain; BASFI 
Cagliyan 2007 Turkey X2/week  n/a 120 (60 min sessions) Joint/ spinal mobility, 
stretching, strength, 
respiration, posture 
Pain, BASDAI, mobility and 
BASFI 
Fernandez-de-
las-Penas 2005 
Spain X1/week Mobility 2x 8-10 reps; 
Stretches up to 4 
minutes 
60 Global Postural Re-education Mobility; function 
Hidding 1995 Netherlands X1/week (group) + 
daily HEP 
n/a 180 (group); 156 
(HEP)  
Physical training (60); 
sports(60); hydrotherapy (60) 
Thoraco-lumbar mobility 
Ince 2006 Turkey X3/week Low intensity aerobic 
(metronome to 
standardise intensity) 
150 (50 min sessions) Stretch, aerobic, chest 
expansion 
Range of mobility measures; 
physical work capacity; vital 
capacity 
Kraag 1990 Canada ‘Daily’ n/a n/a Individual exs program + 
manual techniques 
Finger to floor distance & 
function 
Lee 2007 South Korea Instruction x2/ week; 
daily practice (x2 daily 
for last 2 weeks) 
n/a 315 (45 min sessions) Tai chi for RA (warm up, 21 
tai chi movements, cool down) 
BASDAI; finger to floor 
distance 
Lim 2005 South Korea ‘Daily’ n/a 210 (30 min sessions) HEP – mobility; strength; 
posture 
Pain; mobility; function 
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Masiero 2011 Italy X2/week (group) 
X3-4/week (HEP) 
Mobility 2x10 reps; 
Stretches 30-40 
seconds; aerobic- low 
speed, no resistance 
120 (60 min group 
session) 
HEP n/a 
Mobility, breathing exs, 
balance, posture, 
proprioception, stretch, 
strength, aerobic (walk, 
treadmill, cycle) 
BASDAI, BASFI, BASMI 
So 2012 South. 
Korea 
Daily Incentive spirometer 
breath holds 3-5 
seconds 
Incentive spirometer 
350; HEP 350 
HEP- mobility; stretch; chest 
expansion 
Mobility; BASDAI, BASFI 
(both groups); pulmonary 
function for incentive 
spirometer group 
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Table 3.4 Habitual (‘unsupervised’) exercise volume in individuals with AS, and associations with pain, disease activity, mobility or function 
Author Country N Frequency Intensity Time/ week Type Other findings 
Arends 
(2011) 
The 
Netherlands 
55 n/a n/a Measured in Kilo 
counts / day 
(accelerometer) but 
values not stated 
PAL for 7 days PAL negatively associated with 
inflammatory markers, BASFI; 
positively associated with Schobers test, 
lateral flexion & neck rotation; no 
association with chest expansion, 
BASDAI or occiput to wall distance 
Brodin 
(2007) 
Sweden 50 Never 22%; ≤ x1/week 
18%; 1-2x/week but 
irregular 2%; ≥ x2/ week 
58% 
n/a n/a Pool exs; walk; 
resistance exs; aerobic 
exs; cycle; floorball; 
golf; jogging; Nordic 
walk; tai chi 
Higher exercise frequency (>2x/week) 
predicted by long duration of symptoms, 
prior exercise habits, higher disease 
activity and living alone 
Carter 
(2006) 
UK 131 Daily 35%;3–5 x/ week 
26%; 1–2 x/week 27%; 
< 1x/ week or none 12% 
n/a n/a Walk 73%; swim 27%; 
HEP 18%; pool exs 
14%; cycle 11% 
No associations found for pain, BASDAI 
Cooksey 
(2012) 
UK 326 Moderate-high PAL by 
IPAQ-SF score 
n/a n/a n/a PALS independently associated with 
function 
Falkenbach 
(2003) 
Austria 132 >x2/week 19%; 1-
2x/week 36%; <x1/week 
45% 
n/a n/a Cycle 22%; swim 21%; 
walk 10%; other sports 
47% 
PALS positively associated with  
mobility 
Falkenbach 
(1999) 
Austria 132 <x1/week 36%; 1-
3x/week 46%; >x3/week 
18% 
n/a n/a AS specific HEP Exs frequency positively associated with 
HAQ score 
Fitzpatrick 
(2006) 
Ireland 198 AS-specific 5-7 
days/week 20% 
n/a PAL>200 mins/week 
30% 
n/a Barriers to exercise were lack of 
time and motivation , fear of symptom 
exacerbation and  fatigue  
Haglund 
(2012) 
Sweden 2167 Criteria met for 
moderate (x5-7/ week) 
or vigorous (2-3/week) 
physical activity 68% 
Criteria for 
mod. to 
vigorous PAL 
met / not met 
Exercise sessions>30 
mins/ week met or not 
met 
n/a 68% met WHO PAL recommendations 
for healthy adults 
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O’Shea 
(2008) 
UK 61 Walk 3x/week 35%; 
stretch 3x/week 32% 
n/a n/a n/a High scores for both perceived benefits 
and perceived barriers 
 
Santos 
(2002) 
UK 4282 n/a n/a 0 hrs 21%; 1 hr 20%; 2-
4 hrs 35%; 5-9 hrs 
15%; >10 hrs 9%  
Sport, AS specific HEP 
or hydrotherapy 
2-4 hrs/ week positively associated with 
function & inversely associated with dis. 
act. >10 hrs improved function but not 
dis. act. 
Sundstrom 
(2002) 
Sweden 189 Daily 9%; 3-6 x/week 
15%; 1-2 x/week 30%; 
<1x/week 26%; no exs 
17% 
n/a n/a Walk 57%; pool exs 
38%; cycle 33% 
Most common exercise barriers were 
lack of time and fatigue 
Uhrin 
(2000) 
USA 220 Back exercises: 30%  0 
days/week; 40% 1-4 
days/week; 11% 5-7 
days/week  
n/a Median PAL 85 
mins/week 
Back exs 
Rec exs – several listed  
Back exs> 5days/week & rec. exs > 200 
mins/week associated with decrease in 
pain & stiffness, improvement in 
function 
Ward 
(2002) 
USA 212 Back exs 3±2.6 
days/week 
n/a Rec. exs. 139 ± 161 
mins/week 
Back exs 
Rec exs – several listed 
More frequent back exs associated with 
slower progress of functional disability 
over 5 years 
 
 
BASDAI Bath Ankylosing Spondylitis Disease Activity Index; dis. act. disease activity; BASFI Bath Ankylosing Spondylitis Functional Index; exs. 
Exercises; HAQ – Health Assessment Questionnaire ; HEP Home Exercise Program; PAL Physical Activity Level; rec. exs.  Recreational exercises; 
WHO World Health Organisation; IPAQ-SF International Physical Activity Questionnaire Short Form 
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Table 3.5 Intervention Attributes or Practices that  Promote Physical Activity (Adapted from Ruppar [96], with permission) 
 
Strength of 
Evidence 
Attribute or Practice Definition 
Strong Single target: physical activity only Interventions designed to modify only behaviour related to physical activity, 
rather than multiple health behaviours 
Behavioural approaches Interventions containing at least one behavioural strategy, designed to produce a 
direct change in behaviour related to physical activity 
Self-monitoring Interventions including practices such as keeping an activity diary, tracking 
activity in a calendar, or recording activity on a website 
Moderate Supervised exercise Exercise overseen by a member of the research team or a health care provider 
Tailoring Adapting the intervention to meet the needs of the situation or patient 
Contracting An agreement between patient and provider defining the level and duration of 
physical activity the patient will perform 
Exercise prescription Participants receive written instruction for the mode, duration, frequency, intensity 
and progression of their physical activity 
Fitness testing Patient’s level of physical fitness is evaluated before any physical activity 
program is initiated 
Stimuli and cues Interventions employ prompts that remind participants to exercise 
Moderate or high intensity recommendations Recommendations are for moderate or high intensity (as opposed to low intensity) 
physical activity 
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3.10 Appendices 
 
Appendix A Systematic review methods, included and excluded 
papers 
3A1 Systematic Review Methods 
3A1.1 Search strategy 
• Exercise was defined as:  ‘the prescription of a physical activity program that involves 
the client undertaking voluntary muscle contraction and / or body movement with the 
aim of relieving symptoms or improving function, or improving, retaining or slowing 
deterioration of health’  [1].  
• Each member of the working group (WG) independently submitted their ten most 
important clinical questions about exercise for ankylosing spondylitis (AS). These 
were grouped according to topic by the project co-ordinators (JM and JZ), and an 
overarching question was derived for each topic. 
• For each clinical question, a systematic review (SR) of five databases (Medline; 
PEDro; CINAHL; EMBASE; SPORT discus) was undertaken by the main author 
• Electronic databases prior to 1/12/12 were searched according to PICO: 
 
Patients Adults with ankylosing spondylitis (AS) according to 
modified New York criteria/ rheumatologist diagnosis 
Intervention All therapeutic exercise related interventions 
Comparison No exercise intervention, or a different type of exercise 
intervention, or usual care 
Outcomes Pain, mobility, disease activity, physical function 
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• The process was derived from GRADE (Grading of Recommendations, Assessment,  
Development and Evaluations) Guyatt G, Oxman AD, Akl EA, Kunz R, Vist G, 
Brozek J, et al. GRADE guidelines: 1. Introduction-GRADE evidence profiles and 
summary of findings tables. Journal of clinical epidemiology. 2011;64(4):383-94. 
 
• PubMed Search Strategy 
1. “spondylitis, ankylosing” [MESH] 
2. spondyloarth* [all fields] 
3. ankylosi* [all fields] 
4. 1 OR 2 OR 3 
5. mobil* OR metrology OR range OR movement OR physical 
6. assess* OR measur* OR monitor* 
7. 5 AND 6 
8. exercis* OR “exercise therapy” OR therap* OR rehabil* OR movement OR 
motion OR physical OR physio* OR kinesio*  
9. 4 AND 8  
10. compliance OR adherence OR motivation OR behav* change 
11. “adverse event” OR safety OR harm OR “disease modification” OR “disease 
progression” OR complication* OR “spinal cord injury” OR fracture 
12. mobil* OR cardio* OR pulmonary OR function OR “quality of life” OR pain 
OR fatigue OR postur* OR fitness OR range OR metrology   
13. stretch* OR strength* OR mobil* OR resist* OR stabil* OR core OR 
hydrotherapy OR “posture exercise” 
14. pilates OR tai chi OR aerobic OR swimming OR balneotherapy OR “dance 
therapy” OR yoga OR walk* OR cycl* 
15. land OR group OR home OR pool OR setting OR facility OR spa OR gym 
16. frequency OR duration OR amount OR dosage OR dos* OR intensity OR 
prescription OR repetition 
17. 4 AND 7   [assessment & monitoring] 
18. 9 AND 10 [adherence] 
19. 9 AND 11 [disease management/ safety] 
20. 9 AND 12 [exercise outcome] 
21. 4 AND 13 [exercise-AS specific] 
22. 4 AND 14 [physical activity] 
23. 9 AND 15 [exercise-setting] 
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24. 9 AND 16 [exercise-dosage] 
 
• The above strategy was modified as required for other databases 
• Hand searches of reference lists also completed 
• The principle of selecting the best available level of evidence for each topic was 
applied, and the overarching inclusion and exclusion criteria are shown in Table A1. 
 
3A1.2 Study selection, data extraction and quality assessment 
• The WG members were each allocated a selection of randomised trial papers, to 
review the basis for inclusion (see specific criteria in Table A1) and the evidence 
quality.  
• A pre-determined ‘evidence matrix sheet’ was completed. It was based on the 
Physiotherapy Evidence Database (PEDro) scale, which has been shown to have 
acceptably good reliability [2, 3] and validity [4]. 
• The PEDro 11 point scale results in a total score out of 10: criterion 1 does not count 
towards the score. RCTs were rated ‘high’ quality if they scored 6 or more on the 
PEDro scale, and those with a score of 5 or less were rated ‘low’ quality. 
• The PEDro scoring criteria are as follows: 
1. Eligibility criteria specified? 
2. Subjects randomly allocated 
3. Allocation concealed? 
4. Groups were similar at baseline? 
5. Blinding of subjects? 
6. Blinding of therapists? 
7. Blinding of assessors? 
8. Outcome measures from >85% of subjects? 
9. Treatment as allocated or as ‘intention to treat’? 
10. Statistics presented on between-group analysis for >1 key outcome? 
11. Point measures and measures of variability for >1 key outcome? 
12. Total PEDro score  
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• Included in the evidence matrix pro forma were the following headings/ questions 
regarding the reviewer’s opinion  on the paper: 
1. Provide a summary of study methods and findings 
2. Was the intervention described in sufficient detail to be clinically useful? 
3. What were the strengths of the paper? 
4. What were the limitations of paper? 
5. What is the relevance to the clinical questions for this topic?  
6. Is the intervention readily available in Australia?  
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Table 3A1. Overarching inclusion and exclusion criteria 
 Inclusion Exclusion 
Population Adults with ankylosing spondylitis (AS) 
according to modified New York criteria or 
rheumatologist diagnosis 
Participants with other/  unspecified 
musculoskeletal conditions 
Intervention Subjects participated in active exercise 
interventions prescribed to manage AS 
Exercise was passive only 
Investigation of interventions other 
than exercise 
Provision of exercise information only 
Comparison No exercise, or another type of exercise, or 
usual advice 
 
Purpose of paper:  Addresses the clinical question for the topic of 
interest (i.e. Assessment, Monitoring, Safety, 
Disease Management, AS-Specific Exercise, 
Physical Activity, Dosage, Adherence or  
Setting) 
Does not address the clinical question 
Outcomes: Evaluates pain, spinal mobility, disease 
activity or physical function  
Does not address outcomes of interest 
Evaluation of cost-effectiveness 
Follow up studies 
Type of paper The highest level of available evidence, 
according to National Health and Medical 
Council (NHMRC) guidelines for each topic, 
i.e. Systematic reviews (SRs) or randomised 
controlled trials (RCTs) where available 
Lower levels of evidence, where SRs 
and RCTs are available 
Language English Other languages 
Date of 
publication 
Commencement of the database until 
December 1st, 2012 
Publication after 1st December 2012 
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3A1.3 Data analysis  
• Where data were available, we undertook meta-analyses using the Cochrane 
Collaboration’s Review Manager software (RevMan), version 5.2, for outcomes of 
pain, disease activity, axial mobility and physical function.  
• Data were extracted by the main author only, with subsequent review by all authors. 
• Mean differences were calculated where the same scale was used for all studies, and 
standardised mean differences (SMD) calculated where different scales were reported. 
A random effects model was used due to the heterogeneity of the interventions.  We 
considered heterogeneity of the data statistically significant at P < 0.1 by using a 
standard Chi2 test as well as assessing the I2 statistic; a value greater than 50% was 
considered substantial heterogeneity.  
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Figure 3A1: Search Results 
 
 
 
Adapted from:  Moher D, Liberati A, Tetzlaff J, Altman DG, The PRISMA Group (2009). 
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA 
Statement. PLoS Med 6(6): e1000097. doi:10.1371/journal.pmed10000 
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3A2 Included Papers 
3A2.1 Assessment and monitoring 
1. Auleley GR, Benbouazza K, Spoorenberg A, Collantes E, Hajjaj-Hassouni N, van der Heijde 
D et al: Evaluation of the smallest detectable difference in outcome or process variables in ankylosing 
spondylitis. Arthritis Rheum 2002, 47(6):582-587. 
2. Ayhan-Ardic FF, Oken O, Yorgancioglu ZR, Ustun N, Gokharman FD: Pulmonary 
involvement in lifelong non-smoking patients with rheumatoid arthritis and ankylosing spondylitis 
without respiratory symptoms. Clin Rheumatol 2006, 25(2):213-218. 
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Appendix B: Summary of evidence for recommendations 
Table 3B1 Summary for each recommendation 
Topic 
 
3B1.1 Assessment and monitoring 
Clinical question In adults with ankylosing spondylitis (AS), which measures are beneficial for baseline mobility assessment, in order to inform 
exercise prescription? What are the minimum requirements for monitoring these measures? 
Criteria Inclusion:     
Studies include measures related to mobility assessment. 
Accurately described technique  
Reproducible in usual clinical setting    
Exclusion:   
Mobility measures not well described    
Not reproducible in usual clinical setting   
No & type of studies 40 included papers: 2 – part of RCT; 7 – longitudinal (non-controlled); 9 - cross-sectional (with matched controls); 1 – review; 1 
– guideline; 20 – cross-sectional (no controls) 
Level of evidence Level C/D 
Quality of studies/ risk of bias  n/a 
Relevance to Australian (non-
residential) setting 
High – large number of studies/ information on physical assessment tools 
Reproducibility of exercises Accurate descriptions / instructions available for most measures 
Consistency of results B 
Effect sizes (if applicable) n/a 
Other factors No studies were found which directly related choice of assessment/ monitoring tool to exercise prescription  
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Recommendation(s) Recommendation 1:  Assessment 
Individual assessment prescription should be informed by a thorough and reproducible assessment which includes 
musculoskeletal and psychosocial factors, and AS-specific measures -including objective axial mobility and chest expansion.  
 
Recommendation 2: Monitoring  
Sufficient monitoring and feedback should be provided on an individual basis, to achieve confidence and competence with 
exercise, and to inform changing needs for exercise prescription. This is recommended at least annually, and more often as 
symptoms, function and mobility indicate.  
Grading of 
Recommendation(s)  
Recommendation 1: CBR 
• Despite the large number of studies regarding assessment methodology for AS, no direct evidence was found which 
answered the clinical question.  
• The information obtained regarding assessment methods has been summarised as practice points for recommendations 1 
and 2. 
 
Recommendation 2: CBR 
• No direct evidence on minimum monitoring requirements was found 
• Some evidence was found linking exercise adherence with monitoring of mobility measures (refer to Topic 9- 
adherence). 
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Discussion Most (29) studies were cross-sectional and most (27) did not include controls. Reviews by the Assessment of SpondyloArthritis 
International Society (ASAS) [1, 2] resulted in a recommended ‘core set’ of individual spinal mobility measures, which are 
incorporated in two composite AS anthropometric measures, the Bath AS Metrology Index (BASMI) [3] and the Edmonton AS 
Metrology Index (EDASMI) [4]. Each has advantages and limitations, as outlined in the practice points, however, both fulfil the 
requirement for a validated, easily reproducible tool, which can provide clinical guidance on exercise choice for individual 
patients. 
 
Chest expansion is a measure of thoracic mobility but the WG also questioned whether it could indicate cardiorespiratory 
function (CRF). Ten studies were found which investigated the associations between anthropometic measures, such as chest 
expansion, and laboratory measured CPF. Two small cross-sectional studies [5, 6] did not find such an association, but the 
remainder did, including a larger cross-sectional, controlled study with 147 patients with AS and 121 controls. This 
demonstrated a ‘clear relationship’ between reduced spinal mobility (including chest expansion) and restrictive pulmonary 
function in subjects with AS [7]. Given the importance of thoracic mobility and CRF, monitoring of chest expansion is therefore 
a recommended baseline measure. 
 
No direct evidence was found to inform frequency of monitoring of anthropometric and other measures. However, since AS is a 
progressive condition, and optimal exercise recommendations vary over time, longitudinal repetition of physical measures to 
inform adjustment to individual prescription makes clinical sense. 
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Topic 3B1.2 Safety 
 
Clinical question In adults with AS, what safety aspects should be considered in relation to exercise prescription?  
Criteria Inclusion: 
Studies include aspects which could influence safety in 
exercise prescription, i.e. balance; cardio-vascular & 
pulmonary function, fracture risk/ osteoporosis 
Full text articles  
Experimental studies and reviews 
Guidelines for other chronic conditions (where no direct 
evidence available) 
Exclusion: 
Case studies 
Conference abstracts only 
No & type of studies 53 included papers: 17 - cross-sectional (with matched controls); 11 – cross-sectional (no controls); 18 – review; 3 – systematic 
review; 1- case series; 3- guidelines addressing broader groups (chronic disease, osteoporosis, pre exercise screening) 
Level of evidence Level C/D 
Quality of studies/ risk of bias  n/a 
Relevance to Australian 
setting 
High – large amount of information on disease consequences 
Reproducibility of exercises n/a 
Consistency of results B 
Effect sizes (if applicable) n/a 
Other factors No studies were found which directly related to safety in exercise prescription. Broader information on aspects known to 
influence exercise safety was therefore sought. 
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Recommendation(s) Recommendation  3:  Safety  
Throughout all aspects of exercise prescription, especially for those with more severe or later disease, the physical changes of 
AS must be considered. These include the amount of bony change/ ankylosis, balance and mobility changes, osteoporosis, 
and cardio-pulmonary consequences of the disease (CBR) 
 
Grading of 
Recommendation(s)  
Recommendation 3: CBR 
• No direct evidence was found which answered the clinical question, therefore graded CBR 
• There is considerable evidence regarding known exercise risk factors such as cardio-pulmonary impairment, 
osteoporosis and balance impairment in AS 
• Although adverse events for exercise in AS have not been reported, there is anecdotal evidence within the group of such 
occurrences. This has been incorporated into the practice points. 
Discussion For people with more severe disease, the task of planning exercise that is simultaneously effective in terms of training [8] but 
minimises the risk of an adverse event, requires an appropriate level of knowledge, skill and planning. The evidence underscores 
the importance of adequate assessment prior to commencement of an exercise program, and monitoring of outcomes. BASMI 
and chest expansion, in conjunction with imaging findings, may help guide the level of structural change and potential risk. 
Standard exercise guidelines may require significant modification for an individual with ankylosis, in terms of type of exercise, 
starting position, baseline intensity and grading of progression [9], as indicated in the practice points. These are in addition to the 
pre-exercise screening that is recommended for all adults prior to an increase in aerobic exercise levels [10]. Reference to other 
guidelines for exercise prescription in chronic disease, [11] or osteoporosis [12] may also be indicated. 
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Topic 3B1.3 Disease Management 
 
Clinical questions (a) In adults with AS, is exercise effective in disease modification (reduction in progression), compared with no exercise? 
(b) In adults with ankylosing spondylitis, are exercises in combination with anti-TNFα medication more beneficial (for 
pain/ function/ disease activity/ mobility) than medication alone? 
Criteria Inclusion: 
(a) Experimental studies of any design 
(b) Studies  comparing exercise + anti-TNFα medication 
combinations with medication alone 
             
Exclusion: 
Case studies 
       
No & type of studies (a) 8 included papers: 1 – RCT; 2 – non-random experimental trials; 1 – interrupted time series without control group; 1- 
cross-sectional (no controls); 1- case control study; 1 – case series; 1 - review 
(b) 6 included papers: 2 – RCT (only 1 full article); 2 – non-random experimental trials; 2 – interrupted time series without 
control group 
Level of evidence (a) Level C – several Level 111-3 studies 
(b) Level B – one RCT and several level 11 studies  
Quality of studies/ risk of 
bias  
(a) 1x RCT (abstract only, unable to rate quality) 
(b) 1x high quality RCT (PEDro 7/10), i.e. low risk of bias; 1x RCT with low PEDro score (5/10), i.e. high risk of bias 
Relevance to Australian 
setting 
(a) Highly relevant – there can be clinical concern about increasing disease activity with exercise 
(b) Highly relevant – anti-TNFα medication is widely used; exercise interventions used similar to those available 
Reproducibility of exercises Well described in Masiero paper [13] 
Consistency of results (a) Level C: The evidence suggests that exercise could influence both self-reported disease activity and physiological 
inflammatory markers, however, the direction of effect is conflicting. 
(b) Level A: Small number of papers/ subjects but direction of results appears consistent for function, disease activity, 
mobility and pain 
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Effect sizes (if applicable) (Exercise and anti-TNFα medication) Standardised mean differences for anti-TNFα + exercise versus anti-TNFα   + no exercise 
(Masiero): pain 0.63; mobility 0.29-0.42 and physical function 0.56 in favour of anti-TNFα + exercise.  Mean differences of 0.56 
(Bath AS Disease Activity scale) and 0.95 cm chest expansion in favour of exercise. 
Recommendation Recommendation 4: Disease Management 
Individuals receiving anti-TNFα therapy should continue with regular exercise prescription as it confers an additional benefit 
to anti-TNFα therapy alone. (EBR, grade B) 
Grading of Recommendation 
and Rationale  
EBR - Level B 
(a) No recommendation could be made regarding disease modification due to uncertainty around this issue. 
(b) Exercise in combination with an anti-TNFα medication, and anti-TNFα medication without exercise, were directly 
compared in a small number of studies. One high quality RCT found significant benefits for the anti-TNFα / exercise 
combination. This finding was supported by 5 lower quality studies and by the experience of the writing group. 
Discussion (a) Seven small studies were found investigating the effects of exercise on markers for inflammatory disease activity, with 
conflicting results. One RCT [14] and one non-controlled interrupted time series [15] found no change in cytokine levels 
with aerobic exercise or a multi-modal program respectively. However, a number of other observational studies did find 
statistically significant increases in anti-inflammatory cytokines following exercise [16-19]. No studies were found which 
examined potential local effects of stretch or mobility exercise on entheses or soft tissues. 
 
Despite consistent findings that exercise is effective in AS, the potential interactions between the physiological effects of 
exercise and the pathological processes have yet to be clarified. Although there are more studies demonstrating a trend 
towards mediation of inflammation, there is no definitive evidence for whether exercise produces local effects (for 
example, at the enthesis) or systemically, that is, a general anti-inflammatory effect, and so no recommendation was 
made. 
 
(b) The best quality trial was by Masiero [13], who investigated three groups of patients already stabilised on an anti-TNFα 
medication: one received education; another education plus an out-patient based multi-modal exercise program, and the 
third was a control group. The study design was a single-blinded, randomised controlled trial, with a PEDro score of 7/10 
and ‘high’ scores for reproducibility and relevance. Both intervention groups had improved BASFI and pain levels at 3 
and 6 months, but the combination with exercise also had statistically significant improvements in BASMI, chest 
expansion and quality of life.   
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Topic 3B1.4 AS-Specific Exercise 
 
Key question In adults with AS, is therapeutic (specifically prescribed) exercise aimed at  
(a) improving mobility/ posture  
(b) increasing strength 
(c) improving cardiorespiratory fitness 
(d) improving function (balance, co-ordination, gait, agility and proprioception)  
 more beneficial for pain, mobility, disease activity and physical function than no exercise/ general advice only?  
Criteria Inclusion: 
Systematic reviews or RCTs  
Investigation of AS-Specific (therapeutic/ prescribed) 
exercise 
Full text articles  
Intervention widely available and / or reproducible in 
Australia 
Primary aim is trial of therapeutic benefit 
Outcome measures: mobility, pain, disease activity, 
function 
  
Exclusion: 
Case studies 
Conference abstracts only 
General physical activities not specifically adapted for AS 
Descriptive/ opinion papers 
Primary aim is to investigate cost effectiveness/ adherence 
No & type of studies 19 included papers: 11 x RCTs (6 included in Cochrane Review ‘Physiotherapy interventions for ankylosing spondylitis’ 2008; 5 
RCTs post-Cochrane) 
7 x SRs (3 with meta-analysis) 
1x overview of exercise SRs including AS 
Level of evidence A 
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Quality of studies/ risk of bias  RCTs of mixed quality and small-moderate size; issues of heterogeneity between studies with regard to type of intervention, 
measurement points, measures; PEDro scores for included RCTs: 7/10 x 5; 6/10 x 4; 5/10 x 1; 4/10 x 1. In general there was a 
lack of reporting regarding exercise program design, assessment and outcome measurement for physiological effectiveness. 
 
See table B1 for RCTs rated by PEDro criteria. No studies met the criteria for blinding of subjects or therapists: however, this 
is rarely feasible with exercise interventions. The other criterion that was largely unmet was intention to treat analysis, which was 
generally not specified, and a potential reason for bias. Each intervention arm typically included around 20 participants, with the 
duration of exercise programs varying from six to 36 weeks.  Six studies compared experimental exercises with no exercise or 
information only, whilst five compared two different exercise interventions. Of the outcomes of interest, physical function was 
reported in nine studies, disease activity in seven and pain in only five studies. All studies performed at least one mobility 
measure, but measures chosen varied in both type and methodology. Only three studies utilised the Bath Ankylosing Spondylitis 
Metrology Index (BASMI), and none used the more sensitive BASMI 10 point scale, so calculation of mean differences for a 
composite mobility measure was not possible. Therefore the four most widely reported measures were chosen for further 
analysis: cervical mobility (calculated as standardised mean difference (SMD)); finger to floor distance (calculated as mean 
difference (MD) in centimetres (cm)), chest expansion (MD, cm) and lumbar flexion (SMD).  
Relevance to Australian 
setting 
11 trials were considered highly relevant; 6 RCTs excluded due to low relevance (e.g. spa or in-patient treatment). The only high 
quality RCT comparing two types of flexibility exercise in AS was that of Fernandez [20], who found benefits for Global Posture 
Re-education (GPR), a method mainly practiced in Europe, which targets shortened muscle trains with a series of whole-body 
stretching and strengthening exercises, compared with a series of static stretches. The use of this technique is not known to the 
WG. However, the techniques as described appear similar to other dynamic mobility and static stretch exercises, although with 
perhaps higher repetitions for the former and longer stretch times for the latter, than might commonly be practised in Australia. 
Reproducibility of exercises RCTs mainly provided sufficient information to reproduce exercises in the clinic, except Cagliyan 2007. 
Where exercises were adequately described, they were a combination of dynamic flexibility, static and dynamic stretches, with 
no RCTs examining ballistic stretches. A number of RCTs included strengthening exercises as part of ‘multi-modal’ programs 
[13, 20-23], but no strength outcome measures were reported, and descriptions of the use of weights or other forms of resisted 
exercise were not found in the included studies.  
Consistency of results Highly consistent; no studies found which resulted in a negative outcome for exercise interventions 
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Effect sizes (if applicable) Dagfinrud et al performed a meta-analysis of 11 RCTS or quasi randomised trials, published prior to January 2007, with a total 
of 763 participants, the outcome measures being: pain; stiffness; axial mobility; physical function and patient global assessment. 
Pair-wise comparisons were made for different modes of delivery (individualised home exercise program (HEP), supervised or 
group exercises) and different settings (“dry land”, spa, balneotherapy and fresh water pool exercises). One comparison was 
made between different exercise types (‘Global Postural Re-education versus a ‘conventional’ mobility and stretch program).  
The results were reported in relative percentage differences (RPDs), with ranges of: 5-50% favouring a structured exercise 
program (HEP or supervised) over none for mobility, and 7.5-18% favouring groups over HEPs. 
 
From our meta-analyses, effect sizes [confidence intervals] for included RCTs were all in favour of interventional groups as 
follows: pain SMD -0.42[-0.74, -0.09]; disease activity (BASDAI score) MD  -0.47[-0.84,-0.09]; cervical mobility SMD 0.20[-
0.09,0.49]; fingertip to floor distance (MD, cm) -4.87[-8.38,-1.37]; chest expansion (MD, cm) 0.81[0.35,1.28]; lumbar flexion 
(SMD) 0.35[0.02,0.67] and physical function (SMD) -0.51 [-0.81,-0.21].  
Other factors See Forest plots (figure 2 in main text). There was moderate (I2=26%) statistical trial heterogeneity for lumbar flexion and 
substantial (I2=62%) heterogeneity for physical function.  The reasons for this are unclear but may include methodological 
differences in exercise intervention studies, particularly exercise programme design and dosage attained. 
Recommendation(s) Recommendation 5: AS-Specific Exercise (Mobility) 
Individual exercise prescription with an emphasis on spinal mobility is paramount for best management of AS. 
Maintaining mobility of peripheral joints is also essential. This can be achieved through a number of approaches. At this 
time we are unable to recommend one approach over another, therefore individual goals should be informed by 
assessment findings. (EBR, grade A). 
 
 
Recommendation 6: AS-Specific Exercise (Other) 
Stretching, strengthening, cardiopulmonary and functional fitness are important components to consider in a balanced 
exercise program (EBR grade B)  
Grading of 
Recommendation(s)  
• Systematic reviews and a moderate number of RCTs 
• Findings supported by international consensus and experience of the WG 
• Recommendation 6 downgraded from grade A due to the indirect nature of some of the evidence, i.e. extrapolated from 
the healthy adult/ chronic disease literature.  
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Discussion Exercises described in papers or in patient-directed resources, such as those produced by the UK National Ankylosing 
Spondylitis Society publication ‘Back to Action’ (http://nass.co.uk/exercise/exercise-for-your-as/back-to-action/) typically 
include combination of soft tissue stretch and dynamic joint mobility exercises for ‘tight’ or shortened soft tissues/ restricted 
joints, in conjunction with strengthening of ‘lengthened’ muscles. . The WG was interested in whether specifically prescribed, 
therapeutic exercises, were more beneficial for pain, physical function, disease activity and axial mobility, than no exercise or 
general exercise advice only. 
 
In the 2009 Cochrane review of Physiotherapy interventions for ankylosing spondylitis [24] found ‘Silver’ level evidence (RCTs 
with less than 50 subjects per group) that: individual or home-based exercises are beneficial; that supervised group physiotherapy 
has additional benefit over home exercise, and that combined spa-exercise therapy was more beneficial than group physiotherapy 
alone.  
 
Meta-analysis was also performed in a 2012 ASAS/EULAR update of non-pharmacological recommendations for AS 
management [25], and the findings supported the positive trend for exercise effectiveness in AS. Cohen’s effect sizes (ES) were 
found to be beneficial in a small to moderate range for self-reported pain, disease activity and physical function, and objective 
axial mobility, although in a number of studies statistical significance was not reached.  However, most of the included studies in 
this paper investigated balneotherapy, which is not widely available in Australia (and thus excluded from our analysis) and four 
of the nine included studies were of low quality according to the PEDro scale. In a 2011 paper, Dagfinrud et al analysed the 
reported components of the exercise programs used in twelve previous RCTs, assessing program design and outcomes against 
American College of Sports Medicine (ACSM) criteria [8]. This study had similar findings regarding effectiveness, with positive 
effect sizes of 0.14-0.67 for mobility.  All the reviewers commented on the difficulties of extracting meaningful data, due to 
small sample sizes, heterogeneity of exercise interventions (exercise type, dosage and trial duration) and outcome measures. The 
Cochrane review [24] also noted that most studies (7 out of 11) compared two similar exercise interventions, therefore between-
group differences (unsurprisingly) could not be proved. However, the results were very consistent for small to moderate positive 
effects for exercise in the parameters measured. 
 
(a) Mobility (flexibility) exercise Shortfalls were found in both the descriptions of exercises used and outcome measures.  
Where exercises were adequately described, they were a combination of dynamic flexibility, static and dynamic stretches, with 
no RCTs examined ballistic stretches. The only high quality RCT comparing two types of flexibility exercise in AS was that of 
Fernandez [20], who found benefits for Global Posture Re-education (GPR).  
 
(b) Strengthening exercises have received little attention in the AS literature: despite the large body of evidence 
demonstrating benefits for bone, cardiovascular health and prevention of falls in healthy adults [26, 27]. A number of RCTs 
included strengthening exercises as part of ‘multi-modal’ programs [13, 20-23], but no strength outcome measures have been 
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reported, and descriptions of the use of weights or other forms of resisted exercise were not found in the included studies. 
Indirect evidence suggesting potential benefits in individuals with AS includes controlled cross-sectional studies showing: 
diminished muscle strength compared with matched controls [28-30]; a mild to moderate decrease in vital capacity in association 
with peripheral muscle strength [5] and an association of upper extremity strength with spinal mobility [31]. Finally, the 
biomechanical principles of muscle balance, that is, the maintenance of relative equality of muscle strength/ length between 
antagonist and agonist [32] would suggest strengthening exercise should be part of a balanced exercise program.  
 
(c) Cardiorespiratory exercise training was included in five high quality RCTs of multi-modal programs designed for AS 
[13, 21, 23, 33, 34]. Dagfinrud [8] compared effect sizes for aerobic capacity, with exercise program design relative to ACSM 
guidelines for physical activity levels in healthy adults. The ES ranged from 0.09 (for an in-patient multi-modal exercise 
program) to 2.19 (for an out-patient multi-modal program). The highest ES for aerobic capacity [33] was in the only study where 
the exercise dosage tested met the ACSM guidelines, and Dagfinrud concluded that most study programs are physiologically 
ineffective, highlighting the importance of appropriate exercise program design for effectiveness. One study [34] specifically 
targeted pulmonary function by testing an intensive (30 minutes per day for 16 weeks) regime of incentive spirometer (IC) use in 
addition to conventional exercises (CE). In comparison to CE alone, there were significant improvements in vital capacity with 
the IC method. 
 
(d) Functional (neuromotor) exercise can include motor skills such as balance, co-ordination, gait, agility and 
proprioceptive training, as well as re-education of motor control for specific muscle groups. Regular performance is 
recommended by the ACSM [35] and as part of the national physical activity recommendations for older Australians [36], and 
they gain relevance for individuals who have impaired balance and gait/ movement compensations due to spinal ankylosis. 
Despite the absence of RCTs investigating balance or other neuromotor interventional measures in AS, the indirect evidence and 
WG’s experience supports the inclusion of this group of exercises. 
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Table 3B2 RCT quality assessed by Physiotherapy Evidence Database (PEDro) criteria 
Criterion 
 
 
 
Eligibility  
Criteria 
specified 
* 
Random 
allocation 
Concealed  
allocation 
Baseline 
comparability 
Blinding 
of 
subjects 
Blinding 
of 
therapists 
Blinding 
of 
assessors 
Adequate 
follow up 
Intention 
to 
treat 
analysis 
Between 
group  
comparisons 
Point 
estimates/ 
variability 
Total 
Score/ 
10 
Altan 2012 Yes Yes Yes Yes No No Yes Yes No Yes Yes 7 
Analay 
2003 
No Yes Yes Yes No No Yes Yes No Yes Yes 7 
Cagliyan 
2007 
Yes  Yes No Yes No No No No No Yes Yes 4 
Fernandez- 
Penas 2005 
Yes Yes No Yes No No Yes Yes No Yes Yes 6 
Hidding 
1993 
Yes Yes No Yes No No Yes Yes Yes Yes Yes 7 
Ince 2006 Yes Yes No Yes No No Yes No No Yes Yes 5 
Kraag 1990 Yes Yes No Yes No No Yes Yes Yes Yes Yes 7 
Lee 2008 Yes Yes No Yes No No Yes No Yes Yes Yes 6 
Lim 2005 Yes Yes No Yes No No Yes Yes No Yes Yes 6 
Masiero 
2011 
Yes Yes Yes Yes No no Yes Yes No Yes Yes 7 
So 2012 Yes Yes Yes Yes No No No Yes No Yes Yes 6 
 * Eligibility Criteria does not contribute to total score 
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Topic B1.5 Physical Activity 
 
Clinical question In adults with AS, what types of physical activity are beneficial for pain, mobility, disease activity and function?  
Criteria Inclusion: 
SRs/ RCTs pertinent to clinical question 
Investigate exercise available to general population (may 
be modified for AS)    
Full text article     
      
Exclusion:   
Descriptive/ opinion papers  
No & type of studies 3 - RCTs; 1 - large case series (1538 subjects) 
 
A small RCT by Lee et al in 2007 [37] had 20 subjects and controls, a PEDro score or 6/10, and demonstrated improved 
BASDAI and fingertip to floor distance following an eight week tai chi program.  
A larger study, with 30 subjects and a PEDro score of 8/10, showed significant improvements in BASMI, BASDAI and chest 
expansion following three x one hour sessions of Pilates training for 12 weeks.  
Both studies used programs that were somewhat adapted for the research protocol, so these findings should be used with caution 
when considering ‘mainstream’ tai chi or Pilates programs. 
Swimming is commonly recommended for AS, but only one low quality (PEDro rating 5/10) study was found for this activity 
[38]. A comparison of swimming, walking and conventional exercises over six weeks demonstrated a range of benefits for all 
three groups; however, swimming was statistically superior for disease activity (BASDAI) and six minute walk test.  
Falkenbach’ s cross-sectional study of 1538 patients showed an association between PALs and mobility, but no significant 
differences were found between types of leisure activities/ sports [39]. There is an extensive body of background evidence for 
national physical activity guideline development [26, 27]. 
Level of evidence Direct evidence (AS subjects) – Level  B 
Indirect evidence (population based) – Level A 
Quality of studies/ risk of bias  2x high quality (PEDro score 6/10 & 8/10); 1 x low quality (PEDro score 5/10) RCTs 
Relevance to Australian 
setting 
High – the physical activities studied are widely available (swimming, walking, tai chi, Pilates) 
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Reproducibility of exercises n/a 
Consistency of results B – all activities showed some benefit, with variation among effect sizes 
Effect sizes (if applicable) Small effect sizes (in favour of physical activity intervention) for outcomes of interest: 
• Pilates: Bath AS Disease Activity Index (BASDAI) -0.16; physical function SMD -0.36; chest expansion 0.5 cm 
• Tai chi: BASDAI -0.76; finger to floor distance 0.5cm 
• Swimming: BASMI SMD 0.27; Schober test -0.09 cm 
Data from Dagfinrud (2011) [8] 
Other factors The number of potentially beneficial physical activities studied was small  
Recommendation(s) Recommendation 7: Physical Activity (EBR, grade B) 
Regular physical activity should be encouraged to promote general health, well-being and functional outcomes.  
 
Grading of 
Recommendation(s)  
Recommendation 7: EBR, grade B 
• Large/ consistent body of high level evidence for the general population 
• There is no reason for the benefits for maintaining health/ preventing disease not to be applicable for people with AS 
• Recommendation has been down-graded from A due to small number of studies with subjects who have AS. 
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Topic B1.6 Dosage 
 
Key question In adults with AS, what dosage of exercise is beneficial for pain, mobility, disease activity and function? 
Criteria Inclusion: 
Subjects with AS   
Any research design   
Full text or abstract   
Addresses clinical question (compares quantity of exercise 
with outcome measures)  
  
Exclusion: 
Case studies   
No & type of studies Exercise volume in RCTs – 11 
Habitual exercise volume 13 included papers: 3 – cross-sectional studies; 6 – patient surveys; 4 – case series  
Level of evidence Level C 
Quality of studies/ risk of bias  RCT PEDro scores: 7/10 x 5; 6/10 x 4; 5/10 x 1; 4/10 x 1. 
Surveys were all self-reports (except Arends 2011) and varied in number of subjects, from 50 to 4282. 
Relevance to Australian setting High – studies completed in Europe/ USA/ Canada – however, there is nothing to suggest that exercise response would be 
different in Australians 
Reproducibility of exercises Exercise intensity was only reported in 45% of studies. 
Exercise time was frequently totalled into a weekly amount, with the range being 60 to 700 minutes per week and 30 to 60 
minute sessions being typical. 
In general, the exercise dosage for different components of multi-modal programs was not specified.  
Further limitations were the reliance on self-reported exercise dosage for home exercise programs, and the lack of information 
on progression of exercise dosage. 
Consistency of results B – Studies consistently showed benefit across a range of measures, although there was variation in volume of exercise dosage 
and benefit 
Effect sizes (if applicable) n/a 
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Other factors  
Recommendation(s) Recommendation 8: Dosage  
Exercise frequency, intensity, duration and type must be tailored to the person’s assessment findings, goals and lifestyle.  
(a) For mobility, stretch & postural exercise, consistency is the most important factor  
(b) For other exercise types, national physical activity guidelines may require modification. Consideration should be 
given to disease stage, activity & progression, whilst aiming for optimal effectiveness. 
Grading of Recommendation 
and Rationale 
Recommendation 8: EBR, grade C 
• Dosage for AS-specific exercise is unclear, although frequency and consistency appear to be the most important factors.  
• A wide variation was found in dosage used in clinical trials and in self-reported habitual exercise. A large number of 
factors impact on a person’s exercise response, therefore individual tailoring is recommended. However, the body of 
AS research and nationally recommended physical activity levels for healthy adults can provide some clinical guidance.  
• There is a large volume of high level evidence for physical activity levels and emerging evidence for anti-inflammatory 
effects of exercise in healthy adults.  
Discussion The 2011-12 Australian Health Survey indicated that 57% of adults did not meet the Australian National Physical Activity 
Guidelines for adults [40]. There are similar findings in the Americas and Europe, and this has prompted increased research 
attention on population adherence to physical activity recommendations. A review of this literature is beyond the scope of this 
paper, but is well summarised in publications such as the ACSM’s Guidelines for Exercise Testing and Prescription [41]. 
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Topic B1.7 Adherence 
 
Key question In adults with AS, which interventions are beneficial for supporting adherence to an exercise plan? 
Criteria Inclusion:  
Any research design  
Full text or abstract  
Addresses clinical question  
SR of PALS in chronic conditions 
  
Exclusion: 
Clinical question not addressed  
Case studies 
Small studies <10 subjects 
No & type of studies (Subjects with AS) 20 included papers: 1 – RCT; 1 – non-randomised trial; 7 – cross-sectional (no controls); 2 – qualitative 
studies; 1- retrospective cohort; 1- case series; 3 - surveys 
(Subjects with arthritis/ chronic condition):  4 - SR 
Level of evidence Direct evidence (subjects with AS) – C (level 111 studies) 
Indirect evidence (subjects with arthritis/ chronic conditions) – A (level 1 studies) 
Quality of studies/ risk of bias  Direct evidence - PEDro score for RCT – 7/10 
Relevance to Australian setting High – Physical Activity literature suggests adherence issues are similar in industrialised countries   
Reproducibility of exercises n/a 
Consistency of results B – Heterogeneity in size of effect for improving exercise adherence 
Effect sizes (if applicable) n/a 
Other factors Limited evidence of mixed methodology was obtained for subjects with AS, so the search was broadened to include SRs for 
chronic conditions 
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Recommendation(s) Recommendation 9:  Adherence  
It is important to assess adherence with regular exercise, encourage motivation and promote ongoing self-management. (EBR, 
grade B) 
Grading of 
Recommendation(s) and 
Rationale 
Recommendation 10: CBR 
• There is no reason for the findings regarding exercise adherence in chronic conditions not to apply to AS, therefore the 
level of evidence has been upgraded from C to B 
Discussion Surveys typically found that approximately one third of people with AS reported meeting previously recommended guidelines 
for exercise. Differentiation between therapeutic exercise (performed specifically for AS) and recreational or other forms of 
physical activity was lacking. Nevertheless, it appears that, similar the most developed populations, adherence to exercise 
recommendations is an area where there is large potential for improvement. It has been suggested that having an arthritis 
diagnosis may be a prompt to perform habitual exercise for some, but a barrier for others, [42], and in the experience of the WG 
this also applies to people with AS.  
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Topic B1.8 Exercise Setting 
 
Key question In adults with AS, which widely available exercise settings and modes of delivery are beneficial for pain, mobility, disease 
activity and function? 
Criteria Inclusion:  
Systematic reviews with MA    
RCTs since Jan 2007 (date of Cochrane  r/v) 
Full text articles 
Compares 2 settings 
Setting widely available  
 
Exclusion: 
Descriptive/ opinion papers   
Included in Cochrane review 
Setting not widely available (e.g. in-patient, spa) 
No & type of studies 7 included papers: 3 – SR with meta-analysis; 4 - RCT 
Level of evidence B 
Quality of studies/ risk of bias  2 - RCTs of high quality (PEDro score ≥ 6/10);  2 – RCTs of low quality (PEDro score ≤ 5/10) 
Relevance to Australian setting Significant proportion of RCTs excluded as setting not widely available  
Reproducibility of exercises Interventions were adequately described for reproduction in clinic 
Consistency of results B – Most results consistent, although one (non-randomised) study did not find additional benefit for group over home exercise 
Effect sizes (if applicable) See AS specific section 
Other factors Wide heterogeneity of interventions in balneotherapy studies mean that it is not possible to determine what effects may be due 
to the active exercise components 
Recommendation(s) Recommendation 10:  Exercise Setting  
Priority should be given to patient preference in exercise choice, to enhance adherence and optimise positive outcomes 
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Grading of 
Recommendation(s)  
Recommendation 10: CBR 
• Many studies investigated exercise settings not readily available, particularly on a long-term basis (e.g. spa/ in-patient 
treatment) 
• Effect sizes for studies investigating different settings were often small. It is not clear whether the type of exercise or 
the setting in which it is performed are of most importance. However, since exercise is only effective with ongoing 
performance, personal preference for exercise setting was considered by the group to be the highest priority. 
• There is limited evidence for superior results with supervised group sessions and / or pool based exercise, however, 
WG experience is favourable for these settings. 
Discussion Since the Cochrane review (publications to January 2007) [24], a further four RCTs have been published which meet the 
criteria for this topic. One small lower-quality RCT compared the same exercise program performed at home or in an out-
patient group setting twice per week, finding small improvements in BASDAI and BASFI for the group, but no significant 
difference in BASMI [43]. A short-term (six week) study of swimming and a home exercise program (HEP), walking and HEP 
or HEP alone, resulted in a statistically significant improvement in mobility (BASMI), QoL and pulmonary function (vital 
capacity) measures, with additional gains in maximal oxygen consumption (pVO2) and six minute walk test for the walkers and 
swimmers [38]. Two more recent studies have compared out-patient group rehabilitation [13] and group Pilates [44] to no 
active intervention. These higher quality RCTs (rated 7/10 and 8/10 on the PEDro scale) both demonstrated significant 
improvements in mobility (BASMI and chest expansion) and disease activity (BASDAI). No RCTs demonstrating a negative 
effect for exercise intervention in any setting were found. 
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Table 3B3 Key to Evidence Summaries [45]: Adapted from Australian Government National Health and Medical Research 
Council (NHMRC) additional levels of evidence and grades for recommendations for developers of guidelines [46] 
Level of Evidence A One or more level 1 studies with a low risk of bias or several level 11 studies with a low risk of bias 
B One or two level 11 studies with a low risk of bias, or SR/ several Level 111 studies with a low risk of bias 
C One or two Level 111 studies with a low risk of bias, or Level 1 or 11 studies with a moderate risk of bias 
D Level 1V studies or Level 1 to 111 studies / SRs with a high risk of bias 
Quality of studies/ risk of 
bias 
For RCTs, Physiotherapy Evidence Database (PEDro) score [47] (scoring ≥6 for High, 5 or less for Low) 
Relevance to Australian 
setting 
Reviewer’s opinion. Scored as High (directly relevant to Australian health care setting) or Low (not directly relevant to 
Australian health care setting) 
Reproducibility of exercises Scored as Yes or No. Reviewer’s opinion of whether intervention could be reproduced, based on description in study 
methodology 
Consistency of results A All studies consistent 
B Most studies consistent, and inconsistency may be explained 
C Some inconsistency, reflecting genuine uncertainty around clinical question 
D Evidence is inconsistent 
Effect sizes (if applicable) Mean differences where estimable (i.e. same outcome measures used); standardised mean differences (Cohen’s d) where outcome 
measure varied 
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Other factors Any other factors considered by the group, which may upgrade/ downgrade the recommendation 
Grade of recommendation(s) Evidence Based Recommendation (EBR) Based on body of evidence. A recommendation cannot be graded A or B unless the 
levels of evidence (types of studies) and consistency of results are both graded A or B. 
 A Body of evidence can be trusted to guide clinical practice 
B Body of evidence can be trusted to guide clinical practice in most situations 
C Body of evidence provides some support for recommendation(s), but care should be taken in its application 
D Body of evidence is weak and recommendation must be applied with caution 
 Consensus-based recommendation (CBR): developed by the writing group (WG) when a systematic review of the evidence 
found either an absence of direct evidence which answered the question, or poor quality evidence, not strong enough to form an 
EBR. 
Practice Points (PP): developed by the WG where there was a need to provide practical guidance to support the implementation 
of the EBRs and/or CBRs. 
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 Table 3B4 Designation of Levels of Evidence (NHMRC Evidence Hierarchy) 
Level Intervention Aetiology 
1 A systematic review of randomised 
controlled trials 
A systematic review of level 11 studies 
11 A randomised controlled trial A randomised controlled trial 
111-1 A pseudo randomised controlled trial 
(i.e. alternate allocation or some other 
method) 
A pseudo randomised controlled trial (i.e. alternate allocation or some other method) 
111-2 A comparative study with concurrent 
controls: 
• Non-randomised experimental 
trial 
• Cohort study 
• Case-control study 
• Interrupted time series within a 
parallel control group 
A comparative study with concurrent controls: 
• Non-randomised experimental trial 
• Cohort study 
• Case-control study 
111-3 A comparative study without 
concurrent controls: 
• Historical control study 
• Two or more single arm study 
• Interrupted time series without 
a parallel control group 
A comparative study without concurrent controls: 
• Historical control study 
• Two or more single arm study 
1V Case series with either post-test or pre-
test / post-test outcomes 
Case series 
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B4 Study Types, as defined by NHMRC  
Case-control study – people with the outcome or disease (cases) and an appropriate group of 
controls without the outcome or disease (controls) are selected and information obtained 
about their previous exposure/ non-exposure to the intervention or factor under study. 
 
Case series – a single group of people exposed to the intervention (factor under study). Post-
test – only outcomes after the intervention (factor under study) are recorded in the series of 
people, so no comparisons can be made. Pre-test/ post-test – measures on an outcome are 
taken before and after the intervention is introduced to a series of people and are then 
compared. 
 
Cohort study – outcomes for groups of people observed to be exposed to an intervention, or 
the factor under study, are compared to outcomes for groups of people not exposed.  
 
Prospective cohort study – where groups of people (cohorts) are observed at a point in time 
to be exposed or not exposed to an intervention (or the factor under study) and are then 
followed with further outcomes recorded as they happen. Retrospective cohort study – 
where the cohorts (groups of people exposed and not exposed) are defined at a point of time 
in the past and information collected on subsequent outcomes, e.g. the use of medical records 
to identify a group of women using oral contraceptives five years ago, and a group of women 
not using oral contraceptives, and then contacting these women or identifying in subsequent 
medical records the development of deep vein thrombosis. 
 
Cross-sectional study – a group of people are assessed at a particular point (or cross-section) 
in time and the data collected on outcomes relate to that point in time i.e. proportion of people 
with asthma in October 2004. This type of study is useful for hypothesis-generation, to 
identify whether a risk factor is associated with a certain type of outcome, but more often than 
not (except when the exposure and outcome are stable e.g. genetic mutation and certain 
clinical symptoms) the causal link cannot be proven unless a time dimension is included. 
 
Historical control study – outcomes for a prospectively collected group of people exposed to 
the intervention (factor under study) are compared with either (1) the outcomes of people 
treated at the same institution prior to the introduction of the intervention (i.e. control 
group/usual care), or (2) the outcomes of a previously published series of people undergoing 
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the alternate or control intervention. 
 
Interrupted time series with a control group – trends in an outcome or disease are 
measured over multiple time points before and after the intervention (factor under study) is 
introduced to a group of people, and then compared to the outcomes at the same time points 
for a group of people that do not receive the intervention (factor under study). 
 
Interrupted time series without a parallel control group – trends in an outcome or disease 
are measured over multiple time points before and after the intervention (factor under study) 
is introduced to a group of people, and compared (as opposed to being compared to an 
external control group). 
 
Non-randomised, experimental trial - the unit of experimentation (e.g. people, a cluster of 
people) is allocated to either an intervention group or a control group, using a non-random 
method (such as patient or clinician preference/availability) and the outcomes from each 
group are compared. 
This can include: (1) a controlled before-and-after study, where outcome measurements are 
taken before and after the intervention is introduced, and compared at the same time point to 
outcome measures in the (control) group. (2) an adjusted indirect comparison, where two 
randomised controlled trials compare different interventions to the same comparator i.e. the 
placebo or control condition. The outcomes from the two interventions are then compared 
indirectly.  
 
Pseudo-randomised controlled trial - the unit of experimentation (e.g. people, a cluster of 
people) is allocated to either an intervention (the factor under study) group or a control group, 
using a pseudo-random method (such as alternate allocation, allocation by days of the week or 
odd-even study numbers) and the outcomes from each group are compared. 
 
Randomised controlled trial – the unit of experimentation (e.g. people, or a cluster of 
people) is allocated to either an intervention (the factor under study) group or a control group, 
using a random mechanism (such as a coin toss, random number table, computer-generated 
random numbers) and the outcomes from each group are compared. Cross-over randomised 
controlled trials – where the people in the trial receive one intervention and then cross-over to 
receive the alternate intervention at a point in time – are considered to be the same level of 
evidence as a randomised controlled trial, although appraisal of these trials would need to be 
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tailored to address the risk of bias specific to cross-over trials. 
 
Systematic review – systematic location, appraisal and synthesis of evidence from scientific 
studies. 
 
Two or more single arm study – the outcomes of a single series of people receiving an 
intervention (case series) from two or more studies are compared. Also see entry on 
unadjusted indirect comparisons. 
 
Unadjusted indirect comparisons – an unadjusted indirect comparison compares single 
arms from two or more interventions from two or more separate studies via the use of a 
common reference i.e. A versus B and B versus C allows a comparison of A versus C but 
there is no statistical adjustment for B. Such a simple indirect comparison is unlikely to be 
reliable (see Song et al 2000) 
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Appendix C Survey results, practice point rationale and plain 
language summary 
3C1 Surveys 
3C1.1 Health professional opinion on the use of exercise for the management of 
ankylosing spondylitis 
3C1.1.1 Introduction provided to respondents 
A Consensus Statement has been developed by a group of 10 Physiotherapists and a 
Rheumatologist, with the overall goal of providing guidance for exercise prescription for 
ankylosing spondylitis (AS) in Australia.  
Each of the proposed recommendations is the result of a structured process that included: 
identification of key topic areas (KTAs); a systematic literature review for each KTA; 
identification of levels and quality of available evidence for each KTA, as well as relevance to 
the Australian setting. This information was combined with the collective opinion of the 
group to derive the recommendations.  
The purpose of the survey is to obtain information from a broader group of Health 
Professionals to inform the Strength of Recommendations. The main part of the survey 
comprises each draft recommendation, with questions on your support for the statement, and 
whether you think it will modify your practice. Feedback from people with AS is being 
sought in a similar way. Please note that the supporting information regarding the evidence 
for each recommendation will be provided in the final publication.  
This anonymous survey has been approved by the Tasmanian Social Sciences Human 
Research Ethics Committee and your consent will be implied by its completion and 
submission. Thank you for your interest in this project. 
3C1.1.2 Questions 
For each of the ten recommendations in turn, respondents were asked: 
How strongly to you support this statement? 
• Responses on an 11 point rating scale, with 0 labelled ‘I do not support this statement 
at all’ and 10 labelled ‘I fully support this statement’ 
Please indicate how much this statement will modify your practice 
• Responses required from one of the following: 
This statement will modify my practice significantly 
This statement will modify my practice somewhat 
This statement will not modify my practice as I am already doing this 
This statement will not change my practice as I do not want to change 
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This statement does not apply to my practice 
• Comment (optional) 
 
3C1.2 Survey: Patient opinion on the use of exercise for managing ankylosing 
spondylitis 
3C1.2.1 Introduction 
About this Survey: For many years, it has been known that exercise is beneficial for people 
with Ankylosing Spondylitis (AS). Research has shown that when people perform the right 
sort of exercise regularly, they are usually able to improve their pain and fatigue, and increase 
or maintain their movement (mobility of spine and other joints), strength and overall fitness. 
However, there is less evidence to guide health professionals and patients regarding different 
aspects of exercise 'prescription', such as, what sort of exercises are best, how often and many 
should be performed? To help address this problem, a Consensus Statement has been 
developed by a group of Australian Physiotherapists and a Rheumatologist who are very 
experienced in managing AS. It consists of ten recommendations, with brief dot points to 
provide a little more detail on each. All the recommendations are based on a combination of 
the available research, and the 'consensus' opinion of the group. The overall aim is to help 
guide exercise prescription, and ensure that people with AS  get the best results for the time 
they invest in their AS exercises.  
 
This anonymous survey consists of some questions regarding your own experience with AS, 
followed by a question asking how you rate the importance of each recommendation. There is 
the opportunity to add comments, which may be added to a web link in the future, in order to 
benefit others with this condition. Your consent regarding this survey will be implied by its 
completion and submission. Please note that the researchers are not able to gain access to your 
personal details, and if you choose not to complete the survey no information will be retained. 
This study has been approved by the Tasmanian Social Sciences Human Research Ethics 
Committee. 
3C1.2.2 Questions 
For each of the ten recommendations in turn, respondents were asked: 
How important is this statement to you? 
• Responses on an 11 point rating scale, with 0 labelled ‘Not important to me at all’ and 
10 labelled ‘Highly important to me’ 
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Table 3C1 Patient (n=78) and Health Professional (n=32) Survey Results  
 
Recommendation  Patient Rating - 
Importance 
Health Professional 
(HP) Rating - 
Support 
Recommendation 
will modify practice 
(HP, %) 
Recommendation is 
already my practice 
(HP, %) 
I do not want to 
modify my practice 
(HP, %)  
Does not apply to my 
practice (HP, %) 
1. Assessment 8.3 7.2 35 35 0 29 
2. Monitoring 8.2 8.1 42 42 0 14 
3. Safety 8.4 8.6 17 75 0 8 
4. Disease 
management 
8.0 7.3 17 50 8 25 
5. AS-specific 
exercise (mobility) 
8.7 9.4 17 67 0 17 
6. AS-specific 
exercise (other) 
8.9 9.3 8 75 0 17 
7. Physical activity 
levels 
8.9 8.9 17 67 0 17 
8. Dosage 8.6 9.0 8 75 0 17 
9. Adherence 8.4 9.58 25 58 0 17 
10. Setting 8.48 9.25 25 58 0 17 
Mean for all 
recommendations 
 
8.46 
 
8.66 
 
21.1 
 
60.2 
 
0.8 
 
17.8 
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Table 3C2 Rationale for Practice Points 
 
Topic Practise Point Rationale 
C2.1 
Assessment 
The Bath Ankylosing 
Spondylitis Metrology Index 
(BASMI) is the most widely 
reported, validated objective 
axial mobility measure 
The Bath Ankylosing Spondylitis Metrology Index (BASMI) [1], developed in 1994, remains the 
most widely reported composite measure [2-8] and was considered by the group to be a clinically 
useful measure in exercise prescription. It has been found to have good validity and reliability [1, 9, 
10].  
 BASMI is associated with 
quality of life, physical function 
and psychological status  
A number of (largely non-controlled) cross-sectional studies have found relationships between axial 
mobility (anthropometric) measures and self-reported domains such as physical function, disability, 
quality of life, psychological status and disease activity [3, 4, 7, 8, 11-17]. 
 The BASMI 10-point scoring 
scale (tabular or linear) is 
recommended over the 3-point 
scale 
The two 10-point scoring methods (tabular or linear) have been found to have improved sensitivity to 
change over the original 3-point scoring scale [18], and are therefore more clinically useful for 
evaluation of exercise effectiveness. 
 Imaging review/ discussion 
with medical team may be 
indicated for more advanced 
disease 
As per safety section, knowledge about the location and extent of any ankylosis is pertinent to safe 
exercise prescription 
 Tape-based hip internal rotation 
measure is a responsive 
measure for hip involvement 
Maksymowych et al [10] have developed an alternative composite AS mobility measure, the 
Edmonton AS Metrology Index (EDASMI), which has comparable construct reliability and greater 
sensitivity to change over BASMI. The relatively large EDASMI trial also supported the 
measurement of chest expansion at xiphisternal level, hip internal rotation and lumbar lateral flexion 
as measures responsive to change.   
 Strength, balance or cardio-
respiratory function should be 
assessed as required 
Simple measures to assess these areas can inform exercise strategies and goals appropriately  
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C2.2 
Monitoring 
Feedback, particularly mobility 
measures, can be important for 
exercise adherence. 
In clinical practice, patients appear to value the objective information provided by assessment and it 
appears to have a positive effect on exercise behaviour [19]. Van Weely [16] found that self-reported 
function was typically reported as being more impaired than measured function. Therefore, objective 
measures appear to provide as additional perspective to other scores which rely on self-report. When 
health professional access is not possible or appropriate, self-monitoring techniques for axial mobility 
may be useful. 
 BASMI raw scores are more 
sensitive to change than index 
scores 
May be useful for patient feedback [20] 
 In BASMI, lumbar side flexion 
is the most sensitive to change 
As above 
 The Edmonton AS Metrology 
Index (EDASMI) may be useful 
for patient self-monitoring 
As it is tape measure based and comprises only 4 measurements, it may be suitable as a patient self-
monitoring tool [10, 20].   
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C2.3 
Safety 
Most types of exercise are safe 
for the majority of patients. 
However, the following require 
assessment on a case by case 
basis, and may be contra-
indicated in more advanced AS: 
 
High impact exercise/ physical 
activity (e.g. contact sports, 
martial arts, four wheel driving, 
boating in rough seas, 
fairground rides) 
 
High velocity or strongly 
resisted exercise, especially 
trunk flexion/ rotation 
 
 
It is widely accepted that there is paradoxical spinal osteoporosis in AS [21], which appears related to 
disease activity and duration, and has an incidence of 18-67% [22]. As may be expected, decreased 
shock absorption can be a property of an ankylosed spine [23]. Associated with the combination of 
spinal osteoporosis and ankylosis [24], is an increased spinal fracture risk in AS of between 14 and 
19% [25, 26], which is more likely to result in spinal cord injury (SCI) than in a non-ankylosed spine 
[27-30]. 
 
Evidence based guidelines for physical activity for people with arthritis, osteoporosis and low back 
pain state that those with stable arthritis, osteoporosis or low back pain (without ongoing joint 
damage) can safely perform aerobic or resistance exercise (evidence Level 2, Grade A/B). However, 
it is recommended that people with significant osteoporosis avoid heavy weight bearing, especially 
trunk flexion (Level 2, grade A evidence) and rotation (Level 2, grade C evidence) [31]. 
 
Some information on appropriate activities is provided in the UK National Ankylosing Spondylitis 
Society’s exercise publication ‘Back to Action’ [32]. 
 
 
Five controlled cross-sectional observational studies were found which assessed aspects of balance in 
AS. The literature appeared to confirm the WG’s clinical observations, that early/ mild AS does not 
appear to impact on spinal position sense [33] or balance tested on a platform with a low level of 
perturbance [34]. However, for advanced disease, postural control in standing, bilateral stance 
postural stability and balance during gait were all diminished in AS compared with controls [35-37].  
A number of reviewers have investigated the association of cardio-vascular morbidity with AS [38-
48], with consistent findings of small increases in cardio-vascular risk factors, such as athero-
sclerosis, hypertension and ischaemic heart disease, in association with advanced disease severity. 
There was a statistically significant association of cardio-vascular risk factors with decreased spinal 
mobility (BASMI) [38, 40].  The risk ratio for myocardial infarction after meta-analysis of 3279 
patients with AS was 1.38 [49].  
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 Exercise which excessively 
challenges balance, postural 
stability or cardio-pulmonary 
function (in a non-controlled 
environment) 
 
Excessive spinal or peripheral 
joint mobility gain where there 
is adjacent ankylosis 
 
 
 
Excessive end range mobility 
gain following total hip 
replacement 
 
 
 
 
13 studies were found investigating various aspects of pulmonary function in AS, including 7 
controlled cross-sectional cohorts. Although there was one conflicting study which found no decrease 
in exercise tolerance in AS [50], the others all found a degree of reduction in pulmonary function. In 
general, reduced pulmonary fitness was inversely associated with BASMI score [47, 51] and chest 
expansion [51-55]. Peripheral strength [56], maximal inspiratory pressure [57] and diaphragm 
excursion [58] were also associated with exercise capacity. 
 
One small study investigated changes in sagittal spinal balance in advanced AS, finding an 
association with pseudarthrosis, which was most prevalent at T11/12 level [59] and there is an 
association of atlanto-axial subluxation with radiographic change and disease duration [60]. There 
was anecdotal evidence of pain/ discitis following extension exercises in a person with partial spinal 
ankylosis 
 
A longitudinal study of 95 total hip arthroplasties identified anterior dislocation as a potential 
complication in patients with advanced spinal changes [61]. 
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C2.4 
Disease 
management 
Exercise could theoretically be 
a mediator of inflammation in 
AS, but trial results have been 
conflicting 
As per paper 
 Stabilisation with biological 
therapy can be a ‘window of 
opportunity’ to optimise 
mobility and physical fitness. 
Two studies [62, 63] found improved compliance with exercise once patients were stabilised on anti-
TNF, supporting the WG’s view that commencement of a biological medication may be a ‘window of 
opportunity’ to optimise mobility, strength and physical fitness for individuals with AS. However, 
other studies suggest there is a risk of weight gain, in association with decreased physical activity, 
once stabilisation with biological therapy is attained [64]. 
C2.5 
AS-specific 
exercise 
(mobility) 
Mobility goals may vary from 
restoration of full spinal range 
and normal posture (in early, 
well controlled disease), to 
maintenance of existing range 
(in later disease). 
Clinical experience of WG. Not reflected in studies, as different groups (early vs late AS) have not 
been studied. 
 Exercise choice (e.g. specific 
proprioceptive neuromuscular 
facilitation techniques) can be 
tailored to target movement or 
functional deficits 
In the 1880s, Bulstrode et al [65] developed a series of proprioceptive neuromuscular facilitation 
(PNF) stretches specifically designed to be performed by individuals with AS, without the need for a 
partner. These ‘contract relax’ stretches remain in widespread use, and in the experience of the WG 
appear effective. A randomised trial showed superior results compared to static stretching for hip 
joint range, but this has not been repeated for other regions, although Kraag [66] mentions (without 
describing) PNF techniques.  
C2.6 AS-
specific 
exercise 
(other) 
There is preliminary evidence 
for modified Pilates, tai chi, 
incentive spirometry and global 
postural re-education (GPR) as 
effective modalities 
Single small RCTs (with group sizes of 11-30) have demonstrated effectiveness for these exercise 
types – as detailed in Appendix B, section 1.4. 
C2.7 
Physical 
activity 
No one activity has been found 
to be superior.  
Falkenbach surveyed 1538 people and did not find one sport more beneficial than another [67].  
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 Regular interruption of 
sedentary activities should also 
be encouraged 
Reduction of sedentary behaviour (independently of PALs) is also gaining increasing attention in the 
literature, [68], including the relationship between being sedentary and physically active in all aspects 
of living. Guidelines have consequently incorporated the importance of reducing / interrupting sitting 
time as regularly as possible, [69, 70]: anecdotally this is also a beneficial strategy for managing AS 
related stiffness. 
 Occupational, transport and 
leisure activities also contribute 
to total physical activity levels 
These exercise types are beyond the scope of this review- however, can obviously contribute to total 
physical activity levels. A short-term (six week) study of swimming and a home exercise program 
(HEP), walking and HEP or HEP alone, resulted in a statistically significant improvement in mobility 
(BASMI), quality of life (QoL) and pulmonary function (vital capacity) measures, with additional 
gains in maximal oxygen consumption (pVO2) and six minute walk test for the walkers and 
swimmers [71].  
C2.8 
Dosage 
Factors which may indicate 
modification of baseline 
exercise dose include: pain/ 
fatigue; disease activity and any 
secondary AS consequences 
(cardio-respiratory, ankylosis, 
osteoporosis, balance 
impairment) 
Since up to 30% of individuals with AS meet the criteria for fibromyalgia [72], and those with 
persistent pain have been shown to have a hyperalgesic response to moderate to high intensity 
exercise [73], there may be reasons why it may make clinical sense to commence with a lower 
absolute dosage than otherwise recommended. In other words, the baseline and progression dosage 
relative to the individual concerned is important [74], noting that a low absolute baseline dose should 
not preclude progression to a physiologically adequate one over time [75]. 
 Dosage progression (titration) 
should balance individual 
exercise response with training 
for physiological change  
No evidence was found for adverse events or ‘over-dosing’ of exercise in AS. However, overtraining 
is a well-recognised phenomenon in the PAL literature, with excessive exercise hypothesised to 
produce an increase in systemic inflammation [76]. In addition, a more rapid rate of change of 
dosage, as well as the total amount, have been shown to be determinants of injury [70]. At least as 
important is the concept that an ‘over-dose’ may lead to a poor exercise experience and thus activity 
avoidance [77], therefore careful titration is recommended.   
 Mobility exercise can be 
incorporated in regular breaks 
from sitting 
Whilst more epidemiological studies are required, there is sufficient evidence for national guidelines 
to recommend frequent interruption of prolonged sitting [70]. There is no indication that a set of 
stretch or mobility exercises have to be done consecutively, so if performed as a break from 
prolonged sitting may have a dual purpose. 
 Short-term more intensive The reported dosages of higher quality papers may be useful in guiding an intensive program, for 
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doses may be appropriate for 
specific purposes. 
example, in order to attain optimal spinal mobility following diagnosis. 
C2.9 
Adherence 
Group settings and monitoring 
have been shown to support 
adherence in AS 
In the early 1990s, Barlow studied the effects of self-help AS groups in a cross-sectional study, [78, 
79], finding that group members had a higher belief in the effectiveness of exercise and were more 
likely to perform it regularly. A qualitative study by Porter [19] found that patients valued 
anthropomorphic measurements in supporting exercise behaviour.  
C2.10 
Setting 
AS-specific group therapy and 
warm water exercise 
(hydrotherapy) may be 
beneficial adjuncts to an 
individual’s regular home 
exercise program. 
The 2008 Cochrane review found that there was evidence to support ‘group physiotherapy’ over 
home exercises, and ‘combined inpatient spa-exercise therapy followed by group physiotherapy’ over 
group physiotherapy alone [81]. Two recent studies have compared out-patient group rehabilitation 
[82] and group Pilates [83] to no active intervention. These higher quality RCTs (rated 7/10 and 8/10 
on the PEDro scale) both demonstrated significant improvements in mobility (BASMI and chest 
expansion) and disease activity (BASDAI).  
The WG acknowledges the lack of good quality trials involving warm water exercise in a non-
residential setting. However, clinical experience and trials of balneotherapy (which usually 
incorporate an active exercise component) suggest that it can be effective, especially in more 
advanced disease. NB. No trials investigating the same exercises in cooler water (i.e. less than 30°C) 
were found. However, the thermal properties of water as an exercise medium are considered 
important, and anecdotally, mobility exercise appears more effective and comfortable in warmer 
water. 
 Where available, exercise 
supervision appears to enhance 
effectiveness 
Although home-based exercise has been shown to be effective[84], a component of supervision 
appears to offer the greatest benefits [85, 86]. NB This PP was added following the final literature 
review. 
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Figure 3C1 Plain Language Recommendations and Practice Points 
Exercise for Ankylosing Spondylitis (AS): A Consensus Statement 
Plain Language Summary 
For people who have AS at any stage, including early stages 
Recommendation 1: Assessment for Exercise 
People who have AS should have a thorough assessment which can be repeated at regular 
intervals. It should include all aspects that may relate to planning of exercise, such as personal 
circumstances, history of condition and measures of how AS has affected movement 
• The assessment helps to inform the best 
exercise combination for each person, 
that is, where to start 
 
Recommendation 2 : Monitoring 
A regular review should be offered, so that people with AS can feel confident that they are 
getting the most benefit from their exercises. This should happen at least once per year and 
more often where required 
• Feedback (such as mobility measures) 
can be helpful for motivation to continue 
exercise 
• Self-monitoring techniques may be 
useful where health professional access 
is not possible  
Recommendation 3: Safety 
Any physical effects of the condition must be considered, especially for those with more severe 
or later disease. This includes any spinal fusion, balance or mobility change, osteoporosis 
(bone thinning) or general fitness effects of the condition 
• Most types of exercise are safe for the 
majority of people with AS.  
• However, exercise or activities that are 
‘high impact’ or strenuous should be 
assessed on a case by case basis 
• Examples of activities to avoid if you 
have significant spinal fusion 
(ankylosis): 
- contact sports 
- martial arts 
- four wheel driving 
- boating in rough seas 
- fairground rides 
- forced movements to increase 
mobility (including after hip 
replacement) 
• People who have osteoporosis (bone 
thinning) should avoid strenuous or 
repetitive trunk bending and twisting 
• Some activities may need adaptation to 
manage any balance or fitness 
(breathing) restrictions 
• These precautions to do not apply to 
people who have well-managed and 
early or less severe AS 
Recommendation 4: Condition Management 
When people with AS are treated with ‘anti-TNF’ medication, they should continue with 
regular exercises, as  the combination is more beneficial than the medication on its own  
Starting on a biological medication may provide 
a ‘window of opportunity’ to obtain the best 
possible movement, strength and fitness 
• Exercise has been shown to decrease 
inflammation, but the exact effects in AS 
are not yet clear  
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Recommendation 5: Exercise to treat AS (mobility) 
The most important exercises are those that help keep the spine (and other affected joints) 
moving. Mobility measures may help guide which exercises should be chosen for most benefit 
 
Recommendation 6: Exercise to treat AS (other) 
Stretching, strengthening, and heart/ lung (‘cardio’) fitness are also important for a balanced 
exercise program. 
• People with early AS may be able to 
keep or restore full movement 
• Others who have had AS for longer may 
be aiming to keep their existing 
movement 
• There are small studies to show that 
hydrotherapy, spa exercise, Tai chi, 
swimming, Pilates and walking have 
benefits in AS 
Recommendation 7: Physical activity for general health 
Regular physical activity is important for general health, well-being and the best possible level 
of function. 
• The research does not show that one 
activity is better than another 
• Avoiding sitting for too long (more than 
half an hour) is recommended 
• Lifestyle physical activity (for work, 
transport or leisure) may also help with 
managing AS symptoms 
Recommendation 8: Dosage 
Advice about how much, how often and how vigorously exercises should be performed should 
be tailored to a person’s needs, lifestyle, and condition.  
(a) For mobility, stretch & postural exercise, consistency is important 
(b) For other types of exercise, national physical activity guidelines are helpful, but may 
require adjusting due to AS.  
• When starting to exercise, factors such 
as pain, fatigue and any consequences of 
AS should be considered 
• The ideal amount of exercise for each 
person will take into account these 
factors, but still be enough to have an 
effect 
• Changes to exercise dosage should be 
matched to a person’s goals and 
response to exercise 
• Mobility exercises can be ‘tagged’ to 
other activities, such as a break from 
sitting down at work 
• More intensive exercise, for a limited 
time,  may be helpful for a particular 
goal 
Recommendation 9: Adherence 
It is important to consider motivation for continuation of regular exercise and ongoing self-
management. 
• The challenges of keeping going with  a 
regular exercise routine are 
acknowledged and should be supported 
• Group exercise sessions and monitoring 
(of spinal measures) have been shown to 
be helpful for ongoing motivation 
Recommendation 10: Exercise Setting 
In all exercise choices, a person’s preferences are important, in order to increase the 
likelihood of exercises being carried our regularly and on an ongoing basis. 
• Hydrotherapy and exercise groups  may 
provide extra benefit in addition to 
individual exercises  
• Where available, exercise supervision 
appears to enhance effectiveness 
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3.11  Postscript: Evidence published following completion of this 
study 
The published paper systematically reviewed the literature published up until 1st July, 2015. 
This limitation was addressed by repeating the search strategy utilised in the study from that 
date until 25th August 2018, revealed six additional RCTs that met the inclusion criteria, and 
these are summarised in Table 3.1. Two RCTs [2, 3] aimed to increase balance parameters in 
people with axSpA, both finding that there were significant between group differences in a 
range of balance parameters, favouring the intervention group. A slightly larger RCT (35 
participants per group), compared the effects of a walking and stretch program, with a group 
performing stretching exercises alone [4]. Significant improvements in cardio-pulmonary 
capacity were measured in the walking group, despite the fact that the exercise program 
described did not meet the ACSM guidelines for physiological effectiveness (Table 1.1). 
Taken together, these interventional studies provide limited additional support for the concept 
presented in this chapter of an individually tailored exercise program that addresses measured 
and potential deficits in mobility, strength, cardio-pulmonary and functional parameters, 
including balance.  
Further supporting evidence for also retaining mobility exercise as a key recommendation is 
provided by the cross-sectional observational study by O’Dwyer et al, who found significant 
reductions in validated measures for mobility, strength and cardio-respiratory function in 39 
adults with AS, compared to controls sourced from the general population by advertising, 
who were matched for gender and age. There was also a strong positive correlation between 
spinal mobility and physical function [5], thus recommendation 5 is strengthened.  
A further RCT found that a behavioural intervention aiming to increase physical activity was 
also successful in increasing spinal mobility – although the effect of additional mobility 
exercises was not tested [6]. This latter study, however, strengthens recommendation nine of 
the CS regarding the prioritisation of adherence in the development of exercise programs. 
Lastly, a pilot study investigated the use of a computer-based ‘virtual avatar’ exercise 
program [7] – however, since insufficient detail was provided on the exercise program and 
outcome measures (Table 1.1), it is not possible to incorporate such strategies into evidence 
based guidance at this time.  
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Table 3.6 Studies published since the publication of the AS consensus statement 
Author (year) Study Type Groups (n) Main outcome measures Main findings 
Demontis (2016) 
[2] 
Quasi-randomised, 
single-blinded study  
Rehabilitation 
(supervised) + 
education (22) 
Education alone (20) 
Balance parameters measured by 
stabilometry, BASMI, BASFI, 
BASDAI 
Significant improvement in sway density; trend 
towards improvement in other parameters. 
Gunay (2018) [3] RCT  Balance exercises + 
spa based rehab (11) 
Spa based rehab only 
(10) 
Balance parameters, BASFI, 
BASMI, BASDAI, AsQoL 
Improvement in balance measures for balance 
intervention group; improvement in other 
parameters for both groups 
Jennings (2015) 
[4] 
RCT  Walking + stretch 
exercise (35) 
Stretch alone (35) 
Cardio-pulmonary capacity, 6MWT, 
BASFI, BASMI, BASDAI, AsQoL 
Improvement in cardio-pulmonary capacity & 
6MWT; similar improvement in other measures in 
both groups 
Karahan (2016) [7] RCT ‘Exergames’ (30)  
No exercise (30) 
Pain NRS, BASFI, BASDAI, AsQoL Improvement in pain, BASFI, BASDAI & ASQoL 
scores in the intervention group 
O’Dwyer (2016) 
[5] 
Cross-sectional, 
controlled, 
observational study 
Adults with AS (39) 
Matched controls (39) 
Validated measures of mobility, 
strength, cardio-resp. function, body 
composition 
Significant decrease in mobility, strength, cardio-
respiratory function, & increase in body fat, in AS 
group 
O’Dwyer (2017) 
[6] 
RCT PA behaviour change 
intervention (20) 
Usual care (20) 
Accelerometer measured PA, 
validated measures of mobility, 
strength, cardio-resp. function, body 
composition, ASQoL, BASFI, 
BASDAI 
Significant, mod-large increase in PA, improved 
BASMI & ASQoL in intervention group. No 
significant change in strength, cardio-resp. 
function, body composition, BASFI or BASDAI. 
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Exergames – movements in co-ordination with a ‘virtual avatar’ computer program; 
callisthenics - gross motor/ body weight exercises; BASFI Bath AS Functional Index; 
BASDAI Bath AS Disease Activity Index; ASQoL AS Quality of Life score; BASMI Bath 
AS Metrology Index; BASFI Bath AS Functional Index; 6MWT six minute walk test; PA = 
physical activity 
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Chapter 4: Methods 
4.1 Preface 
The second phase of this thesis aims to strengthen the evidence for exercise in axSpA, by 
obtaining further information about the lumbar paraspinal muscles, which may inform the 
future development of specific exercise management strategies. The participants were a sub-
group of the Tasmanian Ankylosing Spondylitis Study (TASS). This chapter describes TASS 
and the additional research methods used within the sub-study. 
4.2 The Tasmanian Ankylosing Spondylitis Study (TASS) 
This population based, longitudinal inception cohort study aimed to investigate the 
relationship between inflammation and demonstrated structural damage in early axSpA. The 
study was approved by the Health and Human Research Ethics Committee (Tasmania) - 
Network approval number H0009856. The study population were Tasmanian adults with 
rheumatologist-diagnosed inflammatory back pain (IBP), and / or other extra-articular 
features consistent with spondyloarthritis, according to the European Spondylarthropathy 
Study Group (ESSG) criteria for spondyloarthritis. The criteria are ‘inflammatory spinal pain’ 
or ‘synovitis’ (asymmetric or predominately in the lower limbs), and one or more of the 
following variables [1]: 
o Positive family history 
o Psoriasis 
o Inflammatory bowel disease 
o Urethritis, cervicitis or acute diarrhea within one month before the onset of arthritis 
o Buttock pain alternating between right and left gluteal areas 
o Enthesopathy 
o Sacroiliitis 
Inflammatory back pain is further defined by ESSG as: “History or present symptoms of 
spinal pain in back, dorsal, or cervical region, with at least four of the following: (a) onset 
before age 45, (b) insidious onset, (c) improved by exercise, (d) associated with morning 
stiffness, (e) at least 3 months duration” [2]. 
Participation in the sub-study was offered to those consecutively referred to TASS by 
rheumatologists and other health professionals. Exclusion criteria for the sub-study were: 
previous spinal or pelvic surgery; any known contra-indications to MRI, such as metal 
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implants, pacemakers or claustrophobia; significant co-morbidities which may influence 
mobility, and, previous instruction in lumbar muscle strengthening exercises. However, in this 
instance no exclusion criteria were identified amongst potential participants prior to the study. 
Written informed consent was gained for both participation in the study and to undergo the 
MRI procedure.  
 
4.3 Measures utilised for the sub-study 
C-Reactive protein (CRP) is non-specific acute phase reactant of hepatic origin, which is 
commonly used to monitor inflammation in rheumatologic diseases [2]. It is measured in 
milligrams per litre, and values were obtained from medical records for the date closest to the 
MRI scan.  
Sacro-iliac radiographic grade (0-4) 
Sacroiliitis was assessed by a standard antero-posterior radiograph (x-ray) of the pelvis, and 
the degree of sacro-iliac (SI) joint change graded by a physician according to the ASAS 
recommended criteria [4] (Table 4.1): 
 
Table 4.1: Sacro-iliac radiographic grades for AS (modified New York criteria) 
Grade 0 Normal 
Grade 1 Suspicious changes 
Grade 2 Minimal abnormality – small localized areas with erosion or sclerosis, 
without alteration in joint width 
Grade 3 Unequivocal abnormality – moderate or advanced sacroiliitis with one 
or more of: erosions, sclerosis, widening, narrowing or partial 
ankylosis 
Grade 4 Severe abnormality – total ankylosis 
 
Magnetic Resonance Imaging (MRI) scans 
An ultimate goal in exercise therapy is improved function, yet the part that muscles play in 
overall physical function is complex to understand and measure, and this is particularly so 
with regard to the lumbar spine and pelvis. However, it is widely recognised that, without 
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muscle control, the lumbo-pelvic region lacks stability [11] and thus a dynamic platform for 
most bodily movement. A further complexity is the contribution of central nervous system 
(CNS) motor control, for which pain is a known major modifier [12]. Static images, taken in a 
supine position, cannot therefore represent all aspects of muscle ‘fitness for purpose’, 
however, they have been shown to be useful surrogate markers in relation to function, as 
follows: 
 
(a) Morphology and function 
Muscle size and mass have been found to peak at age 24, and decrease by approximately one 
per cent annually from the fifth decade [13]. Accelerated loss of muscle mass is termed 
sarcopaenia: ‘primary’ is said to be age related, and ‘secondary’ is when there is association 
with immobility, inactivity or disease [14]. Although total muscle mass and function do not 
always predict each other [15-16], in the lumbar spine a recent study found significant 
correlations between multifidus/ composite trunk muscle size and functional tasks such as 
‘timed up and go’ and balance tests [17]. And a longitudinal MRI study of 962 participants 
demonstrated an inverse relationship between paraspinal muscle CSA and levels of disability, 
after adjusting for confounders [18]. 
 
(b) Muscle quality and function 
One explanation for the lack of direct association between total muscle mass and function is 
that muscle quality can change over time. Muscle architecture (fibre type and length) may 
degenerate [19], in association with fatty infiltration, that is, deposition of adipocytes within a 
muscle’s fascia. This is known as inter-muscular adipose tissue (IMAT) [20] and is essentially 
ectopic fat deposition. There is now substantial evidence that IMAT is a significant predictor 
of muscle function and overall mobility and physical function [21], as well as metabolic 
dysfunction, due to decreased glucose tolerance [22], and as such is a predictor for mortality 
from mid-life onwards [23]. There is limited evidence from observational studies that 
paraspinal IMAT is associated with a loss of functional capacity [24-25]. 
 
(c) Paraspinal muscle symmetry and function 
Several studies have found an inverse association between paraspinal (particularly LM) CSA 
and unilateral low back pain – whether the latter is ‘non-specific’ or associated with disc 
findings [26-28] or with unilateral bony structural change such as scoliosis [29] or stenosis 
[30]. However, the importance of these findings remains controversial [31]. No studies were 
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found which directly examined the relationship between paraspinal muscle symmetry and 
function.  
 
In summary, assessment of muscles and their function is complex, particularly in the lumbar 
spine. Each MRI measure acts as a partial descriptor only, hence the selection of three 
different measures (size, represented by CSA, IMAT and symmetry) to provide more detailed 
information. To further enrich the information, each measure was performed at lumbar spine 
levels L2/3 to L5/S1. Since the lower fibres of LM have attachments to the sacro-iliac joint 
capsule via the thoraco-lumbar fascia [32], comparison of levels could provide useful 
information about the disease, and potentially influence exercise selection. 
 
Bath Ankylosing Spondylitis Activity Index (BASDAI).  
Since up to 40% of patients with definite AS do not have elevated inflammatory markers, a 
patient reported index is commonly used in conjunction with objective inflammatory marker 
monitoring [3]. The BASDAI questionnaire comprises six questions and the numerical rating 
scale (NRS) version was used during the TASS study (figure 4.2). 
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Figure 4.1 NRS version of BASDAI patient reported outcome measure [2]. 
 
Total score = (Q1 + Q2 + Q3 + Q4 + (Q5 + Q6 / 2)) / 5 where Q1= score for question 1, Q2= 
score for question 2 and so on.  
 
Back pain in previous week – NRS (0-10) As recommended in the ASAS core 
assessment set, a 0-10 numerical rating scale was used to assess back pain during the previous 
week [5]. 
Ankylosing Spondylitis Quality of Life (AS-QoL) The AS-QoL comprises 18 
questions in the following domains: physical mobility; energy; pain; emotional reactions and 
sleep. It has shown excellent internal consistency (α=0.89–0.91) and test-retest reliability 
(rs=0.92). Construct validity was tested by examining the ASQoL domains in comparison 
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with previously validated measures - the Nottingham Health Profile (NHP) and Bath AS 
Functional Index (BASFI).  Spearman rank correlation coefficients for these comparator 
measures were as follows: physical mobility 0.78; energy 0.74; pain 0.81; emotional reactions 
0.72; sleep 0.54; social isolation 0.53, and BASFI 0.72 [6]. 
 
Bath AS Metrology Index  
The most commonly used instrument for measuring axial mobility is the Bath AS Metrology 
Index (BASMI) [7], which consists of five objective measures, as shown in Table 4.2:  
Measure Method Unit 
Spinal posture Tragus to wall distance: distance from ear to wall 
when standing upright with back to wall 
cm 
Lumbar spine mobility - 
flexion 
Schobers test: distraction of two points drawn 
15cm apart on the lumbar spine (using the 
posterior superior iliac spines as bony landmarks), 
after moving from an upright to a flexed position 
cm 
Cervical spine mobility - 
rotation 
Head turning measured in supine with a 
goniometer – mean of left and right 
degrees 
Hip mobility - abduction Distance between ankles on bilateral hip abduction 
whilst supine 
cm 
Lumbar spine mobility – 
lateral flexion 
Distance travelled by fingertips towards floor, 
when performing lateral flexion from an upright 
position – mean of left and right 
cm 
 
There are a two scoring systems: the ten point scale was chosen for our study due to its 
superior validity [8] and each item is scored as in Table 4.3. The mean score of the five 
measures represents the total BASMI score. 
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Table 4.3 Bath AS Metrology Index 10 point scale 
Score 0 1 2 3 4 5 6 7 8 9 10 
Tragus to 
wall  
(cm) 
≤ 10 10-
12.9 
13-
15.9 
16-
18.9 
19-
21.9 
22-
24.9 
25-
27.9 
28-
30.9 
31-
33.9 
34-
36.9 
≥ 
37 
Modified 
Schober’s  
(cm) 
≥ 7.0 6.4-
7.0 
5.7-
6.3 
5.0-
5.6 
4.3-
4.9 
3.6-
4.2 
2.9-
3.5 
2.2-
2.8 
1.5-
2.1 
0.8-
1.4 
≤ 0.7 
Inter- 
malleolar  
distance 
(cm) 
≥ 120 110-
119.9 
100-
109.9 
90-
99.9 
80-
89.9 
70-
79.9 
60-
69.9 
50-
59.9 
40-
49.9 
30-
30.9 
≤ 20 
Cervical 
rotation  
(degrees) 
≥ 85 76.6-
85 
68.1-
76.5 
59.6-
68 
51.1-
59.5 
42.6-
51 
34.1-
42.5 
25.6-
34 
17.1-
25.5 
8.6-
17 
≤ 8.5 
Lumbar 
side flex  
(cm) 
≥ 20 18-20 15.9-
17.9 
13.8-
15.8 
11.7-
13.7 
9.6-
11.6 
7.5-
9.5 
5.4-
7.4 
3.3-
5.3 
1.2-
3.2 
≤ 1.2 
 
The actual values for two components of BASMI (Schober’s test and lumbar lateral flexion) 
are additionally reported in our study, since they are specific to the region of interest and 
provide a visual indication of spinal stiffness.    
Baecke Habitual Activity score This questionnaire has domains for physical activity in 
work, sport and leisure, each having a maximum score of five points, for a total score of 15 
[9]. It was found to have good repeatability, and moderate validity (similar to an exercise 
diary) [10].   
 
Chapter 5 includes details regarding the MRI imaging and analysis and statistical analysis 
(section 5.4). 
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Chapter 5: Size, symmetry and quality of the lumbar 
paraspinal muscles in axial spondyloarthritis: a pilot study 
5.1 Preface 
The previous chapters identified that there is minimal evidence to support the development of 
exercise recommendations for axSpA that address the details of muscle fitness, such as 
strength, endurance, power or motor control. In contrast, strengthening (resistance) exercises 
are an integral component of well-established exercise guidelines for the maintenance of 
health [1, 2]. In axSpA, there is limited and somewhat conflicting, evidence that muscles may 
be primarily or secondarily affected by the condition [3-6], and a recent hypothesis that 
biomechanical stress may play a role in pathogenesis [7-10]. The latter has led to some 
questions about the role of exercise in axSpA management [11, 12]. Although axSpA is a 
systemic disease, the initial inflammatory changes occur in the lumbo-pelvic region, and 
therefore the lumbar paraspinal muscles are a likely target for any primary or secondary 
pathological change. This exploratory pilot study therefore aimed to examine whether further 
investigation of muscle size, symmetry or quality is warranted, as this could be important in 
designing future exercise-based studies that aim to evaluate the effect of addressing any 
identified deficits.    
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5.2 Abstract 
Objective 
There is little information available to inform the prescription of therapeutic strengthening 
exercises in people with axial spondyloarthritis (axSpA), including whether exercise should 
involve the ‘whole body’, or target specific muscles. Since axSpA initially affects the lumbo-
pelvic region, information about muscles with lumbo-pelvic bony attachments could be 
helpful.  This pilot study therefore aimed to describe and quantify the lumbar paraspinal 
muscles in people with axSpA.   
Methods 
Magnetic resonance imaging (MRI) of the lumbar spine was undertaken on 23 individuals 
with axSpA. Bilateral measures of total and fat cross-sectional areas (CSAs) were performed 
for the lumbar multifidus (MF) and lumbar erector spinae (LES) muscles separately at each 
vertebral level from L2/3 to L5/S1, and functional CSAs and percentages of intermuscular 
adipose tissue (IMAT) were calculated.  
Results 
IMAT was typically found in a symmetrical pattern adjacent to the muscle/ bone interfaces in 
both muscles. The highest percentage of IMAT occurred at the L5/S1 vertebral level. IMAT 
was higher in females than males, and the presence of IMAT levels >10% was distributed 
across the age range. There was a small association between age and IMAT (LM β 0.51, 95% 
CI 0.06, 0.96, LES β 0.63, 95% CI 0.06, 1.20) but none between BMI and IMAT.  
Conclusion 
People with axSpA have high levels of intermuscular adipose tissue in both the LM and LES 
muscles, which is largely symmetrical and most pronounced at the lower lumbar levels. A 
number of potentially complex relationships between the muscle changes, and disease 
pathogenesis and progression are plausible.  Regardless, these data support the need to 
develop and test potential exercise interventions targeting these muscles in axSpA, including 
biomechanical effects.   
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5.3 Introduction 
Evidence based management guidelines for axial spondyloarthritis (axSpA) consistently 
include exercise as a key recommendation [1, 2], supported by systematic reviews with meta-
analyses that have found consistent evidence for exercise across multiple outcomes [3-6] [42] 
Despite such universal recommendation, there is inadequate detail regarding the parameters of 
exercise prescription, reflecting limitations in the evidence base. Most attention has been paid 
to mobility exercises. RCTs have not addressed parameters of muscle fitness (such as motor 
control, strength, endurance and/ or power) in people with axSpA [7].  
The muscles that are typically the most symptomatic in axSpA are the lumbar paraspinal 
muscles. Previous MRI studies have found decreased total CSA of the paraspinal muscles in 
people with AS, compared with healthy controls [8], and controls with non-radiographic 
spondyloarthritis (nr-SpA) [9] and low back pain (LBP) [10]. Two of these studies 
additionally assessed muscle quality using semi-quantitative scales [8, 9]. However, there was 
limited information about the nature of the changes seen in individual muscles across all 
lumbar levels – for example, no studies were identified that examined  symmetry of any 
spinal muscle, despite findings of paraspinal asymmetry in association with other spinal 
pathologies, such as scoliosis, stenosis and disc herniation [14-16]. In addition, no studies 
were identified that investigated IMAT and CSA at the L5/S1 level, despite it’s close 
anatomical location to the SI joints and importance in biomechanical assessment and therapy. 
More detailed information about individual paraspinal muscle morphometry (size, symmetry 
and amount of fat within the muscle) at multiple levels, adjusted for age and sex, could 
therefore be helpful in designing optimally effective axSpA exercise programs. For example, 
it would be useful to know whether exercises designed to preferentially recruit specific 
muscles or spinal levels should be trialled, or whether the findings point to a more general 
approach. And, given that ectopic fat deposition within muscle (intermuscular adipose tissue 
(IMAT)) has been shown to be predictive of strength, mobility and metabolic dysfunction 
[11], results could inform future useful lines of enquiry which could enhance current 
knowledge of the axSpA disease process. 
This study therefore aimed to describe and quantify the lumbar paraspinal muscles (multifidus 
(LM) and the lumbar erector spinae (LES) group – longissimus thoracis pars lumborum & 
iliocostalis lumborum pars lumborum) at multiple levels, in people with axSpA.  
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5.4 Methods 
Study participants 
This cross-sectional pilot study was a sub-study of 24 consecutive participants from the larger 
Tasmanian Ankylosing Spondylitis Study (TASS - Health and Human Research Ethics 
Committee (Tasmania) Network approval number H0009856). The latter was a prospective 
longitudinal inception cohort of 188 participants who met the European Spondyloarthropathy 
Study Group (ESSG) criteria for spondyloarthritis [12]. All sub-study participants had been 
diagnosed as having axSpA by a rheumatologist, and exclusion criteria were: previous spinal 
or pelvic surgery; any known contra-indications to MRI, such as metal implants, pacemakers 
or claustrophobia; significant co-morbidities which may influence mobility, and, previous 
instruction in lumbar muscle strengthening exercises.  
TASS participants completed a series of patient reported outcome measures (PROMS) and 
other monitoring tests at six monthly intervals. These included: the Bath AS Disease Activity 
Index (BASDAI) [13]; the AS Quality of Life (AS-QoL) questionnaire [14], SI joint x-rays, 
and the inflammatory markers C-reactive protein (CRP) and erythrocyte sedimentation rate 
(ESR). Those participants enrolled in the muscle sub-study additionally completed a 10 cm 
Numerical Rating Scale (NRS) for back pain; and the Baecke Physical Activity Score [15]. 
Physical parameters were obtained as follows: height in centimetres using a Leicester 
Stadiometer, weight in kilograms using a calibrated Heine electronic scale and axial mobility 
scored by completion of the Bath AS Metrology Index (BASMI) [16], using the 10 point 
scoring scale [17]. The latter includes two specific lumbar spine assessments: Schobers’ test 
measures the distraction of the lumbar spinous processes on movement from an upright to a 
flexed position, and lumbar side flexion measures the lateral bend of the spine in a coronal 
plane (mean of left and right). MRIs were performed on the same day as the participant 
interview and physical examination. Data for symptom duration (years); C-reactive protein 
(CRP) and sacro-iliac x-ray grading were obtained from the TASS dataset, for the assessment 
point closest to the date of the MRI acquisition.  
Image acquisition and analysis 
Participants were positioned on the MRI patient table in a standardised crook lying position 
(supine lying with a pillow placed under the knees and the head and neck supported in a 
neutral position). MRI was performed using a 1.5 Tesla machine (Siemens AG, Germany) 
with true fast imaging in steady-state precession (FISP) sequence, using 14 x 7 mm 
contiguous slices aligned with the lower border of the body of the fourth lumbar vertebra 
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(L4). De-identified images were measured off-line using OsiriX medical imaging software 
(Geneva, Switzerland) by a physiotherapist (JM) with extensive musculoskeletal experience 
and additional training in measurement of paraspinal muscles on MRIs. The axial slice which 
most clearly identified the intervertebral disc and zygapophyseal joints at each lumbar level, 
from L2 to L5, was identified. For each selected slice, the LM and LES muscles on both sides 
were outlined along their fascial boundaries using the software’s ‘polygon’ tool, to obtain the 
total cross-sectional area (TCSA, cm2). Areas within each muscle boundary demonstrating 
bright signal were then outlined and measured. Based on in vivo correlation between the 
bright signal visualised within paraspinal muscles on MRI, and histological findings of 
adipose tissue [18], this measure was labelled fat CSA (cm2). Functional CSA (FCSA) was 
calculated as (TCSA-fat CSA) and intermuscular adipose tissue (IMAT) by (fat 
CSA/TCSA*100) for each set of measures (muscle, level and side). Absolute and percentage 
differences between individual pairs of left and right TCSA and FCSA measures for each 
muscle and level were calculated as (largest value-smallest value) and (largest value-smallest 
value/largest value*100) respectively. Body mass index (BMI) was calculated as weight (kg) / 
(height (m))2. 
Intra-rater repeatability was tested by completion of a second set of measures for total and fat 
CSA for each muscle at the L2/3 and L5/S1 levels, that is, a total of 16 pairs of measures for 
each subject.  
Statistical Analysis 
Statistical analysis was performed using Stata version 14 (StataCorp. 2015. Stata Statistical 
Software: Release 14. College Station, TX: StataCorp LP). Descriptive statistics for 
participant characteristics and muscle symmetry measures are presented as medians and 
interquartile ranges due to positive skewness for most variables. Median values for the 
functional, fat and total CSAs are presented graphically in bar charts stratified by sex, muscle 
and spinal level for right and left sides (Figure 1). Median percentage IMAT was similarly 
explored graphically (Figure 2). Data on muscle symmetry for total and functional CSA for 
each muscle was tabulated (Table 2). Differences in muscle measures at each level, after 
adjusting for sex, age and BMI, were estimated using linear mixed models regression, which 
accounts for the correlation between the repeated measures for individuals (Table 3). Separate 
models were fitted for total CSA, functional CSA, fat CSA and IMAT for the LM and LES 
muscles. Full data for CSA by muscle and sex are also reported (Supplementary Table 1). 
Chapter 5: Size, symmetry and quality of the lumbar paraspinal muscles in axSpA 
 
 
197 
5.5 Results  
All participants completed the study, except for one who was unable to undergo an MRI scan 
due to previously unidentified claustrophobia. Participant characteristics stratified by sex are 
presented in Table 5.1. There was a broad age range of 18-68 years, and median BMI was 
25.1 kg/m2 for males and 23.4 kg/m2 for females. For the whole group, half (11) were within 
‘normal’ BMI range (18.5 to 24.9 kg/m2), ten participants were ‘overweight’ (25 to 29.9 
kg/m2) and two were ‘obese’ (BMI > 30 kg/m2).  Women were younger than men (median age 
28 versus 37 years) and had slightly higher BASDAI, less mobility limitation and lower 
reported physical activity. Median CRP was at the upper end of normal range (3.0 mg/L), 
indicating well-controlled disease, and a median Bath AS Metrology Index of 2.0/10 suggests 
most participants had mild-moderate movement limitation.  
 
Intraclass correlation coefficients for the repeated measures using a two-way mixed-effects 
model were in the excellent range (Table 5.2). 
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Table 5.1: Participant characteristics by sex 
Variable Male, n=16 Female, n=7 Total, n=23 
Age (years) 37.5 (25, 52) 28 (25, 47) 37 (25, 49) 
Body Mass Index (kg/m2) 25.1 (22.6, 26.4) 23.5 (22.3, 28.4) 25.1 (22.3, 26.8) 
Symptom duration (years) 10.5 (6.5, 26.5) 8.0 (5.0, 21.0) 10.0 (6.0, 22.0) 
CRP (mg/L) 3.0 (1.0, 15.0) 2.8 (1.0-5.0) 3.0 (1.0-11.0) 
Sacro-iliac x-ray grade (0-4) 2.0 (1.0, 3.0) 2.5 (1.0, 3.0) 2.5 (1.0, 3.0) 
Back pain in previous week –  
NRS (0-10) 
5.7 (4.5, 6.8) 5.8 (4.5, 7.8) 5.8 (4.5, 7.8) 
AS QoL scale (0-18) 5.0 (0.5, 10.0) 12.0 (6.0, 16.0) 7.0 (1.0, 12.0) 
BASDAI (/10) 4.0 (1.8, 5.7) 5.3 (2.0, 5.5) 4.4 (2.0, 5.6) 
BASMI (/10) 2.1 (1.1, 3.6) 1.4 (1.2, 5.2) 2.0 (1.2, 4.2) 
Schobers test (cm) 5.6 (4.5, 6.0) 4.8 (3.5, 6.0) 5.5 (4.0, 6.0) 
Lumbar side flexion (cm) 15.8 (12.9, 20.3) 18.7 (8.0, 19.5) 16.3 (11.0, 19.5) 
Baecke Habitual PA score - work (/5) 3.06 (2.8, 3.5) 2.6 (2.4, 3.1) 3.0 (2.4, 3.3) 
Baecke Habitual PA score - sport (/5) 2.5 (2.0, 3.1) 2.3 (1.8-3.0) 2.5 (2.0-3.0) 
Baecke Habitual PA score-leisure (/5) 2.9 (2.3, 3.3) 2.5 (2.0, 2.8) 2.8 (2.3, 3.3) 
Baecke Habitual PA score - total (/15) 8.3 (7.3, 9.4) 7.5 (6.6, 7.9) 7.9 (7.1, 8.9) 
Values are presented as medians (25th, 75th percentile).CRP C-reactive protein; NRS numerical rating 
scale: 0=no pain and 10=most severe pain; AS QoL Ankylosing Spondylitis Quality of Life (QoL) 
scale: 0=best QoL, 18=worst QoL; BASDAI Bath AS Disease Activity Index: 0=lowest disease 
activity, 10=highest disease activity; BASMI Bath AS Metrology Index: 0=full axial range or 
movement, 10=highest limitation of range of movement; Schobers test: increase in distance on lumbar 
flexion between two marks placed 15cm apart on the lumbar spine: lower value=larger limitation to 
lumbar flexion; PA physical activity: higher score indicates more physical activity  
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Table 5.2 Intra-rater repeatability: intraclass correlation coefficients (ICC) for repeated 
measures using a two-way mixed-effects model 
 
Muscle/ 
Level 
Total CSA 
ICC (95% CI) 
Fat CSA 
ICC (95% CI) 
LM Right Left Right Left 
L2/3 0.862 (0.706- 
0.939) 
0.758 (0.512-0.899) 0.985 (0.958-0.994) 0.977 (0.946 - 
0.990) 
L5/S1 0.913 (0.806- 
0.968) 
0.828 (0.637-0.923) 0.931 (0.875-0.986) 0.937 (0.887- 
0.987) 
LES  
L2/3 0.965 (0.919-
0.985) 
0.956 (0.900- 0.981) 0.925 (0.835-0.968) 0.992 (0.980-0.996) 
L5/S1 0.770 (0.486-
0.900) 
0.852 (0.685-0.935) 0.926 (0.835-0.968) 0.917 (0.818-0.964) 
 
CSA = cross sectional area; LM = lumbar multifidus; LES = lumbar erector spinae 
 
Muscle Size 
Figure 5.1 illustrates the median size of muscles across vertebral levels for males and females.  
Total (functional + fat) CSA was higher with descending spinal levels for the LM muscle, and 
vice versa for the LES muscles. Total muscle CSAs were larger for males, and for both LM 
and LES, fat CSA was greater in females and increased with descending vertebral levels in 
both sexes.  
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Figure 5.1  Paraspinal fat, functional and total CSA for left and right sides in (a) females 
and (b) males 
 
 
Values are Medians  = functional CSA;  = fat CSA; whole bar = total CSA 
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Quality 
The median percentages of IMAT by muscle, level and sex are shown in Figure 5.2: 
Figure 5.2  Median intermuscular adipose tissue (IMAT) percentage by level and sex for 
(a) LES and (b) LM  
(a) 
 
 
(b) 
 
Data are medians and interquartile ranges; y axis Spinal level 2 = L2/3; 3 = L3/4; 4 = L4/5; 
5 = L5/S1;         = males,         = females 
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 IMAT was commonly present, with a value of greater than 10% found in at least one level, in 
all but one participant. IMAT was almost exclusively located adjacent to the muscle and bony 
interface, that is, adjacent to the vertebral body’s accessory and transverse processes for the 
LES, and the lamina and spinous processes for LM muscles. Thus, the IMAT formed typical 
shapes on the image as shown in Figure 5.3. In males, median IMAT for both muscles 
exceeded 10% at the L5/S1 vertebral level only. However, in females, median IMAT 
exceeded 10% at the L4/5 vertebral level in both muscles, and was over 25% in both muscles 
at L5/S1 (Figure 5.2). IMAT values >10%  were present across the entire age range – for 
example, 5 out of 9 (55%) of participants aged under age 30 had IMAT > 20% for both 
muscles at the L5/S1 vertebral level. 
Symmetry 
Muscle symmetry, comparing the medians of the absolute and percentage differences between 
left and right pairs of measures within individuals for total and functional CSA, is shown in 
Table 5.2. All absolute differences were less than 1.0 cm2, and all percentage differences less 
than 10%, except for the LES muscles at the L5/S1 vertebral level, and the LM muscles at the 
L2/3 vertebral level . 
The multivariable model (Table 5.3) quantifies size differences across levels after adjusting 
for age, sex and BMI. Females had clinically important lower functional CSA of LM (β=-
1.31, 95% CI -2.58, -0.04 for average difference between females and males) and total and 
functional CSA of the LES muscles (β=-2.25, 95% CI -3.84, -0.66 and β=-2.52, 95% CI -
4.94, -0.10 respectively) compared with males. Sex differences for LM total and fat CSA and 
LES fat CSA were not statistically significant. There was only a small association between 
higher BMI (adjusted for mean) and larger LM total CSA (β=0.24, 95% CI -0.08, 0.39), and 
no other associations with BMI were identified. Similarly, age appeared to have only a small 
influence on the findings, after centering for the mean ages of 39.81 and 34.14 years for men 
and women respectively – the most clinically important being positive associations being with 
IMAT in both LM (β=0.51, 95% CI 0.06, 0.96) and LES (β=0.63, 95% CI 0.06, 1.20). 
However, inspection of scatterplots provides evidence that this association is driven by one 
participant aged over 60 years of age, in whom IMAT values at L5/S1 ranged from 70.1 to 
100%.    
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Table 5.3 Muscle Symmetry for multifidus and erector spinae: median percentage and absolute differences between paired larger and 
smaller values, at lumbar levels L2/3 to L5/S1 
 Percentage difference - 
total CSA (%) 
Median ( 25th, 75th %ile) 
Percentage difference -
functional CSA (%) 
Median ( 25th, 75th %ile) 
Absolute difference – 
Median total CSA  
(cm2) 
Absolute difference - 
Median functional CSA 
(cm2) 
Multifidus (n=23) 
L2/3 13.28 (6.81, 15.57) 10.45 (5.01, 15.33) 0.59 (0.34, 0.88) 0.51 (0.24, 0.97) 
L3/4 5.48 (2.55, 9.79) 6.47 (3.47, 11.04) 0.42 (0.21, 0.78) 0.47 (0.23, 0.77) 
L4/5 5.77 (3.74, 12.94) 6.22 (3.41, 14.58) 0.54 (0.25, 1.10) 0.56 (0.29, 0.95) 
L5/S1 6.85 (2.87, 12.69) 10.89 (5.25, 17.52) 0.73 (0.25, 1.34) 0.58 (0.49, 1.30) 
Erector spinae (n=23) 
L2/3 5.67 (1.92, 9.68) 5.09 (1.74, 10.79) 0.94 (0.39, 2.35) 0.84 (0.23, 2.35) 
L3/4 5.72 (2.17, 9.76) 8.85 (4.13, 11.45) 1.11 (0.46, 1.73) 1.30 (0.74, 1.74) 
L4/5 5.89 (3.83, 8.22) 8.80 (3.57, 16.17) 0.72 (0.42, 1.41) 0.90 (0.55, 1.74) 
L5/S1 15.23 (6.42, 21.49) 25.27 (15.72, 34.53) 0.80 (0.25, 1.05) 0.67 (0.35, 0.95) 
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Table 5.4    Multivariable model of associations of muscle CSA (total, fat, functional) and IMAT with spinal level, sex, BMI and age  
 
 Total CSA (cm2) Fat CSA  (cm2) Functional CSA (cm2) IMAT (%) 
 β  95% CI β 95% CI β 95% CI β 95% CI 
Multifidus         
L3/4 1.73*** 1.29, 2.18 0.28* 0.04, 0.52 1.45*** 1.00, 1.90 6.12*** 2.59, 9.72 
L4/5 3.62*** 3.17, 4.06 0.74*** 0.50, 0.98 2.87*** 2.43, 3.32 8.19*** 4.62, 11.76 
L5/S1 4.68*** 4.23, 5.13 1.65*** 1.41, 1.88 3.03*** 2.58, 3.48 17.17*** 13.61, 20.74 
Female -0.81 -1.66, 0.05 0.50 -0.35, 1.35 -1.31* -2.58, -0.04 5.06 -5.41, 15.53 
BMI (kg/m2) 0.24*** 0.08, 0.39 0.11 -0.04, 0.26 0.13 -0.10, 0.36 0.70 -1.17, 2.58 
Age (years) -0.03 -0.07, 0.00 0.03 0.00, 0.07 -0.07* -0.12, -0.01 0.51* 0.06, 0.96 
Erector spinae         
L3/4 -2.79*** -3.77, -1.82 0.36 -0.19, 0.92 -3.36*** -4.15, -2.16 2.49 -2.15, 7.13 
L4/5 -6.17*** -7.15, -5.20 0.59* 0.04, 1.15 -6.77*** -7.77, -5.77 7.11*** 2.47, 11.75 
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L5/S1 -15.11*** -16.08, -14.13 0.50 -0.05, 1.06 -15.61*** -16.61, -14.61 32.37*** 28.12, 37.40 
Female -2.25** -3.84, -0.66 0.26 -1.21, 1.74 -2.52* -4.94, -0.10 3.28 -9.92, 16.49 
BMI (kg/m2) 0.27 -0.02, 0.55 0.05 -0.22, 0.31 0.22 -0.21, 0.66 -0.14 -2.51, 2.22 
Age (years) 0.01 -0.06, 0.08 0.08* 0.01, 0.14 -0.07 -0.17, 0.04 0.63* 0.06, 1.20 
 
Multivariable model: each variable adjusted for other items in table; reference level is L2/3; Covariates centred for mean of age (men 39.81, women 
34.14 years) and BMI (24.82 kg/m2) 
 β regression co-efficient,   CI confidence interval. Bold indicates significance  p<0.05*,  p<0.01**,  p<0.001*** 
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5.6   Discussion 
This is one of the few studies of people with axSpA to provide details about individual 
lumbar muscles at multiple vertebral levels, and includes new information about the muscles 
at the lumbo-sacral junction. The most important and novel finding of our study was the high 
level of fat infiltration in both the LM and LES muscles, distributed symmetrically (Figure 5.2 
and Table 5.2) in a pattern adjacent to the bony insertions of the paraspinal muscles (Figure 
5.3), and present across the age range of participants. The presence of IMAT was most 
extensive at the L5/S1 vertebral level, where a median of approximately one quarter of the 
muscle mass had been replaced with adipose tissue. This is clinically important because such 
ectopic fat deposition (and decreased percentage of viable contractile tissue) points to 
impaired muscle function (diminished motor control and strength), which could be targeted 
using specific muscle re-training. In contrast to IMAT studies in healthy populations [19, 20] 
IMAT was distributed across participants with a wide range of ages, suggesting that ax-SpA 
associated factors may be at play. This is an avenue of inquiry that could enhance 
understanding of the disease and/ or contribute to maintenance of general health in people 
with axSpA.  
 
Figure 5.3 Sample transverse MRI scan at L4/5 level showing location of IMAT (bright white 
tissue) adjacent to the bony interfaces 
 
 
Chapter 5: Size, symmetry and quality of the lumbar paraspinal muscles in axSpA 
 
 
207 
 
The findings broadly concur with those of other MRI axSpA paraspinal muscle studies. 
Paraspinal muscle (LM and LES muscles combined) TCSA  in people with axSpA at lumbar 
vertebral levels L1/2 to L4/5 was smaller compared with healthy age and sex matched 
controls [8]. In  men with axSpA, total CSA at L4/5 level only was smaller  compared with 
controls with LBP matched for lumbo-sacral angle [10]. However, a study comparing the 
muscle sizes of people with non-radiographic axSpA (nr-axSpA) and those with AS found the 
groups had similar paraspinal TCSA [9]. With regard to the IMAT findings, IMAT assessed 
by semi-quantitative grading was higher in AS, compared with nr-axSpA at L4 [9], and for 
total paraspinal muscle CSA at L1/2 to L4/5 in people with AS, compared with controls [8] 
Our finding that IMAT for both muscles significantly increased with each descending 
vertebral level (with the exception of LES from L2/3 to L3/4), was similar to results from 
larger population-based studies in people without AS [20]. However, in contrast to these 
studies, we did not find a statistically significant association between IMAT and BMI, and 
only a small association between age and IMAT. These findings support the concept that the 
axSpA disease process may be additive to the normal effects of BMI and ageing with regard 
to muscle morphology.  
 Implications for exercise prescription 
The lumbar paraspinal muscles are considered to be postural muscles: the dominant fibre type 
is slow-twitch (type 1), supporting the function of constantly resisting gravitational (and 
other) forces (shearing, compression and traction) during upright posture, thus adding to the 
stability of the lumbo-pelvic region [21].  There are some similarities between the findings of 
our study and results reported for people with non-inflammatory LBP. Two systematic 
reviews confirmed evidence for an association between muscle size and ‘non-inflammatory’ 
low back pain (LBP) [22, 23], but the study by Ranger et al found conflicting evidence for an 
association between IMAT and LBP. However, a recent cross-sectional comparison of people 
with chronic versus recurrent LBP found significantly higher amounts of IMAT in both the 
LM and LES muscles in the group with chronic LBP [24]. Specific rehabilitation protocols 
that target motor control training of lumbo-pelvic muscles have been beneficial for reducing 
pain and disability and improving physical function in people with chronic LBP [25-29]. To 
our knowledge, there have not been any studies which have assessed motor control of the 
paraspinal muscles in axSpA, or the effect of an intervention designed to improve their size, 
quality and function and this warrants further investigation.  
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A further consideration is the consistent location of the IMAT changes we found, in the 
deeper aspects of the muscles, that is, adjacent to the bony surfaces. Since LM is thought to be 
particularly adapted to a proprioceptive role, as evidenced by the high density of muscle 
spindles in the deep portion of the muscle [30,31], testing for an association between IMAT 
and this function could again reveal a useful therapeutic pathway.  
Lastly, consideration of the respective roles of the muscles in spinal stability and prime 
movement may prove worthwhile. One role of LM is to maintain the lordosis of the lumbar 
spine, which is thought to be important in controlling shearing and compression forces in the 
spine [32]: it therefore seems plausible that exercises specifically aimed at maintenance and 
control of the lumbar lordosis in axSpA may be beneficial for symptom management.   
Implications for disease understanding 
The relationships between the observed changes in morphology of the lumbar paraspinal 
muscles, and biomechanics, inflammation and physical function in axSpA are likely to be 
complex and could be interpreted in relation to a range of theories around axSpA 
pathophysiology.   
The primary pathological change in axSpA is enthesitis [33,34]. In a model described by 
McGonagle et al, local micro-trauma, secondary to a loss of joint stability at entheseal sites in 
predisposed individuals, has been postulated as a causative trigger for adjacent osteitis and the 
subsequent establishment of axSpA [35, 36], and as a factor in structural progression (that is, 
syndesmophyte formation and bony ankylosis) in established axSpA [37]. The latter authors 
propose that the type and intensity of physical activity is crucial to the maintenance of optimal 
biomechanical stress in axSpA – that is, there should be sufficient muscle activity to maintain 
stability, but not so much as to produce excessive compression. Our findings support this 
concept: due to the association between paraspinal muscle quality and isometric strength [38], 
a reduction in functional paraspinal muscle CSA, and its replacement by adipose tissue, could 
be a source of increased biomechanical stress in the lumbo-pelvic region.  
One explanation for our findings could be that the muscles themselves are a local target tissue 
for the disease process, with migration of inflammatory pathophysiology adjacent structures 
into the muscle tissue itself. Biopsy studies of the paraspinal muscles in axSpA showed 
varying degrees of type I and II fibre atrophy, and fatty and fibrous connective tissue 
infiltration [39-41]. Our finding that the presence of IMAT was most prevalent at the lower 
lumbar levels, and involved both the LES and LM muscles in a bilateral, and largely 
symmetrical, manner, invites consideration of a local, bilaterally distributed, inflammatory 
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environment that includes muscle tissue. This could account for the clinically observed rapid 
symptomatic improvement that some individuals experience with large range mobility 
exercises [42].  
Alternatively, these muscle changes could represent local muscle disuse atrophy, secondary to 
pain and/or structural progression, such as syndesmophytes, in axSpA. Supporting this 
concept, in another MRI study the total and functional CSA of the paraspinal muscles at the 
L4/5 vertebral levels was significantly less in those with axSpA who had a decreased lumbar 
lordosis/ increased sacral slope, compared with matched axSpA participants without spinal 
deformity [10]. Systematic reviews provide evidence of paraspinal muscle atrophy, ipsilateral 
to the side of chronic unilateral LBP compared with healthy controls [22], with changes 
preferentially affecting the LM muscles [23]. However, since IMAT was distributed across 
both the LES and LM muscles in the present study, pain sequelae alone appears unlikely to 
provide a complete explanation.  
Rather than being a local indicator of disease process or disuse, the muscle changes in our 
study could be related to generalised (whole-body) inflammation-mediated, accelerated 
sarcopaenia [42]. Previous evidence examining this concept has been equivocal: sarcopaenia 
has been identified in some axSpA studies [43-46] but not in others [47,48]. However, whilst 
there are a number of reasons why investigation of generalized IMAT is important [11], its 
presence alone does not explain the specific location of IMAT (at the lower lumbar vertebral 
levels and adjacent to the bony interfaces) seen within the paraspinal muscles in our study.  
Strengths/ weaknesses 
This pilot study adds to knowledge about paraspinal muscles in axSpA, by providing detailed 
quantification of size, symmetry and IMAT across multiple lumbar levels.  Due to the specific 
alignment of the MRI scans, we were able to obtain previously unidentified information about 
the L5/S1 vertebral level, which in our study showed the most change.  However, because of 
the small, exploratory nature of the study, it was not possible to stratify participants into 
groups (such as those with bridging sydesmophytosis versus those with no ankylosis), or to 
reliably examine a number of the potential associations in more detail. As there was not a 
control group (or normative data available using similar methodology), a comparison with a 
‘non axSpA’ sample was not possible, and since this was a cross-sectional study, cause and 
effect relationships could not be determined. It is therefore recommended that future 
investigation includes group stratification and examines longitudinal changes. Lastly, MRI 
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may not differentiate between, or detect, all relevant tissue pathology – for example, intra-
muscular triglyceride deposition [49] or other microscopic changes. 
5.7 Conclusion 
People with axSpA have high levels of intermuscular adipose tissue in both the LM and LES 
muscles, which is largely symmetrical and most pronounced at the lower lumbar vertebral 
levels. A number of potentially complex relationships between the muscle changes, 
biomechanics and disease pathogenesis and progression are plausible.  Regardless, these data 
support the need to develop and test potential exercise interventions targeting these muscles in 
axSpA, including biomechanical effects.   
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Supplementary Table 5A: Medians and 25th, 75th percentiles for LM CSA and IMAT by 
sex, level and side 
 
Level Total cross sectional 
area (TCSA), cm2 
  
Fat infiltrate CSA, 
(FatCSA) cm2  
Functional 
(FunCSA), cm2 
(TCSA-FatCSA)  
Intermuscular 
Adipose Tissue 
(IMAT) %  
 
Males 
(n=16) 
 
  Right Left Right Left Right Left Right Left 
L2/3 5.08 
(4.48, 
6.84) 
4.69 
(4.18, 
6.71) 
0.00 
(0.00, 
0.25) 
0.00 
(0.00, 
0.20) 
4.78 
(3.93, 
6.84) 
4.61 
(4.10, 
6.71) 
0.00 
(0.00, 
5.04) 
0.00 
(0.00, 
3.49) 
L3/4 6.83 
(6.69, 
7.73) 
6.85 
(6.24, 
7.56) 
0.26 
(0.00, 
0.90) 
0.10 
(0.00, 
0.30) 
6.66 
(6.34, 
7.30) 
6.51 
(6.00, 
7.19) 
3.74 
(0.00, 
6.37) 
1.51 
(0.00, 
4.12) 
L4/5 9.20 
(8.10, 
10.34) 
8.71 
(8.02, 
9.92) 
0.50 
(0.00, 
0.77) 
0.22 
(0.00, 
1.43) 
8.29 
(7.48, 
9.09) 
8.29 
(7.28, 
8.92) 
5.50 
(0.00, 
8.20) 
3.15 
(0.00, 
14.22) 
L5/S1 10.15 
(8.91, 
11.08) 
9.76 
(9.32, 
10.52) 
1.27 
(0.55, 
3.25) 
1.15 
(0.44, 
2.17) 
7.96 
(7.47, 
9.97) 
8.44 
(7.37, 
9.63) 
11.76 
(5.77, 
29.82) 
11.84 
(7.20, 
22.20) 
 
Females 
(n=7) 
 
  Right Left Right Left Right Left Right Left 
L2/3 3.37 
(3.09, 
6.09) 
4.09 
(3.43, 
7.15) 
0.00 
(0.00, 
0.83) 
0.00 
(0.00, 
0.15) 
3.37 
(2.63, 
5.35) 
3.86 
(3.43, 
5.13) 
0.00 
(0.00, 
15.09) 
0.00 
(0.00, 
3.67) 
L3/4 6.56 
(4.35, 
7.69) 
6.82 
(5.00, 
8.05) 
0.53 
(0.32, 
1.00) 
0.30 
(0.23, 
0.45) 
5.15 
(3.77, 
6.84) 
5.09 
(3.99, 
7.31) 
8.66 
(5.84, 
15.17) 
5.47 
(3.21, 
6.52) 
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L4/5 8.49 
(7.87, 
8.89) 
8.82 
(6.52, 
9.02) 
1.08 
(0.48, 
2.11) 
0.82 
(0.33, 
1.50) 
6.78 
(5.82, 
7.52) 
6.57 
(5.51, 
8.09) 
13.18 
(7.12, 
23.77) 
11.03 
(5.13, 
15.91) 
L5/S1 10.49 
(8.89, 
10.59) 
9.33 
(8.67, 
10.62) 
3.02 
(1.82, 
4.06) 
1.78 
(1.42, 
3.32) 
6.53 
(5.48, 
7.73) 
7.26 
(6.01, 
8.68) 
30.89 
(24.92, 
38.34) 
17.10 
(16.32, 
35.55) 
 
Total 
(n=23) 
 
  Right Left Right Left Right Left Right Left 
L2/3 4.93 
(3.69, 
6.34) 
4.42 
(4.08, 
6.75) 
0.00 
(0.00, 
0.47) 
0.00 
(0.00, 
0.17) 
4.76 
(3.37, 
6.10) 
4.20 
(3.80, 
6.68) 
0.00 
(0.00, 
9.36) 
0.00 
(0.00, 
3.67) 
L3/4 6.76 
(6.50, 
7.69) 
6.82 
(6.14, 
7.67) 
0.36 
(0.00, 
0.67) 
0.23 
(0.00, 
0.36) 
6.45 
(5.15, 
7.03) 
6.38 
(5.14, 
7.22) 
5.27 
(0.00, 
10.61) 
3.32 
(0.00, 
5.48) 
L4/5 8.80 
(7.95, 
10.12) 
8.41 
(7.67, 
9.64) 
0.53 
(0.27, 
1.87) 
0.58 
(0.14, 
1.50) 
7.57 
(6.96, 
8.92) 
7.93 
(6.20, 
8.87) 
6.35 
(1.87, 
16.52) 
6.46 
(1.52, 
15.30) 
L5/S1 10.16 
(8.89, 
10.64) 
9.07 
(9.29, 
10.62) 
1.81 
(0.65, 
3.39) 
1.42 
(0.91, 
2.20) 
7.73 
(6.53, 
9.30) 
8.06 
(7.14, 
9.60) 
18.29 
(5.98, 
33.91) 
15.25 
(8.90, 
23.47) 
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Supplementary Table 5B: Medians and 25th, 75th percentiles for LES CSA and IMAT by 
sex, level and side 
 
Level Total cross sectional 
area (TCSA), cm2 
  
Fat infiltrate  
(FatCSA)CSA, cm2  
Functional 
(FunCSA), cm2 
(TCSA-FatCSA)  
Intermuscular 
Adipose Tissue 
(IMAT) %  
 
Males 
(n=16) 
 
  Right Left Right Left Right Left Right Left 
L2/3 18.97 
(17.72, 
25.41) 
21.28 
(17.64, 
24.54) 
0.13 
(0.00, 
1.47) 
0.10 
(0.00, 
1.05) 
18.97 
(17.52, 
24.33) 
20.89 
(17.25, 
23.09) 
0.56 
(0.00, 
7.11) 
0.48 
(0.00, 
4.44) 
L3/4 17.17 
(13.59, 
20.48) 
16.15 
(14.54, 
20.28) 
0.21 
(0.01, 
0.90) 
0.07 
(0.00, 
0.66) 
15.83 
(12.96, 
19.12) 
15.70 
(13.87, 
19.68) 
1.26 
(0.04, 
6.14) 
0.44 
(0.00, 
3.75) 
L4/5 12.33 
(10.91, 
13.45) 
13.02 
(11.14, 
15.09) 
0.81 
(0.17, 
1.49) 
0.77 
(0.25, 
1.22) 
11.03 
(9.79, 
13.37) 
11.97 
(10.15, 
14.00) 
7.36 
(1.19, 
12.48) 
5.61 
(1.74, 
10.37) 
L5/S1 3.83 
(3.41, 
4.65) 
3.92 
(3.42, 
4.51) 
0.88 
(0.49, 
1.87) 
0.95 
(0.44, 
2.15) 
2.52 
(2.19, 
3.50) 
2.77 
(1.82, 
3.64) 
25.63 
(10.99, 
43.40) 
25.17 
(12.40, 
50.16) 
 
Females 
(n=7) 
 
  Right Left Right Left Right Left Right Left 
L2/3 13.67 
(12.06, 
18.29) 
13.88 
(11.83, 
18.88) 
0.22 
(0.00, 
1.38) 
0.16 
(0.00, 
0.50) 
13.67 
(12.06, 
14.66) 
13.72 
(11.83, 
16.01) 
1.64 
(0.00, 
7.31) 
1.17 
(0.00, 
2.54) 
L3/4 15.64 
(11.82, 
16.44) 
14.83 
(10.66, 
16.62) 
0.65 
(0.00, 
1.38) 
0.51 
(0.00, 
0.77) 
12.21 
(11.30, 
14.98) 
12.42 
(10.62, 
15.51) 
4.16 
(0.00, 
8.37) 
3.04 
(0.00, 
4.71) 
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L4/5 14.05 
(10.51, 
15.06) 
14.34 
(10.93, 
14.70) 
1.39 
(1.18, 
4.00) 
0.73 
(0.43, 
4.14) 
10.97 
(8.68, 
12.90) 
11.03 
(10.30, 
13.78) 
12.79 
(8.20, 
26.39) 
5.85 
(3.03, 
28.34) 
L5/S1 4.33 
(3.77, 
5.27) 
3.53 
(2.48, 
5.27) 
1.94 
(1.02, 
3.07) 
1.50 
(0.73, 
2.32) 
2.04 
(1.40, 
3.09) 
2.05 
(1.54, 
2.96) 
47.14 
(23.56, 
72.83) 
45.38 
(20.76, 
54.67) 
 
Total 
(n=23) 
 
  Right Left Right Left Right Left Right Left 
L2/3 18.50 
(15.74, 
22.99) 
18.88 
(16.01, 
22.27) 
0.20 
(0.00, 
1.34) 
0.11 
(0.00, 
0.70) 
17.98 
(14.46, 
22.99) 
18.75 
(14.72, 
22.19) 
0.81 
(0.00, 
7.31) 
0.60 
(0.00, 
3.71) 
L3/4 16.05 
(13.10, 
19.24) 
15.96 
(14.08, 
19.08) 
0.49 
(0.00, 
1.19) 
0.36 
(0.00, 
0.71) 
14.86 
(12.31, 
17.93) 
14.48 
(12.42, 
18.33) 
3.55 
(0.00, 
7.25) 
2.78 
(0.00, 
4.12) 
L4/5 12.50 
(10.71, 
14.47) 
13.16 
(10.93, 
14.70) 
1.11 
(0.27, 
1.87) 
0.76 
(0.27, 
1.33) 
10.97 
(9.27, 
13.02) 
11.59 
(10.30, 
13.78) 
8.57 
(1.49, 
15.52) 
5.78 
(1.79, 
10.42) 
L5/S1 4.00 
(3.55, 
4.66) 
3.92 
(2.92, 
4.57) 
1.46 
(0.64, 
2.13) 
1.28 
(0.49, 
2.32) 
2.46 
(2.03, 
3.09) 
2.70 
(1.69, 
3.06) 
38.86 
(18.16, 
68.74) 
35.18 
(12.81, 
52.26) 
 
 
         
         
Chapter 5: Size, symmetry and quality of the lumbar paraspinal muscles in axSpA 
 
   
  215   
    
 
5.8 References 
1. van den Berg R, Baraliakos X, Braun J, van der Heijde D: First update of the 
current evidence for the management of ankylosing spondylitis with non-
pharmacological treatment and non-biologic drugs: a systematic literature 
review for the ASAS/EULAR management recommendations in ankylosing 
spondylitis. Rheumatology (Oxford) 2012, 51(8):1388-1396. 
2. Ward MM, Deodhar A, Akl EA, Lui A, Ermann J, Gensler LS, Smith JA, Borenstein 
D, Hiratzka J, Weiss PF: American College of Rheumatology/Spondylitis 
Association of America/Spondyloarthritis Research and Treatment Network 
2015 recommendations for the treatment of ankylosing spondylitis and 
nonradiographic axial spondyloarthritis. Arthritis & Rheumatology 2016, 
68(2):282-298. 
3. Dagfinrud H, Kvien TK, Hagen KB: Physiotherapy interventions for ankylosing 
spondylitis. Cochrane Database of Systematic Reviews 2008(1). 
4. Millner J, Barron J, Beinke K, Butterworth R, Chasle B, Dutton L, Lewington M, Lim 
E, Morley T, O'Reilly J et al: Exercise for ankylosing spondylitis in Australia: an 
evidence-based consensus statement. In.: Menzies Research Institute Hobart; 2014. 
5. O'Dwyer T, O'Shea F, Wilson F: Exercise therapy for spondyloarthritis: a 
systematic review. Rheumatol Int 2014, 34(7):887-902. 
6. Pécourneau V, Degboé Y, Barnetche T, Cantagrel A, Constantin A, Ruyssen-Witrand 
A: Effectiveness of exercise programs in ankylosing spondylitis: A meta-analysis 
of randomized controlled trials. Archives of physical medicine and rehabilitation 
2018, 99(2):383-389. e381. 
7. Dagfinrud H, Halvorsen S, Vollestad NK, Niedermann K, Kvien TK, Hagen KB: 
Exercise Programs in Trials for Patients with Ankylosing Spondylitis: Do They 
Really Have the Potential for Effectiveness? Arthritis Care and Research 2011, 
63(4):597-603. 
8. Resorlu H, Savas Y, Aylanc N, Gokmen F: Evaluation of paravertebral muscle 
atrophy and fatty degeneration in ankylosing spondylitis. Mod Rheumatol 2017, 
27(4):683-687. 
9. Akgul O, Gulkesen A, Akgol G, Ozgocmen S: MR-defined fat infiltration of the 
lumbar paravertebral muscles differs between non-radiographic axial 
spondyloarthritis and established ankylosing spondylitis. Mod Rheumatol 2012. 
Chapter 5: Size, symmetry and quality of the lumbar paraspinal muscles in axSpA 
 
   
  216   
    
10. Bok DH, Kim J, Kim T-H: Comparison of MRI-defined back muscles volume 
between patients with ankylosing spondylitis and control patients with chronic 
back pain: age and spinopelvic alignment matched study. European Spine Journal 
2016:1-10. 
11. Addison O, Marcus RL, LaStayo PC, Ryan AS: Intermuscular fat: a review of the 
consequences and causes. International journal of endocrinology 2014, 2014. 
12. Amor B, Dougados M, Listrat V, Menkes C, Dubost J, Roux H, Benhamou C, 
Blotman F, Pattin S, Paolaggi J: Evaluation of the Amor criteria for 
spondylarthropathies and European Spondylarthropathy Study Group (ESSG). 
A cross-sectional analysis of 2,228 patients. In: Annales de médecine interne: 1991; 
1991: 85-89. 
13. Garrett S, Jenkinson T, Kennedy LG, Whitelock H, Gaisford P, Calin A: A new 
approach to defining disease status in ankylosing spondylitis: the Bath 
Ankylosing Spondylitis Disease Activity Index. J Rheumatol 1994, 21. 
14. Doward L, Spoorenberg A, Cook S, Whalley D, Helliwell P, Kay L, McKenna S, 
Tennant A, van der Heijde D, Chamberlain MA: Development of the ASQoL: a 
quality of life instrument specific to ankylosing spondylitis. Annals of the 
rheumatic diseases 2003, 62(1):20-26. 
15. Baecke JA, Burema J, Frijters JE: A short questionnaire for the measurement of 
habitual physical activity in epidemiological studies. The American journal of 
clinical nutrition 1982, 36(5):936-942. 
16. Jenkinson T, Mallorie P, Whitelock H, Kennedy G, Garret S, Calin A: Defining 
Spinal Mobility in Ankylosing Spondylitis (AS). The Bath Metrology Index. The 
Journal of Rheumatology 1994, 21(9):1694-1698. 
17. van der Heijde D, Deodhar A, Inman RD, Braun J, Hsu B, Mack M: Comparison of 
three methods for calculating the Bath Ankylosing Spondylitis Metrology Index 
in a randomized placebo-controlled study. Arthritis Care Res (Hoboken) 2012, 
64(12):1919-1922. 
18. Rossi A, Zoico E, Goodpaster BH, Sepe A, Di Francesco V, Fantin F, Pizzini F, 
Corzato F, Vitali A, Micciolo R: Quantification of intermuscular adipose tissue in 
the erector spinae muscle by MRI: agreement with histological evaluation. 
Obesity 2010, 18(12):2379-2384. 
Chapter 5: Size, symmetry and quality of the lumbar paraspinal muscles in axSpA 
 
   
  217   
    
19. Dahlqvist JR, Vissing CR, Hedermann G, Thomsen C, Vissing J: Fat Replacement of 
Paraspinal Muscles with Aging in Healthy Adults. Medicine and science in sports 
and exercise 2017, 49(3):595-601. 
20. Crawford R, Filli L, Elliott J, Nanz D, Fischer M, Marcon M, Ulbrich E: Age-and 
level-dependence of fatty infiltration in lumbar paravertebral muscles of healthy 
volunteers. American Journal of Neuroradiology 2016, 37(4):742-748. 
21. Bogduk N: Clinical anatomy of the lumbar spine and sacrum: Elsevier Health 
Sciences; 2005. 
22. Fortin M, Macedo LG: Multifidus and paraspinal muscle group cross-sectional 
areas of patients with low back pain and control patients: a systematic review 
with a focus on blinding. Physical therapy 2013, 93(7):873-888. 
23. Ranger TA, Cicuttini FM, Jensen TS, Peiris WL, Hussain SM, Fairley J, Urquhart 
DM: Are the size and composition of the paraspinal muscles associated with low 
back pain? A systematic review. The Spine Journal 2017, 17(11):1729-1748. 
24. Goubert D, De Pauw R, Meeus M, Willems T, Cagnie B, Schouppe S, Van 
Oosterwijck J, Dhondt E, Danneels L: Lumbar muscle structure and function in 
chronic versus recurrent low back pain: a cross-sectional study. The Spine Journal 
2017, 17(9):1285-1296. 
25. Gomes-Neto M, Lopes JM, Conceição CS, Araujo A, Brasileiro A, Sousa C, Carvalho 
VO, Arcanjo FL: Stabilization exercise compared to general exercises or manual 
therapy for the management of low back pain: A systematic review and meta-
analysis. Physical therapy in Sport 2017, 23:136-142. 
26. Luomajoki HA, Beltran MBB, Careddu S, Bauer CM: Effectiveness of movement 
control exercise on patients with non-specific low back pain and movement 
control impairment: A systematic review and meta-analysis. Musculoskeletal 
Science and Practice 2018. 
27. Martins NA, Furtado GE, Campos MJ, Leitao JC, Filaire E, Ferreira JP: Exercise and 
ankylosing spondylitis with New York modified criteria: a systematic review of 
controlled trials with meta-analysis. Acta Reumatol Port 2014, 39(4):298-308. 
28. Ferreira PH, Ferreira ML, Maher CG, Herbert RD, Refshauge K: Specific 
stabilisation exercise for spinal and pelvic pain: a systematic review. Australian 
Journal of Physiotherapy 2006, 52(2):79-88. 
 
Chapter 5: Size, symmetry and quality of the lumbar paraspinal muscles in axSpA 
 
   
  218   
    
29. Saragiotto BT, Maher CG, Yamato TP, Costa LO, Menezes Costa LC, Ostelo RW, 
Macedo LG: Motor control exercise for chronic non-specific low-back pain. 
Cochrane Database Syst Rev 2016(1):Cd012004. 
30. Adams MA, Burton K, Bogduk N: The biomechanics of back pain, vol. 55: Elsevier 
health sciences; 2006. 
31. Brumagne S, Cordo P, Lysens R, Verschueren S, Swinnen S: The role of paraspinal 
muscle spindles in lumbosacral position sense in individuals with and without low 
back pain. Spine 2000, 25(8):989-994. 
32. Aspden R: The spine as an arch. A new mathematical model. Spine 1989, 
14(3):266-274. 
33. Benjamin M, McGonagle D: The Enthesis Organ Concept and Its Relevance to the 
Spondylarthropathies. 2009. 
34. McGonagle D, Stockwin L, Isaacs J, Emery P: An enthesitis based model for the 
pathogenesis of spondyloarthropathy. Additive effects of microbial adjuvant and 
biomechanical factors at disease sites. J Rheumatol 2001, 28(10):2155-2159. 
35. McGonagle D, Khan M, Marzo-Ortege H, O'Connor P, Gibbon W, Emery P: 
Enthesitis in spondyloarthropathy. Curr Opin Rheumatol 1999, 11:244-250. 
36. Debusschere K, Cambré I, Gracey E, Elewaut D: Born to run: The paradox of 
biomechanical force in spondyloarthritis from an evolutionary perspective. Best 
Practice & Research Clinical Rheumatology 2018. 
37. Benjamin M, Toumi H, Suzuki D, Redman S, Emery P, McGonagle D: Microdamage 
and altered vascularity at the enthesis–bone interface provides an anatomic 
explanation for bone involvement in the HLA–B27–associated spondylarthritides 
and allied disorders. Arthritis & Rheumatology 2007, 56(1):224-233. 
38. Schlaeger S, Inhuber S, Rohrmeier A, Dieckmeyer M, Freitag F, Klupp E, Weidlich 
D, Feuerriegel G, Kreuzpointner F, Schwirtz A: Association of paraspinal muscle 
water–fat MRI-based measurements with isometric strength measurements. 
European radiology 2018:1-10. 
39. Cooper RG, Freemont AJ, Fitzmaurice R, Alani SM, Jayson MIV: Paraspinal muscle 
fibrosis: a specific pathological component in ankylosing spondylitis. Annals of 
Rheumatic Diseases 1991, 50(755-759). 
40. Hopkins GO, McDougall J, Mills K, Isenberg D, Ebringer A: Muscle involvement in 
ankylosing spondylitis. Annals of Rheumatic Diseases 1982, 1982(41). 
Chapter 5: Size, symmetry and quality of the lumbar paraspinal muscles in axSpA 
 
   
  219   
    
41. Edwards M, Dennison E, Sayer AA, Fielding R, Cooper C: Osteoporosis and 
sarcopenia in older age. Bone 2015, 80:126-130. 
42. Bulstrode SJ, Barefoot J, Harrison A, Clarke AK: The Role of Passive Stretching in 
the Treatment od Ankyl;osing Spondylitis Rheumatology 1987, 26(1):40–42 
43. El Maghraoui A, Ebo'o FB, Sadni S, Majjad A, Hamza T, Mounach A: Is there a 
relation between pre-sarcopenia, sarcopenia, cachexia and osteoporosis in 
patients with ankylosing spondylitis? BMC Musculoskelet Disord 2016, 17:268. 
44. Marcora S, Casanova F, Williams E, Jones J, Elamanchi R, Lemmey A: Preliminary 
evidence for cachexia in patients with well-established ankylosing spondylitis. 
Rheumatology 2006, 45(11):1385-1388. 
45. Roren Norden K, Dagfinrud H, Lovstad A, Raastad T: Reduced Appendicular Lean 
Body Mass, Muscle Strength, and Size of Type II Muscle Fibers in Patients with 
Spondyloarthritis versus Healthy Controls: A Cross-Sectional Study. 
TheScientificWorldJournal 2016, 2016:6507692. 
46. Zhang Y, Xu H, Hu X, Zhang C, Chu T, Zhou Y: Histopathological changes in 
supraspinous ligaments, ligamentum flava and paraspinal muscle tissues of 
patients with ankylosing spondylitis. Int J Rheum Dis 2016, 19(4):420-429 
47. Plasqui G, Boonen A, Geusens P, Kroot EJ, Starmans M, van der Linden S: Physical 
activity and body composition in patients with ankylosing spondylitis. Arthritis 
Care Res (Hoboken) 2012, 64(1):101-107. 
48. Toussirot É, Grandclément É, Gaugler B, Michel F, Saas P, Dumoulin G: Serum 
adipokines and adipose tissue distribution in rheumatoid arthritis and ankylosing 
spondylitis. A comparative study. Frontiers in immunology 2013, 4:453. 
49. Conte M, Vasuri F, Trisolino G, Bellavista E, Santoro A, Degiovanni A, Martucci E, 
D’Errico-Grigioni A, Caporossi D, Capri M: Increased Plin2 expression in human 
skeletal muscle is associated with sarcopenia and muscle weakness. PLoS One 
2013, 8(8):e73709. 
 
 
 
Chapter 6: Summary 
 
   
  220   
    
Chapter 6: Summary 
6.1 Background and aims of the thesis 
Regular and lifelong exercise is frequently recommended to people diagnosed with axSpA – 
however, as discussed in chapter 1, details regarding the best type, dosage and setting are less 
often provided. For the individual concerned, implementing this advice can therefore be 
daunting and difficult [1]. Some find great benefit, whilst others are unable to change their 
exercise habits and continue with low levels of physical activity [2]. Particularly for those 
people who have little belief in the value of exercise, it perhaps seems unreasonable to expect 
such a large lifestyle change, without a complete evidence base. And for the health 
professional tasked with ‘guiding’ exercise planning and skills development, evidence and 
recommendations on which to base interventions is lacking. This thesis therefore aimed to 
identify and analyse the current evidence for exercise in axSpA, develop more specific 
recommendations to guide the work of HPs, and explore the morphometry and quality of the 
lumbar paraspinal muscles - with a view to informing future trials of exercise interventions. 
6.2 Major findings and implications 
Strength of evidence for exercise in axSpA 
The study presented in Chapter 3 comprised eight systematic reviews and meta-analyses 
where RCTs were available, in response to the clinical questions developed by an expert 
panel. Overall, the results confirmed the previous Cochrane systematic review [3], that is, a 
consistent trend for moderate effect sizes in favour of exercise for AS, based on Level 1B 
evidence – that is, pooled results of RCTs with less than 50 participants per group. There was 
an increase in the number of high quality trials, when measured by a scale of trial internal 
validity (PEDro) [4]. However, the subsequent analysis presented in Table 1.2 demonstrates 
poor therapeutic validity (design of the actual exercise program under investigation) in 55% 
of the included RCTs. This problem contributes to the evidence gaps noted below.  
Individual recommendations 
Ten recommendations to provide more details about exercise prescription in AS were 
developed, supported by a number of Practice Points where there was consensus derived 
information that the panel considered clinically important. The initial results were tested by 
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surveying healthcare providers and people with axSpA (chapter 3), and the wording adjusted 
accordingly. The subject and context for each recommendation is listed as follows: 
1. Assessment – to inform exercise prescription. Recommendations 1 and 2 are the first 
to describe how exercise prescription should be individually tailored according to 
axSpA assessment findings. 
2. Monitoring – to review effectiveness, inform exercise program adjustment and assist 
adherence. 
3. Safety – to describe precautions. This is one of the few recommendations to highlight 
the risks of inappropriate exercise in people with advanced axSpA: largely due to the 
increased incidence of falls and spinal fracture linked to the combination of spinal 
ankylosis, osteoporosis and decreased balance. This recommendation was specifically 
reinforced in a review of spinal fractures related to AS [5]. 
4. Disease management – exercise should be continued with bDMARDS - Although 
there was insufficient evidence that exercise alone can be disease modifying, several 
RCTs demonstrated a synergistic effect when exercise is performed concurrently with 
bDMARD therapy. This is important, as the advent of bDMARDs has placed a greater 
emphasis on pharmacological disease management – perhaps at the expense of non-
pharmacological strategies - despite findings that there can be a reduction in physical 
activity levels and gain in adiposity / body mass index, following commencement of 
these drugs [6, 7]. 
5. AS-specific exercise: mobility - This recommendation supports the continuation of 
‘traditional’ mobility exercises, as there is now a considerable body of evidence 
supporting their effectiveness. 
6. AS-specific exercise: other -The purpose of this recommendation is to highlight the 
importance of including other exercise types, such as stretching, strengthening, 
cardiopulmonary and functional fitness, to build a balanced program.  
7. Physical activity - There was no evidence that one type of activity is superior to 
another for axSpA. The relationships between physical activity, inflammatory 
autoimmune disease and the local manifestations of axSpA require further 
clarification, however, it is now clear that appropriate amounts of exercise can be anti-
inflammatory in effect [8].  
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8. Dosage - The conclusion was made that mobility exercise needs to repeated frequently 
and consistently (at least on most days). The need to address dosage for different 
exercise types and aim for physiological effectiveness whilst simultaneously adapting 
dosage to an individual’s disease presentation, and changing needs, was also 
recognised. This concept of “just right” dosage has recently been discussed in the 
context of new information concerning axSpA biomechanics [9] (Figure 6.1). 
 
Figure 6.1 Postulated ‘ideal’ exercise dosage range in healthy people and those 
with, or susceptible to, axSpA 
 
 
 
 
Blue zone = low physical activity/ inadequate muscle strength 
Red zone = high physical activity/ musculo-skeletal ‘overload’. 
It is proposed that the “Goldilocks” or ‘just right’ zone is smaller for those with axSpA – 
range represented by the solid lines, compared to those without axSpA, represented by dotted 
lines   
 
From Debusschere (2018) Born to run: The paradox of biomechanical force in 
spondyloarthritis from an evolutionary perspective; used with permission (granted 10/10/18) 
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9. Adherence. The importance of addressing adherence as part of therapy was 
acknowledged - although the supporting evidence was mainly found in the general 
arthritis literature. A more recent RCT, however, has assessed the impact of a 
behavioural change intervention in axSpA, finding that physical activity, mobility and 
quality of life improved significantly, and this improvement was maintained at three 
months [10] – thus directly supporting this recommendation.  
10. Setting. Several RCTs compare exercise settings, rather than exercise types, and the 
CS panel concluded that a number of settings, such as in-patient or group 
physiotherapy or hydrotherapy, were difficult to access in Australia. Consensus 
opinion also prioritised patient choice and enjoyment in association with sustained 
adherence. For these reasons, a consensus-based (rather than evidence based) 
recommendation (CBR) was made regarding exercise setting.  
The recommendations appear to be translating into clinical practice, having been referenced 
in the TGL Therapeutic Guidelines: Rheumatology (3rd Edition) [11], and recommended by 
the patient support groups in the USA and Germany, including translation into the German 
language by the latter group.   
Framework 
A novel feature of the paper presented in Chapter 3 was the representation of the requirements 
for exercise prescription in a framework (Figure 3.1). The purpose of the framework is to 
highlight the relationship of, and interaction between, the different components. For example, 
exercises which improve thoracic spine mobility may allow better biomechanical positioning 
of the shoulder girdle muscles, so that muscle strength may be improved. This in turn may 
enhance motivation to perform a complementary physical activity, such as swimming – 
leading to increased lifestyle integration of exercise and thus facilitating sustained adherence. 
The arrows indicate that the process is dynamic and requires ongoing review and progression, 
in order to optimise physiological effectiveness. This framework has been cited by the 
American Spondylitis Society [12] and been used for teaching purposes by presentation at 
specialist physiotherapy courses in the United Kingdom, and adapted as patient education 
resource (Figure 6.2). 
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Figure 6.2 Adaptation of the exercise framework (Figure 3.1) as an exercise planning tool 
 
 
 
Paraspinal muscles in axSpA 
A significant gap in the evidence for exercise in SpA was identified – there was a paucity of 
information regarding exercises that might strengthen muscles, including those that would be 
physiologically effective in strengthening trunk muscles. It is generally accepted that 
strengthening exercises are important for the maintenance of health, especially from middle 
life onwards [13]. However, in order to design axSpA-specific, effective exercise regimes, 
more information is also required about the muscles themselves, and any changes they 
undergo as part of, or consequent to, the inflammatory disease process. This foundation 
knowledge is particularly important within the lumbo-pelvic region, where the complex 
biomechanics play an essential role in normal movement, and where enthesitis (the 
fundamental pathophysiological disease process in axSpA), is thought to be influenced by 
biomechanical strain.  
 
Our study to examine the paraspinal muscles in axSpA, presented in Chapter 5, therefore 
provided some novel information,that points to potentially productive lines of enquiry 
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regarding future trials of axSpA-specific strengthening exercises. The major finding is that 
lumbar paraspinal muscle tissue is commonly replaced by adipose tissue. This change is 
apparent symmetrically, in both main muscle groups and most pronounced at the lower 
lumbar levels. IMAT is a significant predictor of muscle function and overall mobility and 
physical function. In the lumbar spine, such changes make it likely that the muscles are 
weaker and that their function as spinal stabilisers is diminished, due to the reduction in 
functional muscle mass. Since IMAT and other muscle changes are potentially modifiable by 
exercise, there is a rationale to support potential improved biomechanics in axSpA, linking 
back to the relationship between biomechanical stress and disease process. Of particular 
interest is the concept of a ‘just right’ amount of biomechanical compression or loading, in 
which the paraspinal muscles play a key role.  
 
Recent research attention has also highlighted the presence of intermuscular adipose tissue as 
an indicator of systemic inflammatory state, general wellness and longevity [14-15]. 
Therefore, in addition to indicating a target for further evaluation of novel exercise strategies, 
the results may also have implications for our understanding of axSpA pathophysiology and 
its relationships with co-morbidities, such as osteoporosis and cardiovascular disease [16].  
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Chapter 7: Future directions 
This thesis has highlighted a number of limitations and research gaps regarding exercise for 
people with axSpA. The high personal commitment for individuals in adapting to lifelong 
exercise advice, high socioeconomic costs of this disease, recent insights into axSpA 
biomechanics, and increased understanding of the importance of physical exercise for the 
maintenance of health all paint to the need for greater clarity in exercise advice.  
7.1 Research recommendations 
Exercise advice 
In general, larger RCTs would allow for stratification of exercise interventions for different 
groups: appropriate exercise advice for a young adult who has low disease activity, and good 
axial mobility, is likely to be different to that for an older adult who has total spinal ankylosis. 
No studies were identified that specifically targeted either group. Addressing the paucity of 
longer duration studies, and including longitudinally measured outcomes, would provide 
much needed insight into the interactions (if any) between exercise and axSpA structural 
progression and disease activity. The role of emerging new serum markers for inflammation 
in evaluating the relationship between exercise and inflammation in axSpA [1], could also be 
explored. Greater attention should be paid to the design of exercise programs, in particular, 
dosage. Chapter 1 discussed how exercise dosage may require initial adaptation (reduction) 
due to the presence of symptoms, primarily pain, and yet exercise dosage in many studies was 
insufficient to produce the physiological change that was being measured. Studies of longer 
duration would allow assessment of interventions that started from a lower exercise baseline 
and were appropriately progressed to a more physiologically effective dose. 
The largely theoretical concern around exercise type and intensity in relation to 
biomechanical force in axSpA is encapsulated in a recent review [2]. Clarification is highly 
important, in order that the message about optimising exercise type does not inadvertently 
generate misinformation, with the unintended consequence of fewer people with axSpA 
benefitting from exercise. Thus evaluation of an exercise program that specifically aims to 
improve spinal stability without adding to compressive biomechanical stresses, is highly 
desirable.  
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Exercise Planning 
People with other arthritis/ inflammatory conditions experience similar challenges when 
attempting to integrate exercise into their lifestyles as people with axSpA [3-6]. The exercise 
framework presented in chapter 3 is adaptable as a client-centred planning tool, and this could 
be evaluated with people who have a range of conditions, with a view to facilitating safe and 
effective exercise practice across the broader population with chronic conditions. 
The impact of exercise on disease 
Chapter 5 discussed the paucity of information regarding muscle pathophysiology in axSpA, 
and its possible relationship with disease development and progression. A further unknown is 
whether the disease has any impact on trunk muscle motor control (or vice versa) - that is, the 
ability to appropriately recruit muscles in a coordinated manner, in order to continuously 
adjust to compression/ shearing forces. This could be tested using real-time ultrasound 
techniques that have been validated in other groups [7, 8].  Further MRI studies, perhaps 
examining trunk muscle volume longitudinally, could elucidate changes, and their 
relationship to physical activity, structural progression and comorbidities such as spinal 
osteoporosis.  
Exercise, bDMARDs and cost-effectiveness 
In the era of bDMARDs, many countries (including Australia) have seen a transition of 
rheumatology care from a hospital or rehabilitation centre in-patient setting, to out-patient or 
community care. At the same time, the large effect size of bDMARDs on disease activity (for 
most people), has led to a decreased emphasis on exercise as an integral management strategy 
[9]. A number of reasons why it is be important to retain knowledge about, and funding for, 
exercise advice have been discussed in this thesis. However, the large disparity in funding (for 
both research and interventions) between pharmacological and non-pharmacological therapy 
is only likely to be narrowed if there is sufficient high-quality evidence for the effectiveness 
of exercise. Further research into the interactions of exercise and bDMARDs could provide 
useful information for funders.  
It is known that exercise and bDMARDs have some similarities in effects of action at 
microscopic level, such as inhibition of pro-inflammatory cytokines [10] and that they appear 
synergistic in effect [11]. The latter studies have led to the suggestion that exercise may 
enhance the cost-effectiveness of bDMARDs, by enabling dose reduction [12] – such a 
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finding could support the retention of exercise as integral to disease management in axSpA. It 
is also plausible that adequate exercise may allow for bDMARD dose tapering - increasing 
cost effectiveness and potentially allowing easing of the criteria for accessing these drugs. 
7.2 Conclusion 
Systematic reviews and meta-analysis provided sufficient information to inform the 
development of ten specific recommendations to guide health professionals’ exercise advice 
for people with axSpA. The recommendations were the first to specifically address: exercise-
related assessment and monitoring; safety; concurrent medication use; mobility, functional 
(including strength) and cardio-respiratory exercise; dosage; adherence and setting. A 
framework was developed that facilitates adaptation of the recommendations to each 
individual’s presentation. Information about muscle pathophysiology and function in axSpA 
was prominent amongst a number of identified knowledge gaps. An exploratory study 
indicated that paraspinal muscle fitness is sub-optimal and thus is a potential target for future 
axSpA exercise studies. 
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